Yield-related polynucleotides and polypeptides in plants

ABSTRACT

The invention relates to plant transcription factor polypeptides, polynucleotides that encode them, homologs from a variety of plant species, and methods of using the polynucleotides and polypeptides to produce transgenic plants having advantageous properties compared to a reference plant. Sequence information related to these polynucleotides and polypeptides can also be used in bioinformatic search methods and is also disclosed.

This application claims the benefit of U.S. Non-provisional Application No. Ser. 09/837,444, filed Apr. 18, 2001, U.S. Provisional Application No. 60/310,847, filed Aug. 9, 2001, U.S. Provisional Application No. 60/336,049, filed Dec. 5, 2001, U.S. Provisional Application No. 60/338,692, filed Dec. 11, 2001, and U.S. Non-provisional Application Ser. No. 10/171,468, filed Jun. 14, 2002, the entire contents of which are hereby incorporated by reference.

FIELD OF THE INVENTION

This invention relates to the field of plant biology. More particularly, the present invention pertains to compositions and methods for phenotypically modifying a plant.

INTRODUCTION

A plant's traits, such as its biochemical, developmental, or phenotypic characteristics, may be controlled through a number of cellular processes. One important way to manipulate that control is through transcription factors—proteins that influence the expression of a particular gene or sets of genes. Transformed and transgenic plants that comprise cells having altered levels of at least one selected transcription factor, for example, possess advantageous or desirable traits. Strategies for manipulating traits by altering a plant cell's transcription factor content can therefore result in plants and crops with commercially valuable properties. Applicants have identified polynucleotides encoding transcription factors, developed numerous transgenic plants using these polynucleotides, and have analyzed the plants for a variety of important traits. In so doing, applicants have identified important polynucleotide and polypeptide sequences for producing commercially valuable plants and crops as well as the methods for making them and using them. Other aspects and embodiments of the invention are described below and can be derived from the teachings of this disclosure as a whole.

BACKGROUND OF THE INVENTION

Transcription factors can modulate gene expression, either increasing or decreasing (inducing or repressing) the rate of transcription. This modulation results in differential levels of gene expression at various developmental stages, in different tissues and cell types, and in response to different exogenous (e.g., environmental) and endogenous stimuli throughout the life cycle of the organism.

Because transcription factors are key controlling elements of biological pathways, altering the expression levels of one or more transcription factors can change entire biological pathways in an organism. For example, manipulation of the levels of selected transcription factors may result in increased expression of economically useful proteins or metabolic chemicals in plants or to improve other agriculturally relevant characteristics. Conversely, blocked or reduced expression of a transcription factor may reduce biosynthesis of unwanted compounds or remove an undesirable trait. Therefore, manipulating transcription factor levels in a plant offers tremendous potential in agricultural biotechnology for modifying a plant's traits.

The present invention provides novel transcription factors useful for modifying a plant's phenotype in desirable ways.

SUMMARY OF THE INVENTION

In a first aspect, the invention relates to a recombinant polynucleotide comprising a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding a polypeptide comprising a polypeptide sequence selected from those of the Sequence Listing, SEQ ID NOs: 2 to 2N, where N=2-561, or those listed in Table 4, or a complementary nucleotide sequence thereof; (b) a nucleotide sequence encoding a polypeptide comprising a variant of a polypeptide of (a) having one or more, or between 1 and about 5, or between 1 and about 10, or between 1 and about 30, conservative amino acid substitutions; (c) a nucleotide sequence comprising a sequence selected from those of SEQ ID NOs: 1 to (2N −1), where N=2−561, or those included in Table 4, or a complementary nucleotide sequence thereof; (d) a nucleotide sequence comprising silent substitutions in a nucleotide sequence of (c); (e) a nucleotide sequence which hybridizes under stringent conditions over substantially the entire length of a nucleotide sequence of one or more of: (a), (b), (c), or (d); (f) a nucleotide sequence comprising at least 10 or 15, or at least about 20, or at least about 30 consecutive nucleotides of a sequence of any of (a)-(e), or at least 10 or 15, or at least about 20, or at least about 30 consecutive nucleotides outside of a region encoding a conserved domain of any of (a)-(e); (g) a nucleotide sequence comprising a subsequence or fragment of any of (a)-(f), which subsequence or fragment encodes a polypeptide having a biological activity that modifies a plant's characteristic, functions as a transcription factor, or alters the level of transcription of a gene or transgene in a cell; (h) a nucleotide sequence having at least 31% sequence identity to a nucleotide sequence of any of (a)-(g); (i) a nucleotide sequence having at least 60%, or at least 70%, or at least 80%, or at least 90%, or at least 95% sequence identity to a nucleotide sequence of any of (a)-(g) or a 10 or 15 nucleotide, or at least about 20, or at least about 30 nucleotide region of a sequence of (a)-(g) that is outside of a region encoding a conserved domain; (j) a nucleotide sequence that encodes a polypeptide having at least 31% sequence identity to a polypeptide listed in Table 4, or the Sequence Listing; (k) a nucleotide sequence which encodes a polypeptide having at least 60%, or at least 70%, or at least 80%, or at least 90%, or at least 95% sequence identity to a polypeptide listed in Table 4, or the Sequence Listing; and (I) a nucleotide sequence that encodes a conserved domain of a polypeptide having at least 85%, or at least 90%, or at least 95%, or at least 98% sequence identity to a conserved domain of a polypeptide listed in Table 4, or the Sequence Listing. The recombinant polynucleotide may further comprise a constitutive, inducible, or tissue-specific promoter operably linked to the nucleotide sequence. The invention also relates to compositions comprising at least two of the above-described polynucleotides.

In a second aspect, the invention comprises an isolated or recombinant polypeptide comprising a subsequence of at least about 10, or at least about 15, or at least about 20, or at least about 30 contiguous amino acids encoded by the recombinant or isolated polynucleotide described above, or comprising a subsequence of at least about 8, or at least about 12, or at least about 15, or at least about 20, or at least about 30 contiguous amino acids outside a conserved domain.

In a third aspect, the invention comprises an isolated or recombinant polynucleotide that encodes a polypeptide that is a paralog of the isolated polypeptide described above. In one aspect, the invention is an paralog which, when expressed in Arabidopsis, modifies a trait of the Arabidopsis plant.

In a fourth aspect, the invention comprises an isolated or recombinant polynucleotide that encodes a polypeptide that is an ortholog of the isolated polypeptide described above. In one aspect, the invention is an ortholog which, when expressed in Arabidopsis, modifies a trait of the Arabidopsis plant.

In a fifth aspect, the invention comprises an isolated polypeptide that is a paralog of the isolated polypeptide described above. In one aspect, the invention is an paralog which, when expressed in Arabidopsis, modifies a trait of the Arabidopsis plant.

In a sixth aspect, the invention comprises an isolated polypeptide that is an ortholog of the isolated polypeptide described above. In one aspect, the invention is an ortholog which, when expressed in Arabidopsis, modifies a trait of the Arabidopsis plant.

The present invention also encompasses transcription factor variants. A preferred transcription factor variant is one having at least 40% amino acid sequence identity, a more preferred transcription factor variant is one having at least 50% amino acid sequence identity and a most preferred transcription factor variant is one having at least 65% amino acid sequence identity to the transcription factor amino acid sequence SEQ ID NOs: 2 to 2N, where N=2-561, and which contains at least one functional or structural characteristic of the transcription factor amino acid sequence. Sequences having lesser degrees of identity but comparable biological activity are considered to be equivalents.

In another aspect, the invention is a transgenic plant comprising one or more of the above-described isolated or recombinant polynucleotides. In yet another aspect, the invention is a plant with altered expression levels of a polynucleotide described above or a plant with altered expression or activity levels of an above-described polypeptide. Further, the invention is a plant lacking a nucleotide sequence encoding a polypeptide described above or substantially lacking a polypeptide described above. The plant may be any plant, including, but not limited to, Arabidopsis, mustard, soybean, wheat, corn, potato, cotton, rice, oilseed rape, sunflower, alfalfa, sugarcane, turf, banana, blackberry, blueberry, strawberry, raspberry, cantaloupe, carrot, cauliflower, coffee, cucumber, eggplant, grapes, honeydew, lettuce, mango, melon, onion, papaya, peas, peppers, pineapple, pumpkin, spinach, squash, sweet corn, tobacco, tomato, watermelon, rosaceous fruits, vegetable brassicas, and mint or other labiates. In yet another aspect, the inventions is an isolated plant material of a plant, including, but not limited to, plant tissue, fruit, seed, plant cell, embryo, protoplast, pollen, and the like. In yet another aspect, the invention is a transgenic plant tissue culture of regenerable cells, including, but not limited to, embryos, meristematic cells, microspores, protoplast, pollen, and the like.

In yet another aspect the invention is a transgenic plant comprising one or more of the above described polynucleotides wherein the encoded polypeptide is expressed and regulates transcription of a gene.

In a further aspect the invention provides a method of using the polynucleotide composition to breed a progeny plant from a transgenic plant including crossing plants, producing seeds from transgenic plants, and methods of breeding using transgenic plants, the method comprising transforming a plant with the polynucleotide composition to create a transgenic plant, crossing the transgenic plant with another plant, selecting seed, and growing the progeny plant from the seed.

In a further aspect, the invention provides a progeny plant derived from a parental plant wherein said progeny plant exhibits at least three fold greater messenger RNA levels than said parental plant, wherein the messenger RNA encodes a DNA-binding protein which is capable of binding to a DNA regulatory sequence and inducing expression of a plant trait gene, wherein the progeny plant is characterized by a change in the plant trait compared to said parental plant. In yet a further aspect, the progeny plant exhibits at least ten fold greater messenger RNA levels compared to said parental plant. In yet a further aspect, the progeny plant exhibits at least fifty fold greater messenger RNA levels compared to said parental plant.

In a further aspect, the invention relates to a cloning or expression vector comprising the isolated or recombinant polynucleotide described above or cells comprising the cloning or expression vector.

In yet a further aspect, the invention relates to a composition produced by incubating a polynucleotide of the invention with a nuclease, a restriction enzyme, a polymerase; a polymerase and a primer; a cloning vector, or with a cell.

Furthermore, the invention relates to a method for producing a plant having a modified trait. The method comprises altering the expression of an isolated or recombinant polynucleotide of the invention or altering the expression or activity of a polypeptide of the invention in a plant to produce a modified plant, and selecting the modified plant for a modified trait. In one aspect, the plant is a monocot plant. In another aspect, the plant is a dicot plant. In another aspect the recombinant polynucleotide is from a dicot plant and the plant is a monocot plant. In yet another aspect the recombinant polynucleotide is from a monocot plant and the plant is a dicot plant. In yet another aspect the recombinant polynucleotide is from a monocot plant and the plant is a monocot plant. In yet another aspect the recombinant polynucleotide is from a dicot plant and the plant is a dicot plant.

In another aspect, the invention is a transgenic plant comprising an isolated or recombinant polynucleotide encoding a polypeptide wherein the polypeptide is selected from the group consisting of SEQ ID NOs: 2-2N, where N=2-561. In yet another aspect, the invention is a plant with altered expression levels of a polypeptide described above or a plant with altered expression or activity levels of an above-described polypeptide. Further, the invention is a plant lacking a polynucleotide sequence encoding a polypeptide described above or substantially lacking a polypeptide described above. The plant may be any plant, including, but not limited to, Arabidopsis, mustard, soybean, wheat, corn, potato, cotton, rice, oilseed rape, sunflower, alfalfa, sugarcane, turf, banana, blackberry, blueberry, strawberry, raspberry, cantaloupe, carrot, cauliflower, coffee, cucumber, eggplant, grapes, honeydew, lettuce, mango, melon, onion, papaya, peas, peppers, pineapple, pumpkin, spinach, squash, sweet corn, tobacco, tomato, watermelon, rosaceous fruits, vegetable brassicas, and mint or other labiates. In yet another aspect, the inventions is an isolated plant material of a plant, including, but not limited to, plant tissue, fruit, seed, plant cell, embryo, protoplast, pollen, and the like. In yet another aspect, the invention is a transgenic plant tissue culture of regenerable cells, including, but not limited to, embryos, meristematic cells, microspores, protoplast, pollen, and the like.

In another aspect, the invention relates to a method of identifying a factor that is modulated by or interacts with a polypeptide encoded by a polynucleotide of the invention. The method comprises expressing a polypeptide encoded by the polynucleotide in a plant; and identifying at least one factor that is modulated by or interacts with the polypeptide. In one embodiment the method for identifying modulating or interacting factors is by detecting binding by the polypeptide to a promoter sequence, or by detecting interactions between an additional protein and the polypeptide in a yeast two hybrid system, or by detecting expression of a factor by hybridization to a microarray, subtractive hybridization, or differential display.

In yet another aspect, the invention is a method of identifying a molecule that modulates activity or expression of a polynucleotide or polypeptide of interest. The method comprises placing the molecule in contact with a plant comprising the polynucleotide or polypeptide encoded by the polynucleotide of the invention and monitoring one or more of the expression level of the polynucleotide in the plant, the expression level of the polypeptide in the plant, and modulation of an activity of the polypeptide in the plant.

In yet another aspect, the invention relates to an integrated system, computer or computer readable medium comprising one or more character strings corresponding to a polynucleotide of the invention, or to a polypeptide encoded by the polynucleotide. The integrated system, computer or computer readable medium may comprise a link between one or more sequence strings to a modified plant trait.

In yet another aspect, the invention is a method for identifying a sequence similar or homologous to one or more polynucleotides of the invention, or one or more polypeptides encoded by the polynucleotides. The method comprises providing a sequence database, and querying the sequence database with one or more target sequences corresponding to the one or more polynucleotides or to the one or more polypeptides to identify one or more sequence members of the database that display sequence similarity or homology to one or more of the one or more target sequences.

The method may further comprise of linking the one or more of the polynucleotides of the invention, or encoded polypeptides, to a modified plant phenotype.

BRIEF DESCRIPTION OF THE SEQUENCE LISTING, TABLES, AND FIGURE

The Sequence Listing provides exemplary polynucleotide and polypeptide sequences of the invention. The traits associated with the use of the sequences are included in the Examples.

CD-ROM1 (Copy 1) is a read-only memory computer-readable compact disc and contains a copy of the Sequence Listing in ASCII text format. The Sequence Listing is named “Seq Listing.txt” and is 923 kilobytes in size. The copies of the Sequence Listing on the CD-ROM disc are hereby incorporated by reference in their entirety.

CD-ROM2 (Copy 2) is an exact copy of CD-R1 (Copy 1).

CD-ROM3 contains a CRF copy of the Sequence Listing as a text (.txt) file and is 1846 kilobytes in size.

Table 4 shows the polynucleotides and polypeptides identified by SEQ ID NO; Mendel Gene ID No.; conserved domain of the polypeptide; and if the polynucleotide was tested in a transgenic assay. The first column shows the polynucleotide SEQ ID NO; the second column shows the Mendel Gene ID No., GID; the third column shows the trait(s) resulting from the knock out or overexpression of the polynucleotide in the transgenic plant; the fourth column shows the category of the trait; the fifth column shows the transcription factor family to which the polynucleotide belongs; the sixth column (“Comment”), includes specific effects and utilities conferred by the polynucleotide of the first column; the seventh column shows the SEQ ID NO of the polypeptide encoded by the polynucleotide; and the eighth column shows the amino acid residue positions of the conserved domain in amino acid (AA) co-ordinates.

Table 5 lists a summary of orthologous and homologous sequences identified BLAST (tblastx program). The first column shows the polynucleotide sequence identifier (SEQ ID NO), the second column shows the corresponding cDNA identifier (Gene ID), the third column shows the orthologous or homologous polynucleotide GenBank Accession Number (Test Sequence ID), the fourth column shows the calculated probability value that the sequence identity is due to chance (Smallest Sum Probability), the fifth column shows the plant species from which the test sequence was isolated (Test Sequence Species), and the sixth column shows the orthologous or homologous test sequence GenBank annotation (Test Sequence GenBank Annotation).

FIG. 1 shows a phylogenic tree of related plant families adapted from Daly et al. (2001 Plant Physiology 127:1328-1333).

DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS

In an important aspect, the present invention relates to polynucleotides and polypeptides, e.g. for modifying phenotypes of plants. Throughout this disclosure, various information sources are referred to and/or are specifically incorporated. The information sources include scientific journal articles, patent documents, textbooks, and World Wide Web browser-inactive page addresses, for example. While the reference to these information sources clearly indicates that they can be used by one of skill in the art, applicants specifically incorporate each and every one of the information sources cited herein, in their entirety, whether or not a specific mention of “incorporation by reference” is noted. The contents and teachings of each and every one of the information sources can be relied on and used to make and use embodiments of the invention.

It must be noted that as used herein and in the appended claims, the singular forms “a,” “an,” and “the” include plural reference unless the context clearly dictates otherwise. Thus, for example, a reference to “a plant” includes a plurality of such plants, and a reference to “a stress” is a reference to one or more stresses and equivalents thereof known to those skilled in the art, and so forth.

The polynucleotide sequences of the invention encode polypeptides that are members of well-known transcription factor families, including plant transcription factor families, as disclosed in Table 4. Generally, the transcription factors encoded by the present sequences are involved in cell differentiation and proliferation and the regulation of growth. Accordingly, one skilled in the art would recognize that by expressing the present sequences in a plant, one may change the expression of autologous genes or induce the expression of introduced genes. By affecting the expression of similar autologous sequences in a plant that have the biological activity of the present sequences, or by introducing the present sequences into a plant, one may alter a plant's phenotype to one with improved traits. The sequences of the invention may also be used to transform a plant and introduce desirable traits not found in the wild-type cultivar or strain. Plants may then be selected for those that produce the most desirable degree of over- or underexpression of target genes of interest and coincident trait improvement.

The sequences of the present invention may be from any species, particularly plant species, in a naturally occurring form or from any source whether natural, synthetic, semi-synthetic or recombinant. The sequences of the invention may also include fragments of the present amino acid sequences. In this context, a “fragment” refers to a fragment of a polypeptide sequence which is at least 5 to about 15 amino acids in length, most preferably at least 14 amino acids, and which retain some biological activity of a transcription factor. Where “amino acid sequence” is recited to refer to an amino acid sequence of a naturally occurring protein molecule, “amino acid sequence” and like terms are not meant to limit the amino acid sequence to the complete native amino acid sequence associated with the recited protein molecule.

As one of ordinary skill in the art recognizes, transcription factors can be identified by the presence of a region or domain of structural similarity or identity to a specific consensus sequence or the presence of a specific consensus DNA-binding site or DNA-binding site motif (see, for example, Riechmann et al., (2000) Science 290: 2105-2110). The plant transcription factors may belong to one of the following transcription factor families: the AP2 (APETALA2) domain transcription factor family (Riechmann and Meyerowitz (1998) Biol. Chem. 379:633-646); the MYB transcription factor family (Martin and Paz-Ares, (1997) Trends Genet. 13:67-73); the MADS domain transcription factor family (Riechmann and Meyerowitz (1997) Biol. Chem. 378:1079-1101); the WRKY protein family (Ishiguro and Nakamura (1994) Mol. Gen. Genet. 244:563-571); the ankyrin-repeat protein family (Zhang et al. (1992) Plant Cell 4:1575-1588); the zinc finger protein (Z) family (Klug and Schwabe (1995) FASEB J. 9: 597-604); the homeobox (HB) protein family (Buerglin in Guidebook to the Homeobox Genes, Duboule (ed.) (1994) Oxford University Press); the CAAT-element binding proteins (Forsburg and Guarente (1989) Genes Dev. 3:1166-1178); the squamosa promoter binding proteins (SPB) (Klein et al. (1996) Mol. Gen. Genet. 1996 250:7-16); the NAM protein family (Souer et al. (1996) Cell 85:159-170); the IAA/AUX proteins (Rouse et al. (1998) Science 279:1371-1373); the HLH/MYC protein family (Littlewood et al. (1994) Prot. Profile 1:639-709); the DNA-binding protein (DBP) family (Tucker et al. (1994) EMBO J. 13:2994-3002); the bZIP family of transcription factors (Foster et al. (1994) FASEB J. 8:192-200); the Box P-binding protein (the BPF-1) family (da Costa e Silva et al. (1993) Plant J. 4:125-135); the high mobility group (HMG) family (Bustin and Reeves (1996) Prog. Nucl. Acids Res. Mol. Biol. 54:35-100); the scarecrow (SCR) family (Di Laurenzio et al. (1996) Cell 86:423-433); the GF14 family (Wu et al. (1997) Plant Physiol. 114:1421-1431); the polycomb (PCOMB) family (Kennison (1995) Annu. Rev. Genet. 29:289-303); the teosinte branched (TEO) family (Luo et al. (1996) Nature 383:794-799; the AB13 family (Giraudat et al. (1992) Plant Cell 4:1251-1261); the triple helix (TH) family (Dehesh et al. (1990) Science 250:1397-1399); the EIL family (Chao et al. (1997) Cell 89:1133-44); the AT-HOOK family (Reeves and Nissen (1990) J. Biol. Chem. 265:8573-8582); the SIFA family (Zhou et al. (1995) Nucleic Acids Res. 23:1165-1169); the bZIPT2 family (Lu and Ferl (1995) Plant Physiol. 109:723); the YABBY family (Bowman et al. (1999) Development 126:2387-96); the PAZ family (Bohmert et al. (1998) EMBO J. 17:170-80); a family of miscellaneous (MISC) transcription factors including the DPBF family (Kim et al. (1997) Plant J. 11:1237-1251) and the SPFI family (Ishiguro and Nakamura (1994) Mol. Gen. Genet. 244:563-571); the golden (GLD) family (Hall et al. (1998) Plant Cell 10:925-936), the TUBBY family (Boggin et al, (1999) Science 286:2119-2125), the heat shock family (Wu C (1995)Annu Rev Cell Dev Biol 11:441-469), the ENBP family (Christiansen et al (1996) Plant Mol Biol 32:809-821), the RING-zinc family (Jensen et al. (1998) FEBS letters 436:283-287), the PDBP family (Janik et al Virology. (1989) 168:320-329), the PCF family (Cubas P, et al. Plant J. (1999) 18:215-22), the SRS (SHI-related) family (Fridborg et al Plant Cell (1999) 11:1019-1032), the CPP (cysteine-rich polycomb-like) family (Cvitanich et al Proc. Natl. Acad. Sci. USA. (2000) 97:8163-8168), the ARF (auxin response factor) family (Ulmasov, et al. (1999) Proc. Natl. Acad. Sci. USA 96: 5844-5849), the SWI/SNF family (Collingwood et al J. Mol. End. 23:255-275), the ACBF family (Seguin et al (1997) Plant Mol Biol. 35:281-291), PCGL (CG-1 like) family (da Costa e Silva et al. (1994) Plant Mol Biol. 25:921-924) the ARID family (Vazquez et al. (1999) Development. 126: 733-42), the Jumonji family, Balciunas et al (2000, Trends Biochem Sci. 25: 274-276), the bZIP-NIN family (Schauser et al (1999) Nature 402: 191-195), the E2F family Kaelin et al (1992) Cell 70: 351-364) and the GRF-like fam ily (Knaap et al (2000) Plant Physiol. 122: 695-704). As indicated by any part of the list above and as known in the art, transcription factors have been sometimes categorized by class, family, and sub-family according to their structural content and consensus DNA-binding site motif, for example. Many of the classes and many of the families and sub-families are listed here. However, the inclusion of one sub-family and not another, or the inclusion of one family and not another, does not mean that the invention does not encompass polynucleotides or polypeptides of a certain family or sub-family. The list provided here is merely an example of the types of transcription factors and the knowledge available concerning the consensus sequences and consensus DNA-binding site motifs that help define them as known to those of skill in the art (each of the references noted above are specifically incorporated herein by reference). A transcription factor may include, but is not limited to, any polypeptide that can activate or repress transcription of a single gene or a number of genes. This polypeptide group includes, but is not limited to. DNA-binding proteins. DNA-binding protein binding proteins, protein kinases, protein phosphatases, GTP-binding proteins, and receptors, and the like.

In addition to methods for modifying a plant phenotype by employing one or more polynucleotides and polypeptides of the invention described herein, the polynucleotides and polypeptides of the invention have a variety of additional uses. These uses include their use in the recombinant production (i.e., expression) of proteins; as regulators of plant gene expression, as diagnostic probes for the presence of complementary or partially complementary nucleic acids (including for detection of natural coding nucleic acids); as substrates for further reactions, e.g., mutation reactions, PCR reactions, or the like; as substrates for cloning e.g., including digestion or ligation reactions; and for identifying exogenous or endogenous modulators of the transcription factors. A “polynucleotide” is a nucleic acid sequence comprising a plurality of polymerized nucleotides, e.g., at least about 15 consecutive polymerized nucleotides, optionally at least about 30 consecutive nucleotides, at least about 50 consecutive nucleotides. In many instances, a polynucleotide comprises a nucleotide sequence encoding a polypeptide (or protein) or a domain or fragment thereof. Additionally, the polynucleotide may comprise a promoter, an intron, an enhancer region, a polyadenylation site, a translation initiation site, 5′ or 3′ untranslated regions, a reporter gene, a selectable marker, or the like. The polynucleotide can be single stranded or double stranded DNA or RNA. The polynucleotide optionally comprises modified bases or a modified backbone. The polynucleotide can be, e.g., genomic DNA or RNA, a transcript (such as an mRNA), a cDNA, a PCR product, a cloned DNA, a synthetic DNA or RNA, or the like. The polynucleotide can comprise a sequence in either sense or antisense orientations.

A “recombinant polynucleotide” is a polynucleotide that is not in its native state, e.g., the polynucleotide comprises a nucleotide sequence not found in nature, or the polynucleotide is in a context other than that in which it is naturally found, e.g., separated from nucleotide sequences with which it typically is in proximity in nature, or adjacent (or contiguous with) nucleotide sequences with which it typically is not in proximity. For example, the sequence at issue can be cloned into a vector, or otherwise recombined with one or more additional nucleic acid.

An “isolated polynucleotide” is a polynucleotide whether naturally occurring or recombinant, that is present outside the cell in which it is typically found in nature, whether purified or not. Optionally, an isolated polynucleotide is subject to one or more enrichment or purification procedures, e.g., cell lysis, extraction, centrifugation, precipitation, or the like.

A “polypeptide” is an amino acid sequence comprising a plurality of consecutive polymerized amino acid residues e.g., at least about 15 consecutive polymerized amino acid residues, optionally at least about 30 consecutive polymerized amino acid residues, at least about 50 consecutive polymerized amino acid residues. In many instances, a polypeptide comprises a polymerized amino acid residue sequence that is a transcription factor or a domain or portion or fragment thereof. Additionally, the polypeptide may comprise a localization domain, 2) an activation domain, 3) a repression domain, 4) an oligomerization domain or 5) a DNA-binding domain, or the like. The polypeptide optionally comprises modified amino acid residues, naturally occurring amino acid residues not encoded by a codon, non-naturally occurring amino acid residues.

A “recombinant polypeptide” is a polypeptide produced by translation of a recombinant polynucleotide. A “synthetic polypeptide” is a polypeptide created by consecutive polymerization of isolated amino acid residues using methods well known in the art. An “isolated polypeptide,” whether a naturally occurring or a recombinant polypeptide, is more enriched in (or out of) a cell than the polypeptide in its natural state in a wild type cell, e.g., more than about 5% enriched, more than about 10% enriched, or more than about 20%, or more than about 50%, or more, enriched, i.e., alternatively denoted: 105%, 110%, 120%, 150% or more, enriched relative to wild type standardized at 100%. Such an enrichment is not the result of a natural response of a wild type plant. Alternatively, or additionally, the isolated polypeptide is separated from other cellular components with which it is typically associated, e.g., by any of the various protein purification methods herein.

“Identity” or “similarity” refers to sequence similarity between two polynucleotide sequences or between two polypeptide sequences, with identity being a more strict comparison. The phrases “percent identity” and “% identity” refer to the percentage of sequence similarity found in a comparison of two or more polynucleotide sequences or two or more polypeptide sequences. Identity or similarity can be determined by comparing a position in each sequence that may be aligned for purposes of comparison. When a position in the compared sequence is occupied by the same nucleotide base or amino acid, then the molecules are identical at that position. A degree of similarity or identity between polynucleotide sequences is a function of the number of identical or matching nucleotides at positions shared by the polynucleotide sequences. A degree of identity of polypeptide sequences is a function of the number of identical amino acids at positions shared by the polypeptide sequences. A degree of homology or similarity of polypeptide sequences is a function of the number of amino acids, i.e., structurally related, at positions shared by the polypeptide sequences.

“Altered” nucleic acid sequences encoding polypeptide include those sequences with deletions, insertions, or substitutions of different nucleotides, resulting in a polynucleotide encoding a polypeptide with at least one functional characteristic of the polypeptide. Included within this definition are polymorphisms that may or may not be readily detectable using a particular oligonucleotide probe of the polynucleotide encoding polypeptide, and improper or unexpected hybridization to allelic variants, with a locus other than the normal chromosomal locus for the polynucleotide sequence encoding polypeptide. The encoded polypeptide protein may also be “altered”, and may contain deletions, insertions, or substitutions of amino acid residues that produce a silent change and result in a functionally equivalent polypeptide. Deliberate amino acid substitutions may be made on the basis of similarity in residue side chain chemistry, including, but not limited to, polarity, charge, solubility, hydrophobicity, hydrophilicity, and/or the amphipathic nature of the residues, as long as the biological activity of polypeptide is retained. For example, negatively charged amino acids may include aspartic acid and glutamic acid, positively charged amino acids may include lysine and arginine, and amino acids with uncharged polar head groups having similar hydrophilicity values may include leucine, isoleucine, and valine; glycine and alanine; asparagine and glutamine; serine and threonine; and phenylalanine and tyrosine. Alignments between different polypeptide sequences may be used to calculate “percentage sequence similarity”.

The term “plant” includes whole plants, shoot vegetative organs/structures (e.g., leaves, stems and tubers), roots, flowers and floral organs/structures (e.g., bracts, sepals, petals, stamens, carpels, anthers and ovules), seed (including embryo, endosperm, and seed coat) and fruit (the mature ovary), plant tissue (e.g., vascular tissue, ground tissue, and the like) and cells (e.g., guard cells, egg cells, and the like), and progeny of same. The class of plants that can be used in the method of the invention is generally as broad as the class of higher and lower plants amenable to transformation techniques, including angiosperms (monocotyledonous and dicotyledonous plants), gymnosperms, ferns, horsetails, psilophytes, lycophytes, bryophytes, and multicellular algae. (See for example, FIG. 1, adapted from Daly et al. 2001 Plant Physiology 127:1328-1333; and see also Tudge, C., The Variety of Life, Oxford University Press, New York, 2000, pp. 547-606.)

A “transgenic plant” refers to a plant that contains genetic material not found in a wild type plant of the same species, variety or cultivar. The genetic material may include a transgene, an insertional mutagenesis event (such as by transposon or T-DNA insertional mutagenesis), an activation tagging sequence, a mutated sequence, a homologous recombination event or a sequence modified by chimeraplasty. Typically, the foreign genetic material has been introduced into the plant by human manipulation, but any method can be used as one of skill in the art recognizes.

A transgenic plant may contain an expression vector or cassette. The expression cassette typically comprises a polypeptide-encoding sequence operably linked (i.e., under regulatory control of) to appropriate inducible or constitutive regulatory sequences that allow for the expression of polypeptide. The expression cassette can be introduced into a plant by transformation or by breeding after transformation of a parent plant. A plant refers to a whole plant as well as to a plant part, such as seed, fruit, leaf, or root, plant tissue, plant cells or any other plant material, e.g., a plant explant, as well as to progeny thereof, and to in vitro systems that mimic biochemical or cellular components or processes in a cell.

“Ectopic expression or altered expression” in reference to a polynucleotide indicates that the pattern of expression in, e.g., a transgenic plant or plant tissue, is different from the expression pattern in a wild type plant or a reference plant of the same species. The pattern of expression may also be compared with a reference expression pattern in a wild type plant of the same species. For example, the polynucleotide or polypeptide is expressed in a cell or tissue type other than a cell or tissue type in which the sequence is expressed in the wild type plant, or by expression at a time other than at the time the sequence is expressed in the wild type plant, or by a response to different inducible agents, such as hormones or environmental signals, or at different expression levels (either higher or lower) compared with those found in a wild type plant. The term also refers to altered expression patterns that are produced by lowering the levels of expression to below the detection level or completely abolishing expression. The resulting expression pattern can be transient or stable, constitutive or inducible. In reference to a polypeptide, the term “ectopic expression or altered expression” further may relate to altered activity levels resulting from the interactions of the polypeptides with exogenous or endogenous modulators or from interactions with factors or as a result of the chemical modification of the polypeptides.

A “fragment” or “domain,” with respect to a polypeptide, refers to a subsequence of the polypeptide. In some cases, the fragment or domain, is a subsequence of the polypeptide which performs at least one biological function of the intact polypeptide in substantially the same manner, or to a similar extent, as does the intact polypeptide. For example, a polypeptide fragment can comprise a recognizable structural motif or functional domain such as a DNA-binding site or domain that binds to a DNA promoter region, an activation domain, or a domain for protein-protein interactions. Fragments can vary in size from as few as 6 amino acids to the full length of the intact polypeptide, but are preferably at least about 30 amino acids in length and more preferably at least about 60 amino acids in length. In reference to a polynucleotide sequence, “a fragment” refers to any subsequence of a polynucleotide, typically, of at least about 15 consecutive nucleotides, preferably at least about 30 nucleotides, more preferably at least about 50 nucleotides, of any of the sequences provided herein.

The invention also encompasses production of DNA sequences that encode transcription factors and transcription factor derivatives, or fragments thereof, entirely by synthetic chemistry. After production, the synthetic sequence may be inserted into any of the many available expression vectors and cell systems using reagents well known in the art. Moreover, synthetic chemistry may be used to introduce mutations into a sequence encoding transcription factors or any fragment thereof.

A “conserved domain”, with respect to a polypeptide, refers to a domain within a transcription factor family which exhibits a higher degree of sequence homology, such as at least 65% sequence identity including conservative substitutions, and preferably at least 80% sequence identity, and more preferably at least 85%, or at least about 86%, or at least about 87%, or at least about 88%, or at least about 90%, or at least about 95%, or at least about 98% amino acid residue sequence identity of a polypeptide of consecutive amino acid residues. A fragment or domain can be referred to as outside a consensus sequence or outside a consensus DNA-binding site that is known to exist or that exists for a particular transcription factor class, family, or sub-family. In this case, the fragment or domain will not include the exact amino acids of a consensus sequence or consensus DNA-binding site of a transcription factor class, family or sub-family, or the exact amino acids of a particular transcription factor consensus sequence or consensus DNA-binding site. Furthermore, a particular fragment, region, or domain of a polypeptide, or a polynucleotide encoding a polypeptide, can be “outside a conserved domain” if all the amino acids of the fragment, region, or domain fall outside of a defined conserved domain(s) for a polypeptide or protein. The conserved domains for each of polypeptides of SEQ ID NOs: 2-2N, where N=2-561, are listed in Table 4 as described in Example VII. Also, many of the polypeptides of Table 4 have conserved domains specifically indicated by start and stop sites. A comparison of the regions of the polypeptides in SEQ ID NOs: 2-2N, where N=2-561, or of those in Table 4, allows one of skill in the art to identify conserved domain(s) for any of the polypeptides listed or referred to in this disclosure, including those in Table 4.

A “trait” refers to a physiological, morphological, biochemical, or physical characteristic of a plant or particular plant material or cell. In some instances, this characteristic is visible to the human eye, such as seed or plant size, or can be measured by biochemical techniques, such as detecting the protein, starch, or oil content of seed or leaves, or by observation of a metabolic or physiological process, e.g. by measuring uptake of carbon dioxide, or by the observation of the expression level of a gene or genes, e.g., by employing Northern analysis, RT-PCR, microarray gene expression assays, or reporter gene expression systems, or by agricultural observations such as stress tolerance, yield, or pathogen tolerance. Any technique can be used to measure the amount of, comparative level of, or difference in any selected chemical compound or macromolecule in the transgenic plants, however.

“Trait modification” refers to a detectable difference in a characteristic in a plant ectopically expressing a polynucleotide or polypeptide of the present invention relative to a plant not doing so, such as a wild type plant. In some cases, the trait modification can be evaluated quantitatively. For example, the trait modification can entail at least about a 2% increase or decrease in an observed trait (difference), at least a 5% difference, at least about a 10% difference, at least about a 20% difference, at least about a 30%, at least about a 50%, at least about a 70%, or at least about a 100%, or an even greater difference compared with a wild type plant. It is known that there can be a natural variation in the modified trait. Therefore, the trait modification observed entails a change of the normal distribution of the trait in the plants compared with the distribution observed in wild type plant.

I. TRAITS WHICH MAY BE MODIFIED

Trait modifications of particular interest include those to seed (such as embryo or endosperm), fruit, root, flower, leaf, stem, shoot, seedling or the like, including: enhanced tolerance to environmental conditions including freezing, chilling, heat, drought, water saturation, radiation and ozone; improved tolerance to microbial, fungal or viral diseases; improved tolerance to pest infestations, including nematodes, mollicutes, parasitic higher plants or the like; decreased herbicide sensitivity; improved tolerance of heavy metals or enhanced ability to take up heavy metals; improved growth under poor photoconditions (e.g., low light and/or short day length), or changes in expression levels of genes of interest. Other phenotype that can be modified relate to the production of plant metabolites, such as variations in the production of taxol, tocopherol, tocotrienol, sterols, phytosterols, vitamins, wax monomers, anti-oxidants, amino acids, lignins, cellulose, tannins, prenyllipids (such as chlorophylls and carotenoids), glucosinolates, and terpenoids, enhanced or compositionally altered protein or oil production (especially in seeds), or modified sugar (insoluble or soluble) and/or starch composition. Physical plant characteristics that can be modified include cell development (such as the number of trichomes), fruit and seed size and number, yields of plant parts such as stems, leaves, inflorescences, and roots, the stability of the seeds during storage, characteristics of the seed pod (e.g., susceptibility to shattering), root hair length and quantity, internode distances, or the quality of seed coat. Plant growth characteristics that can be modified include growth rate, germination rate of seeds, vigor of plants and seedlings, leaf and flower senescence, male sterility, apomixis, flowering time, flower abscission, rate of nitrogen uptake, osmotic sensitivity to soluble sugar concentrations, biomass or transpiration characteristics, as well as plant architecture characteristics such as apical dominance, branching patterns, number of organs, organ identity, organ shape or size.

TRANSCRIPTION FACTORS MODIFY EXPRESSION OF ENDOGENOUS GENES

Expression of genes which encode transcription factors that modify expression of endogenous genes, polynucleotides, and proteins are well known in the art. In addition, transgenic plants comprising isolated polynucleotides encoding transcription factors may also modify expression of endogenous genes, polynucleotides, and proteins. Examples include Peng et al. (1997, Genes and Development 11:3194-3205) and Peng et al. (1999, Nature, 400:256-261). In addition, many others have demonstrated that an Arabidopsis transcription factor expressed in an exogenous plant species elicits the same or very similar phenotypic response. See, for example, Fu et al. (2001, Plant Cell 13:1791-1802); Nandi et al. (2000, Curr. Biol. 10:215-218); Coupland (1995, Nature 377:482-483); and Weigel and Nilsson (1995, Nature 377:482-500).

In another example, Mandel et al. (1992, Cell 71-133-143) and Suzuki et al. (2001, Plant J. 28:409-418) teach that a transcription factor expressed in another plant species elicits the same or very similar phenotypic response of the endogenous sequence, as often predicted in earlier studies of Arabidopsis transcription factors in Arabidopsis (see Mandel et al., 1992, supra; Suzuki et al., 2001, supra).

Other examples include Muller et al. (2001, Plant J. 28:169-179); Kim et al. (2001, Plant J. 25:247-259); Kyozuka and Shimamoto (2002, Plant Cell Physiol. 43:130-135); Boss and Thomas (2002, Nature, 416:847-850); He et al. (2000, Transgenic Res., 9:223-227); and Robson et al. (2001, Plant J. 28:619-631).

In yet another example, Gilmour et al. (1998, Plant J. 16:433-442) teach an Arabidopsis AP2 transcription factor, CBF1, which, when overexpressed in transgenic plants, increases plant freezing tolerance. Jaglo et al (2001, Plant Physiol. 127:910-017) further identified sequences in Brassica napus which encode CBF-like genes and that transcripts for these genes accumulated rapidly in response to low temperature. Transcripts encoding CBF-like proteins were also found to accumulate rapidly in response to low temperature in wheat, as well as in tomato. An alignment of the CBF proteins from Arabidopsis, B. napus, wheat, rye, and tomato revealed the presence of conserved amino acid sequences, PKK/RPAGRxKFxETRHP and DSAWR, that bracket the AP2/EREBP DNA binding domains of the proteins and distinguish them from other members of the AP2/EREBP protein family. (See Jaglo et al., supra.)

III. POLYPEPTIDES AND POLYNUCLEOTIDES OF THE INVENTION

The present invention provides, among other things, transcription factors (TFs), and transcription factor homologue polypeptides, and isolated or recombinant polynucleotides encoding the polypeptides, or novel variant polypeptides or polynucleotides encoding novel variants of transcription factors derived from the specific sequences provided here. These polypeptides and polynucleotides may be employed to modify a plant's characteristic.

Exemplary polynucleotides encoding the polypeptides of the invention were identified in the Arabidopsis thaliana GenBank database using publicly available sequence analysis programs and parameters. Sequences initially identified were then further characterized to identify sequences comprising specified sequence strings corresponding to sequence motifs present in families of known transcription factors. In addition, further exemplary polynucleotides encoding the polypeptides of the invention were identified in the plant GenBank database using publicly available sequence analysis programs and parameters. Sequences initially identified were then further characterized to identify sequences comprising specified sequence strings corresponding to sequence motifs present in families of known transcription factors. Polynucleotide sequences meeting such criteria were confirmed as transcription factors.

Additional polynucleotides of the invention were identified by screening Arabidopsis thaliana and/or other plant cDNA libraries with probes corresponding to known transcription factors under low stringency hybridization conditions. Additional sequences, including full length coding sequences were subsequently recovered by the rapid amplification of cDNA ends (RACE) procedure, using a commercially available kit according to the manufacturer's instructions. Where necessary, multiple rounds of RACE are performed to isolate 5′ and 3′ ends. The full length cDNA was then recovered by a routine end-to-end polymerase chain reaction (PCR) using primers specific to the isolated 5′ and 3′ ends. Exemplary sequences are provided in the Sequence Listing.

The polynucleotides of the invention can be or were ectopically expressed in overexpressor or knockout plants and the changes in the characteristic(s) or trait(s) of the plants observed. Therefore, the polynucleotides and polypeptides can be employed to improve the characteristics of plants.

The polynucleotides of the invention can be or were ectopically expressed in overexpressor plant cells and the changes in the expression levels of a number of genes, polynucleotides, and/or proteins of the plant cells observed. Therefore, the polynucleotides and polypeptides can be employed to change expression levels of a genes, polynucleotides, and/or proteins of plants.

IV. PRODUCING POLYPEPTIDES

The polynucleotides of the invention include sequences that encode transcription factors and transcription factor homologue polypeptides and sequences complementary thereto, as well as unique fragments of coding sequence, or sequence complementary thereto. Such polynucleotides can be, e.g., DNA or RNA, e.g., mRNA, cRNA, synthetic RNA, genomic DNA, cDNA synthetic DNA, oligonucleotides, etc. The polynucleotides are either double-stranded or single-stranded, and include either, or both sense (i.e., coding) sequences and antisense (i.e., non-coding, complementary) sequences. The polynucleotides include the coding sequence of a transcription factor, or transcription factor homologue polypeptide, in isolation, in combination with additional coding sequences (e.g., a purification tag, a localization signal, as a fusion-protein, as a pre-protein, or the like), in combination with non-coding sequences (e.g., introns or inteins, regulatory elements such as promoters, enhancers, terminators, and the like), and/or in a vector or host environment in which the polynucleotide encoding a transcription factor or transcription factor homologue polypeptide is an endogenous or exogenous gene.

A variety of methods exist for producing the polynucleotides of the invention. Procedures for identifying and isolating DNA clones are well known to those of skill in the art, and are described in, e.g., Berger and Kimmel, Guide to Molecular Cloning Techniques, Methods in Enzymology volume 152 Academic Press, Inc., San Diego, Calif. (“Berger”); Sambrook et al., Molecular Cloning—A Laboratory Manual (2nd Ed.), Vol. 1-3, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., 1989 (“Sambrook”) and Current Protocols in Molecular Biology, F. M. Ausubel et al., eds., Current Protocols, a joint venture between Greene Publishing Associates, Inc. and John Wiley & Sons, Inc., (supplemented through 2000) (“Ausubel”).

Alternatively, polynucleotides of the invention, can be produced by a variety of in vitro amplification methods adapted to the present invention by appropriate selection of specific or degenerate primers. Examples of protocols sufficient to direct persons of skill through in vitro amplification methods, including the polymerase chain reaction (PCR) the ligase chain reaction (LCR), Qbeta-replicase amplification and other RNA polymerase mediated techniques (e.g., NASBA), e.g., for the production of the homologous nucleic acids of the invention are found in Berger (supra), Sambrook (supra), and Ausubel (supra), as well as Mullis et al., (1987) PCR Protocols A Guide to Methods and Applications (Innis et al. eds) Academic Press Inc. San Diego, Calif. (1990) (Innis). Improved methods for cloning in vitro amplified nucleic acids are described in Wallace et al., U.S. Pat. No. 5,426,039. Improved methods for amplifying large nucleic acids by PCR are summarized in Cheng et al. (1994) Nature 369: 684-685 and the references cited therein, in which PCR amplicons of up to 40 kb are generated. One of skill will appreciate that essentially any RNA can be converted into a double stranded DNA suitable for restriction digestion, PCR expansion and sequencing using reverse transcriptase and a polymerase. See, e.g., Ausubel, Sambrook and Berger, all supra.

Alternatively, polynucleotides and oligonucleotides of the invention can be assembled from fragments produced by solid-phase synthesis methods. Typically, fragments of up to approximately 100 bases are individually synthesized and then enzymatically or chemically ligated to produce a desired sequence, e.g., a polynucleotide encoding all or part of a transcription factor. For example, chemical synthesis using the phosphoramidite method is described, e.g., by Beaucage et al. (1981) Tetrahedron Letters 22:1859-1869; and Matthes et al. (1984) EMBO J. 3:801-805. According to such methods, oligonucleotides are synthesized, purified, annealed to their complementary strand, ligated and then optionally cloned into suitable vectors. And if so desired, the polynucleotides and polypeptides of the invention can be custom ordered from any of a number of commercial suppliers.

V. HOMOLOGOUS SEQUENCES

Sequences homologous, i.e., that share significant sequence identity or similarity, to those provided in the Sequence Listing, derived from Arabidopsis thaliana or from other plants of choice are also an aspect of the invention. Homologous sequences can be derived from any plant including monocots and dicots and in particular agriculturally important plant species, including but not limited to, crops such as soybean, wheat, corn, potato, cotton, rice, rape, oilseed rape (including canola), sunflower, alfalfa, sugarcane and turf; or fruits and vegetables, such as banana, blackberry, blueberry, strawberry, and raspberry, cantaloupe, carrot, cauliflower, coffee, cucumber, eggplant, grapes, honeydew, lettuce, mango, melon, onion, papaya, peas, peppers, pineapple, pumpkin, spinach, squash, sweet corn, tobacco, tomato, watermelon, rosaceous fruits (such as apple, peach, pear, cherry and plum) and vegetable brassicas (such as broccoli, cabbage, cauliflower, Brussels sprouts, and kohlrabi). Other crops, fruits and vegetables whose phenotype can be changed include barley rye, millet, sorghum, currant, avocado, citrus fruits such as oranges, lemons, grapefruit and tangerines, artichoke, cherries, nuts such as the walnut and peanut, endive, leek, roots, such as arrowroot, beet, cassava, turnip, radish, yam, and sweet potato, and beans. The homologous sequences may also be derived from woody species, such pine, poplar and eucalyptus, or mint or other labiates.

Orthologs And Paralogs

Several different methods are known by those of skill in the art for identifying and defining these functionally homologous sequences. Three general methods for defining paralogs and orthologs are described; a paralog or ortholog or homolog may be identified by one or more of the methods described below.

Orthologs and paralogs are evolutionarily related genes that have similar sequence and similar functions. Orthologs are structurally related genes in different species that are derived from a speciation event. Paralogs are structurally related genes within a single species that are derived by a duplication event.

Within a single plant species, gene duplication may cause two copies of a particular gene, giving rise to two or more genes with similar sequence and similar function known as paralogs. A paralog is therefore a similar gene with a similar function within the same species. Paralogs typically cluster together or in the same clade (a group of similar genes) when a gene family phylogeny is analyzed using programs such as CLUSTAL (Thompson et al. (1994) Nucleic Acids Res. 22:4673-4680; Higgins et al. (1996) Methods Enzymol. 266 383-402). Groups of similar genes can also be identified with pair-wise BLAST analysis (Feng and Doolittle (1987) J. Mol. Evol. 25:351-360). For example, a clade of very similar MADS domain transcription factors from Arabidopsis all share a common function in flowering time (Ratcliffe et al. (2001) Plant Physiol. 126:122-132), and a group of very similar AP2 domain transcription factors from Arabidopsis are involved in tolerance of plants to freezing (Gilmour et al. (1998) Plant J. 16:433-442). Analysis of groups of similar genes with similar function that fall within one clade can yield sub-sequences that are particular to the clade. These sub-sequences, known as consensus sequences, can not only be used to define the sequences within each lade, but define the functions of these genes; genes within a lade may contain paralogous or orthologous sequences that share the same function. (See also, for example, Mount, D. W. (2001) Bioinformatics: Sequence and Genome Analysis Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. page 543.)

Speciation, the production of new species from a parental species, can also give rise to two or more genes with similar sequence and similar function. These genes, termed orthologs, often have an identical function within their host plants and are often interchangeable between species without losing function. Because plants have common ancestors, many genes in any plant species will have a corresponding orthologous gene in another plant species. Once a phylogenic tree for a gene family of one species has been constructed using a program such as CLUSTAL (Thompson et al. (1994) Nucleic Acids Res. 22:4673-4680; Higgins et al. (1996) Methods Enzymol. 266:383-402), potential orthologous sequences can placed into the phylogenetic tree and its relationship to genes from the species of interest can be determined. Once the ortholog pair has been identified, the function of the test ortholog can be determined by determining the function of the reference ortholog.

Transcription factors that are homologous to the listed sequences will typically share at least about 30% amino acid sequence identity, or at least about 30% amino acid sequence identity outside of a known consensus sequence or consensus DNA-binding site. More closely related transcription factors can share at least about 50%, about 60%, about 65%, about 70%, about 75% or about 80% or about 90% or about 95% or about 98% or more sequence identity with the listed sequences, or with the listed sequences but excluding or outside a known consensus sequence or consensus DNA-binding site, or with the listed sequences excluding one or all conserved domain. Factors that are most closely related to the listed sequences share, e.g., at least about 85%, about 90% or about 95% or more % sequence identity to the listed sequences, or to the listed sequences but excluding or outside a known consensus sequence or consensus DNA-binding site or outside one or all conserved domain. At the nucleotide level, the sequences will typically share at least about 40% nucleotide sequence identity, preferably at least about 50%, about 60%, about 70% or about 80% sequence identity, and more preferably about 85%, about 90%, about 95% or about 97% or more sequence identity to one or more of the listed sequences, or to a listed sequence but excluding or outside a known consensus sequence or consensus DNA-binding site, or outside one or all conserved domain. The degeneracy of the genetic code enables major variations in the nucleotide sequence of a polynucleotide while maintaining the amino acid sequence of the encoded protein. Conserved domains within a transcription factor family may exhibit a higher degree of sequence homology, such as at least 65% sequence identity including conservative substitutions, and preferably at least 80% sequence identity, and more preferably at least 85%, or at least about 86%, or at least about 87%, or at least about 88%, or at least about 90%, or at least about 95%, or at least about 98% sequence identity. Transcription factors that are homologous to the listed sequences should share at least 30%, or at least about 60%, or at least about 75%, or at least about 80%, or at least about 90%, or at least about 95% amino acid sequence identity over the entire length of the polypeptide or the homolog. In addition, transcription factors that are homologous to the listed sequences should share at least 30%, or at least about 60%, or at least about 75%, or at least about 80%, or at least about 90%, or at least about 95% amino acid sequence similarity over the entire length of the polypeptide or the homolog.

Percent identity can be determined electronically, e.g., by using the MEGALIGN program (DNASTAR, Inc. Madison, Wis.). The MEGALIGN program can create alignments between two or more sequences according to different methods, e.g., the clustal method. (See, e.g., Higgins, D. G. and P. M. Sharp (1988) Gene 73:237-244.) The clustal algorithm groups sequences into clusters by examining the distances between all pairs. The clusters are aligned pairwise and then in groups. Other alignment algorithms or programs may be used, including FASTA, BLAST, or ENTREZ, FASTA and BLAST. These are available as a part of the GCG sequence analysis package (University of Wisconsin, Madison, Wis.), and can be used with or without default settings. ENTREZ is available through the National Center for Biotechnology Information. In one embodiment, the percent identity of two sequences can be determined by the GCG program with a gap weight of 1, e.g., each amino acid gap is weighted as if it were a single amino acid or nucleotide mismatch between the two sequences (see U.S. Pat. No. 6,262,333).

Other techniques for alignment are described in Methods in Enzymology, vol. 266: Computer Methods for Macromolecular Sequence Analysis (1996), ed. Doolittle, Academic Press, Inc., San Diego, Calif., USA. Preferably, an alignment program that permits gaps in the sequence is utilized to align the sequences. The Smith-Waterman is one type of algorithm that permits gaps in sequence alignments. See Methods Mol. Biol. 70: 173-187 (1997). Also, the GAP program using the Needleman and Wunsch alignment method can be utilized to align sequences. An alternative search strategy uses MPSRCH software, which runs on a MASPAR computer. MPSRCH uses a Smith-Waterman algorithm to score sequences on a massively parallel computer. This approach improves ability to pick up distantly related matches, and is especially tolerant of small gaps and nucleotide sequence errors. Nucleic acid-encoded amino acid sequences can be used to search both protein and DNA databases.

The percentage similarity between two polypeptide sequences, e.g., sequence A and sequence B, is calculated by dividing the length of sequence A, minus the number of gap residues in sequence A, minus the number of gap residues in sequence B, into the sum of the residue matches between sequence A and sequence B, times one hundred. Gaps of low or of no similarity between the two amino acid sequences are not included in determining percentage similarity. Percent identity between polynucleotide sequences can also be counted or calculated by other methods known in the art, e.g., the Jotun Hein method. (See, e.g., Hein, J. (1990) Methods Enzymol. 183:626-645.) Identity between sequences can also be determined by other methods known in the art, e.g., by varying hybridization conditions (see U.S. patent application Ser. No. 20,010,010,913).

Thus, the invention provides methods for identifying a sequence similar or paralogous or orthologous or homologous to one or more polynucleotides as noted herein, or one or more target polypeptides encoded by the polynucleotides, or otherwise noted herein and may include linking or associating a given plant phenotype or gene function with a sequence. In the methods, a sequence database is provided (locally or across an inter or intra net) and a query is made against the sequence database using the relevant sequences herein and associated plant phenotypes or gene functions.

In addition, one or more polynucleotide sequences or one or more polypeptides encoded by the polynucleotide sequences may be used to search against a BLOCKS (Bairoch et al. (1997) Nucleic Acids Res. 25:217-221), PFAM, and other databases which contain previously identified and annotated motifs, sequences and gene functions. Methods that search for primary sequence patterns with secondary structure gap penalties (Smith et al. (1992) Protein Engineering 5:35-51) as well as algorithms such as Basic Local Alignment Search Tool (BLAST; Altschul, S. F. (1993) J. Mol. Evol. 36:290-300; Altschul et al. (1990) supra), BLOCKS (Henikoff, S. and Henikoff, G. J. (1991) Nucleic Acids Research 19:6565-6572), Hidden Markov Models (HMM; Eddy, S. R. (1996) Cur. Opin. Str. Biol. 6:361-365; Sonnhammer et al. (1997) Proteins 28:405-420), and the like, can be used to manipulate and analyze polynucleotide and polypeptide sequences encoded by polynucleotides. These databases, algorithms and other methods are well known in the art and are described in Ausubel et al. (1997; Short Protocols in Molecular Biology, John Wiley & Sons, New York N.Y., unit 7.7) and in Meyers, R. A. (1995; Molecular Biology and Biotechnology, Wiley VCH, New York N.Y., p 856-853).

Furthermore, methods using manual alignment of sequences similar or homologous to one or more polynucleotide sequences or one or more polypeptides encoded by the polynucleotide sequences may be used to identify regions of similarity and conserved domains. Such manual methods are well-known of those of skill in the art and can include, for example, comparisons of tertiary structure between a polypeptide sequence encoded by a polynucleotide which comprises a known function with a polypeptide sequence encoded by a polynucleotide sequence which has a function not yet determined. Such examples of tertiary structure may comprise predicted alpha helices, beta-sheets, amphipathic helices, leucine zipper motifs, zinc finger motifs, proline-rich regions, cysteine repeat motifs, and the like.

VI. IDENTIFYING POLYNUCLEOTIDES OR NUCLEIC ACIDS BY HYBRIDIZATION

Polynucleotides homologous to the sequences illustrated in the Sequence Listing and tables can be identified, e.g., by hybridization to each other under stringent or under highly stringent conditions. Single stranded polynucleotides hybridize when they associate based on a variety of well characterized physical-chemical forces, such as hydrogen bonding, solvent exclusion, base stacking and the like. The stringency of a hybridization reflects the degree of sequence identity of the nucleic acids involved, such that the higher the stringency, the more similar are the two polynucleotide strands. Stringency is influenced by a variety of factors, including temperature, salt concentration and composition, organic and non-organic additives, solvents, etc. present in both the hybridization and wash solutions and incubations (and number thereof), as described in more detail in the references cited above. Encompassed by the invention are polynucleotide sequences that are capable of hybridizing to the claimed polynucleotide sequences, and, in particular, to those shown in SEQ ID NOs: 860; 802; 240; 274; 558; 24; 1120; 44; 460; 286; 120; 130; 134; 698; 832; 580; 612; 48, and fragments thereof under various conditions of stringency. (See, e.g., Wahl, G. M. and S. L. Berger (1987) Methods Enzymol. 152:399-407; Kimmel, A. R. (1987) Methods Enzymol. 152:507-511.) Estimates of homology are provided by either DNA-DNA or DNA-RNA hybridization under conditions of stringency as is well understood by those skilled in the art (Hames and Higgins, Eds. (1985) Nucleic Acid Hybridisation, IRL Press, Oxford, U.K.). Stringency conditions can be adjusted to screen for moderately similar fragments, such as homologous sequences from distantly related organisms, to highly similar fragments, such as genes that duplicate functional enzymes from closely related organisms. Post-hybridization washes determine stringency conditions.

In addition to the nucleotide sequences listed in Tables 4 and 5, full length cDNA, orthologs, paralogs and homologs of the present nucleotide sequences may be identified and isolated using well known methods. The cDNA libraries orthologs, paralogs and homologs of the present nucleotide sequences may be screened using hybridization methods to determine their utility as hybridization target or amplification probes.

An example of stringent hybridization conditions for hybridization of complementary nucleic acids which have more than 100 complementary residues on a filter in a Southern or northern blot is about 5° C. to 20° C. lower than the thermal melting point (T_(m)) for the specific sequence at a defined ionic strength and pH. The T_(m) is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to a perfectly matched probe. Nucleic acid molecules that hybridize under stringent conditions will typically hybridize to a probe based on either the entire cDNA or selected portions, e.g., to a unique subsequence, of the cDNA under wash conditions of 0.2×SSC to 2.0×SSC, 0.1% SDS at 50-65° C. For example, high stringency is about 0.2×SSC, 0.1% SDS at 65° C. Ultra-high stringency will be the same conditions except the wash temperature is raised about 3 to about 5° C., and ultra-ultra-high stringency will be the same conditions except the wash temperature is raised about 6 to about 9° C. For identification of less closely related homologues washes can be performed at a lower temperature, e.g., 50° C. In general, stringency is increased by raising the wash temperature and/or decreasing the concentration of SSC, as known in the art.

In another example, stringent salt concentration will ordinarily be less than about 750 mM NaCl and 75 mM trisodium citrate, preferably less than about 500 mM NaCl and 50 mM trisodium citrate, and most preferably less than about 250 mM NaCl and 25 mM trisodium citrate. Low stringency hybridization can be obtained in the absence of organic solvent, e.g., formamide, while high stringency hybridization can be obtained in the presence of at least about 35% formamide, and most preferably at least about 50% formamide. Stringent temperature conditions will ordinarily include temperatures of at least about 30° C., more preferably of at least about 37° C., and most preferably of at least about 42° C. Varying additional parameters, such as hybridization time, the concentration of detergent, e.g., sodium dodecyl sulfate (SDS), and the inclusion or exclusion of carrier DNA, are well known to those skilled in the art. Various levels of stringency are accomplished by combining these various conditions as needed. In a preferred embodiment, hybridization will occur at 30° C. in 750 mM NaCl, 75 mM trisodium citrate, and 1% SDS. In a more preferred embodiment, hybridization will occur at 37° C. in 500 mM NaCl, 50 mM trisodium citrate, 1% SDS, 35% formamide, and 100 μg/ml denatured salmon sperm DNA (ssDNA). In a most preferred embodiment, hybridization will occur at 42° C. in 250 mM NaCl, 25 mM trisodium citrate, 1% SDS, 50% formamide, and 200 μg/ml ssDNA. Useful variations on these conditions will be readily apparent to those skilled in the art.

The washing steps that follow hybridization can also vary in stringency. Wash stringency conditions can be defined by salt concentration and by temperature. As above, wash stringency can be increased by decreasing salt concentration or by increasing temperature. For example, stringent salt concentration for the wash steps will preferably be less than about 30 mM NaCl and 3 mM trisodium citrate, and most preferably less than about 15 mM NaCl and 1.5 mM trisodium citrate. Stringent temperature conditions for the wash steps will ordinarily include temperature of at least about 25° C., more preferably of at least about 42° C. Another preferred set of highly stringent conditions uses two final washes in 0.1×SSC, 0.1% SDS at 65° C. The most preferred high stringency washes are of at least about 68° C. For example, in a preferred embodiment, wash steps will occur at 25° C. in 30 mM NaCl, 3 mM trisodium citrate, and 0.1% SDS. In a more preferred embodiment, wash steps will occur at 42° C. in 15 mM NaCl, 1.5 mM trisodium citrate, and 0.1% SDS. In a most preferred embodiment, the wash steps will occur at 68° C. in 15 mM NaCl, 1.5 mM trisodium citrate, and 0.1% SDS. Additional variations on these conditions will be readily apparent to those skilled in the art (see U.S. patent application Ser. No. 20,010,010,913).

As another example, stringent conditions can be selected such that an oligonucleotide that is perfectly complementary to the coding oligonucleotide hybridizes to the coding oligonucleotide with at least about a 5-10× higher signal to noise ratio than the ratio for hybridization of the perfectly complementary oligonucleotide to a nucleic acid encoding a transcription factor known as of the filing date of the application. Conditions can be selected such that a higher signal to noise ratio is observed in the particular assay which is used, e.g., about 15×, 25×, 35×, 50× or more. Accordingly, the subject nucleic acid hybridizes to the unique coding oligonucleotide with at least a 2× higher signal to noise ratio as compared to hybridization of the coding oligonucleotide to a nucleic acid encoding known polypeptide. Again, higher signal to noise ratios can be selected, e.g., about 5×, 10×, 25×, 35×, 50× or more. The particular signal will depend on the label used in the relevant assay, e.g., a fluorescent label, a colorimetric label, a radioactive label, or the like.

Alternatively, transcription factor homolog polypeptides can be obtained by screening an expression library using antibodies specific for one or more transcription factors. With the provision herein of the disclosed transcription factor, and transcription factor homologue nucleic acid sequences, the encoded polypeptide(s) can be expressed and purified in a heterologous expression system (e.g., E. coli) and used to raise antibodies (monoclonal or polyclonal) specific for the polypeptide(s) in question. Antibodies can also be raised against synthetic peptides derived from transcription factor, or transcription factor homologue, amino acid sequences. Methods of raising antibodies are well known in the art and are described in Harlow and Lane (1988) Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, New York. Such antibodies can then be used to screen an expression library produced from the plant from which it is desired to clone additional transcription factor homologues, using the methods described above. The selected cDNAs can be confirmed by sequencing and enzymatic activity.

VII. SEQUENCE VARIATIONS

It will readily be appreciated by those of skill in the art, that any of a variety of polynucleotide sequences are capable of encoding the transcription factors and transcription factor homologue polypeptides of the invention. Due to the degeneracy of the genetic code, many different polynucleotides can encode identical and/or substantially similar polypeptides in addition to those sequences illustrated in the Sequence Listing. Nucleic acids having a sequence that differs from the sequences shown in the Sequence Listing, or complementary sequences, that encode functionally equivalent peptides (i.e., peptides having some degree of equivalent or similar biological activity) but differ in sequence from the sequence shown in the sequence listing due to degeneracy in the genetic code, are also within the scope of the invention.

Altered polynucleotide sequences encoding polypeptides include those sequences with deletions, insertions, or substitutions of different nucleotides, resulting in a polynucleotide encoding a polypeptide with at least one functional characteristic of the instant polypeptides. Included within this definition are polymorphisms which may or may not be readily detectable using a particular oligonucleotide probe of the polynucleotide encoding the instant polypeptides, and improper or unexpected hybridization to allelic variants, with a locus other than the normal chromosomal locus for the polynucleotide sequence encoding the instant polypeptides.

Allelic variant refers to any of two or more alternative forms of a gene occupying the same chromosomal locus. Allelic variation arises naturally through mutation, and may result in phenotypic polymorphism within populations. Gene mutations can be silent (i.e., no change in the encoded polypeptide) or may encode polypeptides having altered amino acid sequence. The term allelic variant is also used herein to denote a protein encoded by an allelic variant of a gene. Splice variant refers to alternative forms of RNA transcribed from a gene. Splice variation arises naturally through use of alternative splicing sites within a transcribed RNA molecule, or less commonly between separately transcribed RNA molecules, and may result in several mRNAs transcribed from the same gene. Splice variants may encode polypeptides having altered amino acid sequence. The term splice variant is also used herein to denote a protein encoded by a splice variant of an mRNA transcribed from a gene.

Those skilled in the art would recognize that G681, SEQ ID NO: 580, represents a single transcription factor; allelic variation and alternative splicing may be expected to occur. Allelic variants of SEQ ID NO: 579 can be cloned by probing cDNA or genomic libraries from different individual organisms according to standard procedures. Allelic variants of the DNA sequence shown in SEQ ID NO: 579, including those containing silent mutations and those in which mutations result in amino acid sequence changes, are within the scope of the present invention, as are proteins which are allelic variants of SEQ ID NO: 580. cDNAs generated from alternatively spliced mRNAs, which retain the properties of the transcription factor are included within the scope of the present invention, as are polypeptides encoded by such cDNAs and mRNAs. Allelic variants and splice variants of these sequences can be cloned by probing cDNA or genomic libraries from different individual organisms or tissues according to standard procedures known in the art (see U.S. Pat. No. 6,388,064).

For example, Table 1 illustrates, e.g., that the codons AGC, AGT, TCA, TCC, TCG, and TCT all encode the same amino acid: serine. Accordingly, at each position in the sequence where there is a codon encoding serine, any of the above trinucleotide sequences can be used without altering the encoded polypeptide. TABLE 1 Amino acid Possible Codons Alanine Ala A GCA GCC GCG GCU Cysteine Cys C TGC TGT Aspartic acid Asp D GAC GAT Glutamic acid Glu E GAA GAG Phenylalanine Phe F TTC TTT Glycine Gly G GGA GGC GGG GGT Histidine His H CAC CAT Isoleucine Ile I ATA ATC ATT Lysine Lys K AAA AAG Leucine Leu L TTA TTG CTA CTC CTG CTT Methionine Met M ATG Asparagine Asn N AAC AAT Proline Pro P CCA CCC CCG CCT Glutamine Gln Q CAA CAG Arginine Arg R AGA AGG CGA CGC CGG CGT Serine Ser S AGC AGT TCA TCC TCG TCT Threonine Thr T ACA ACC ACG ACT Valine Val V GTA GTC GTG GTT Tryptophan Trp W TGG Tyrosine Tyr Y TAC TAT

Sequence alterations that do not change the amino acid sequence encoded by the polynucleotide are termed “silent” variations. With the exception of the codons ATG and TGG, encoding methionine and tryptophan, respectively, any of the possible codons for the same amino acid can be substituted by a variety of techniques, e.g., site-directed mutagenesis, available in the art. Accordingly, any and all such variations of a sequence selected from the above table are a feature of the invention.

In addition to silent variations, other conservative variations that alter one, or a few amino acids in the encoded polypeptide, can be made without altering the function of the polypeptide, these conservative variants are, likewise, a feature of the invention.

For example, substitutions, deletions and insertions introduced into the sequences provided in the Sequence Listing are also envisioned by the invention. Such sequence modifications can be engineered into a sequence by site-directed mutagenesis (Wu (ed.) Meth. Enzymol. (1993) vol. 217, Academic Press) or the other methods noted below. Amino acid substitutions are typically of single residues; insertions usually will be on the order of about from 1 to 10 amino acid residues; and deletions will range about from 1 to 30 residues. In preferred embodiments, deletions or insertions are made in adjacent pairs, e.g., a deletion of two residues or insertion of two residues. Substitutions, deletions, insertions or any combination thereof can be combined to arrive at a sequence. The mutations that are made in the polynucleotide encoding the transcription factor should not place the sequence out of reading frame and should not create complementary regions that could produce secondary mRNA structure. Preferably, the polypeptide encoded by the DNA performs the desired function.

Conservative substitutions are those in which at least one residue in the amino acid sequence has been removed and a different residue inserted in its place. Such substitutions generally are made in accordance with the Table 2 when it is desired to maintain the activity of the protein. Table 2 shows amino acids which can be substituted for an amino acid in a protein and which are typically regarded as conservative substitutions. TABLE 2 Conservative Residue Substitutions Ala Ser Arg Lys Asn Gln; His Asp Glu Gln Asn Cys Ser Glu Asp Gly Pro His Asn; Gln Ile Leu, Val Leu Ile; Val Lys Arg; Gln Met Leu; Ile Phe Met; Leu; Tyr Ser Thr; Gly Thr Ser; Val Trp Tyr Tyr Trp; Phe Val Ile; Leu

Similar substitutions are those in which at least one residue in the amino acid sequence has been removed and a different residue inserted in its place. Such substitutions generally are made in accordance with the Table 3 when it is desired to maintain the activity of the protein. Table 3 shows amino acids which can be substituted for an amino acid in a protein and which are typically regarded as structural and functional substitutions. For example, a residue in column 1 of Table 3 may be substituted with residue in column 2; in addition, a residue in column 2 of Table 3 may be substituted with the residue of column 1. TABLE 3 Residue Similar Substitutions Ala Ser; Thr; Gly; Val; Leu; Ile Arg Lys; His; Gly Asn Gln; His; Gly; Ser; Thr Asp Glu, Ser; Thr Gln Asn; Ala Cys Ser; Giy Glu Asp Gly Pro; Arg His Asn; Gln; Tyr; Phe; Lys; Arg Ile Ala; Leu; Val; Gly; Met Leu Ala; Ile; Val; Gly; Met Lys Arg; His; Gln; Gly; Pro Met Leu; Ile; Phe Phe Met; Leu; Tyr; Trp; His; Val; Ala Ser Thr; Gly; Asp; Ala; Val; Ile; His Thr Ser; Val; Ala; Gly Trp Tyr; Phe; His Tyr Trp; Phe; His Val Ala; Ile; Leu; Gly; Thr; Ser; Glu

Substitutions that are less conservative than those in Table 2 can be selected by picking residues that differ more significantly in their effect on maintaining (a) the structure of the polypeptide backbone in the area of the substitution, for example, as a sheet or helical conformation, (b) the charge or hydrophobicity of the molecule at the target site, or (c) the bulk of the side chain. The substitutions which in general are expected to produce the greatest changes in protein properties will be those in which (a) a hydrophilic residue, e.g., seryl or threonyl, is substituted for (or by) a hydrophobic residue, e.g., leucyl, isoleucyl, phenylalanyl, valyl or alanyl; (b) a cysteine or proline is substituted for (or by) any other residue; (c) a residue having an electropositive side chain, e.g., lysyl, arginyl, or histidyl, is substituted for (or by) an electronegative residue, e.g., glutamyl or aspartyl; or (d) a residue having a bulky side chain, e.g., phenylalanine, is substituted for (or by) one not having a side chain, e.g., glycine.

VIII. FURTHER MODIFYING SEQUENCES OF THE INVENTION—MUTATION/FORCED EVOLUTION

In addition to generating silent or conservative substitutions as noted, above, the present invention optionally includes methods of modifying the sequences of the Sequence Listing. In the methods, nucleic acid or protein modification methods are used to alter the given sequences to produce new sequences and/or to chemically or enzymatically modify given sequences to change the properties of the nucleic acids or proteins.

Thus, in one embodiment, given nucleic acid sequences are modified, e.g., according to standard mutagenesis or artificial evolution methods to produce modified sequences. The modified sequences may be created using purified natural polynucleotides isolated from any organism or may be synthesized from purified compositions and chemicals using chemical means well know to those of skill in the art. For example, Ausubel, supra, provides additional details on mutagenesis methods. Artificial forced evolution methods are described, for example, by Stemmer (1994) Nature 370:389-391, Stemmer (1994) Proc. Natl. Acad. Sci. USA 91:10747-10751, and U.S. Pat. Nos. 5,811,238, 5,837,500, and 6,242,568. Methods for engineering synthetic transcription factors and other polypeptides are described, for example, by Zhang et al. (2000) J. Biol. Chem. 275:33850-33860, Liu et al. (2001) J. Biol. Chem. 276:11323-11334, and Isalan et al. (2001) Nature Biotechnol. 19:656-660. Many other mutation and evolution methods are also available and expected to be within the skill of the practitioner.

Similarly, chemical or enzymatic alteration of expressed nucleic acids and polypeptides can be performed by standard methods. For example, sequence can be modified by addition of lipids, sugars, peptides, organic or inorganic compounds, by the inclusion of modified nucleotides or amino acids, or the like. For example, protein modification techniques are illustrated in Ausubel, supra. Further details on chemical and enzymatic modifications can be found herein. These modification methods can be used to modify any given sequence, or to modify any sequence produced by the various mutation and artificial evolution modification methods noted herein.

Accordingly, the invention provides for modification of any given nucleic acid by mutation, evolution, chemical or enzymatic modification, or other available methods, as well as for the products produced by practicing such methods, e.g., using the sequences herein as a starting substrate for the various modification approaches.

For example, optimized coding sequence containing codons preferred by a particular prokaryotic or eukaryotic host can be used e.g., to increase the rate of translation or to produce recombinant RNA transcripts having desirable properties, such as a longer half-life, as compared with transcripts produced using a non-optimized sequence. Translation stop codons can also be modified to reflect host preference. For example, preferred stop codons for Saccharomyces cerevisiae and mammals are TAA and TGA, respectively. The preferred stop codon for monocotyledonous plants is TGA, whereas insects and E. coli prefer to use TAA as the stop codon.

The polynucleotide sequences of the present invention can also be engineered in order to alter a coding sequence for a variety of reasons, including but not limited to, alterations which modify the sequence to facilitate cloning, processing and/or expression of the gene product. For example, alterations are optionally introduced using techniques which are well known in the art, e.g., site-directed mutagenesis, to insert new restriction sites, to alter glycosylation patterns, to change codon preference, to introduce splice sites, etc.

Furthermore, a fragment or domain derived from any of the polypeptides of the invention can be combined with domains derived from other transcription factors or synthetic domains to modify the biological activity of a transcription factor. For instance, a DNA-binding domain derived from a transcription factor of the invention can be combined with the activation domain of another transcription factor or with a synthetic activation domain. A transcription activation domain assists in initiating transcription from a DNA-binding site. Examples include the transcription activation region of VP16 or GAL4 (Moore et al. (1998) Proc. Natl. Acad. Sci. USA 95: 376-381; and Aoyama et al. (1995) Plant Cell 7:1773-1785), peptides derived from bacterial sequences (Ma and Ptashne (1987) Cell 51; 113-119) and synthetic peptides (Giniger and Ptashne, (1987) Nature 330:670-672).

IX. EXPRESSION MODIFICATION OF POLYPEPTIDES

Typically, polynucleotide sequences of the invention are incorporated into recombinant DNA (or RNA) molecules that direct expression of polypeptides of the invention in appropriate host cells, transgenic plants, in vitro translation systems, or the like. Due to the inherent degeneracy of the genetic code, nucleic acid sequences which encode substantially the same or a functionally equivalent amino acid sequence can be substituted for any listed sequence to provide for cloning and expressing the relevant homologue.

X. VECTORS, PROMOTORS, AND EXPRESSION SYSTEMS

The present invention includes recombinant constructs comprising one or more of the nucleic acid sequences herein. The constructs typically comprise a vector, such as a plasmid, a cosmid, a phage, a virus (e.g., a plant virus), a bacterial artificial chromosome (BAC), a yeast artificial chromosome (YAC), or the like, into which a nucleic acid sequence of the invention has been inserted, in a forward or reverse orientation. In a preferred aspect of this embodiment, the construct further comprises regulatory sequences, including, for example, a promoter, operably linked to the sequence. Large numbers of suitable vectors and promoters are known to those of skill in the art, and are commercially available.

General texts that describe molecular biological techniques useful herein, including the use and production of vectors, promoters and many other relevant topics, include Berger, Sambrook and Ausubel, supra. Any of the identified sequences can be incorporated into a cassette or vector, e.g., for expression in plants. A number of expression vectors suitable for stable transformation of plant cells or for the establishment of transgenic plants have been described including those described in Weissbach and Weissbach, (1989) Methods for Plant Molecular Biology, Academic Press, and Gelvin et al., (1990) Plant Molecular Biology Manual, Kluwer Academic Publishers. Specific examples include those derived from a Ti plasmid of Agrobacterium tumefaciens, as well as those disclosed by Herrera-Estrella et al. (1983) Nature 303:209, Bevan (1984) Nucl Acid Res. 12: 8711-8721, Klee (1985) Bio/Technology 3:637-642, for dicotyledonous plants.

Alternatively, non-Ti vectors can be used to transfer the DNA into monocotyledonous plants and cells by using free DNA delivery techniques. Such methods can involve, for example, the use of liposomes, electroporation, microprojectile bombardment, silicon carbide whiskers, and viruses. By using these methods transgenic plants such as wheat, rice (Christou (1991) Bio/Technology 9: 957-962) and corn (Gordon-Kamm (1990) Plant Cell 2: 603-618) can be produced. An immature embryo can also be a good target tissue for monocots for direct DNA delivery techniques by using the particle gun (Weeks et al. (1993) Plant Physiol 102: 1077-1084; Vasil (1993) Bio/Technology 10: 667-674; Wan and Lemeaux (1994) Plant Physiol 104: 37-48, and for Agrobacterium-mediated DNA transfer (Ishida et al. (1996) Nature Biotech 14: 745-750).

Typically, plant transformation vectors include one or more cloned plant coding sequence (genomic or cDNA) under the transcriptional control of 5′ and 3′ regulatory sequences and a dominant selectable marker. Such plant transformation vectors typically also contain a promoter (e.g., a regulatory region controlling inducible or constitutive, environmentally-or developmentally-regulated, or cell- or tissue-specific expression), a transcription initiation start site, an RNA processing signal (such as intron splice sites), a transcription termination site, and/or a polyadenylation signal.

Examples of constitutive plant promoters which can be useful for expressing the TF sequence include: the cauliflower mosaic virus (CaMV) 35S promoter, which confers constitutive, high-level expression in most plant tissues (see, e.g., Odell et al. (1985) Nature 313:810-812); the nopaline synthase promoter (An et al. (1988) Plant Physiol 88:547-552); and the octopine synthase promoter (Fromm et al. (1989) Plant Cell 1: 977-984).

A variety of plant gene promoters that regulate gene expression in response to environmental, hormonal, chemical, developmental signals, and in a tissue-active manner can be used for expression of a TF sequence in plants. Choice of a promoter is based largely on the phenotype of interest and is determined by such factors as tissue (e.g., seed, fruit, root, pollen, vascular tissue, flower, carpel, etc.), inducibility (e.g., in response to wounding, heat, cold, drought, light, pathogens, etc.), timing, developmental stage, and the like. Numerous known promoters have been characterized and can favorably be employed to promote expression of a polynucleotide of the invention in a transgenic plant or cell of interest. For example, tissue specific promoters include: seed-specific promoters (such as the napin, phaseolin or DC3 promoter described in U.S. Pat. No. 5,773,697), fruit-specific promoters that are active during fruit ripening (such as the dru 1 promoter (U.S. Pat. No. 5,783,393), or the 2A11 promoter (U.S. Pat. No. 4,943,674) and the tomato polygalacturonase promoter (Bird et al. (1988) Plant Mol Biol 11:651), root-specific promoters, such as those disclosed in U.S. Pat. Nos. 5,618,988, 5,837,848 and 5,905,186, pollen-active promoters such as PTA29, PTA26 and PTA13 (U.S. Pat. No. 5,792,929), promoters active in vascular tissue (Ringli and Keller (1998) Plant Mol Biol 37:977-988), flower-specific (Kaiser et al, (1995) Plant Mol Biol 28:231-243), pollen (Baerson et al. (1994) Plant Mol Biol 26:1947-1959), carpels (Ohl et al. (1990) Plant Cell 2:837-848), pollen and ovules (Baerson et al. (1993) Plant Mol Biol 22:255-267), auxin-inducible promoters (such as that described in van der Kop et al. (1999) Plant Mol Biol 39:979-990 or Baumann et al. (1999) Plant Cell 11:323-334), cytokinin-inducible promoter (Guevara-Garcia (1998) Plant Mol Biol 38:743-753), promoters responsive to gibberellin (Shi et al. (1998) Plant Mol Biol 38:1053-1060, Willmott et al. (1998) 38:817-825) and the like. Additional promoters are those that elicit expression in response to heat (Ainley et al. (1993) Plant Mol Biol 22: 13-23), light (e.g., the pea rbcS-3A promoter, Kuhlemeier et al. (1989) Plant Cell 1:471, and the maize rbcS promoter, Schaffner and Sheen (1991) Plant Cell 3: 997); wounding (e.g., wunI, Siebertz et al. (1989) Plant Cell 1: 961); pathogens (such as the PR-1 promoter described in Buchel et al. (1999) Plant Mol. Biol. 40:387-396, and the PDF1.2 promoter described in Manners et al. (1998) Plant Mol. Biol. 38:1071-80), and chemicals such as methyl jasmonate or salicylic acid (Gatz et al. (1997) Plant Mol Biol 48: 89-108). In addition, the timing of the expression can be controlled by using promoters such as those acting at senescence (An and Amazon (1995) Science 270: 1986-1988); or late seed development (Odell et al. (1994) Plant Physiol 106:447-458).

Plant expression vectors can also include RNA processing signals that can be positioned within, upstream or downstream of the coding sequence. In addition, the expression vectors can include additional regulatory sequences from the 3′-untranslated region of plant genes, e.g., a 3′ terminator region to increase mRNA stability of the mRNA, such as the PI-II terminator region of potato or the octopine or nopaline synthase 3′ terminator regions.

Additional Expression Elements

Specific initiation signals can aid in efficient translation of coding sequences. These signals can include, e.g., the ATG initiation codon and adjacent sequences. In cases where a coding sequence, its initiation codon and upstream sequences are inserted into the appropriate expression vector, no additional translational control signals may be needed. However, in cases where only coding sequence (e.g., a mature protein coding sequence), or a portion thereof, is inserted, exogenous transcriptional control signals including the ATG initiation codon can be separately provided. The initiation codon is provided in the correct reading frame to facilitate transcription. Exogenous transcriptional elements and initiation codons can be of various origins, both natural and synthetic. The efficiency of expression can be enhanced by the inclusion of enhancers appropriate to the cell system in use.

Expression Hosts

The present invention also relates to host cells which are transduced with vectors of the invention, and the production of polypeptides of the invention (including fragments thereof) by recombinant techniques. Host cells are genetically engineered (i.e., nucleic acids are introduced, e.g., transduced, transformed or transfected) with the vectors of this invention, which may be, for example, a cloning vector or an expression vector comprising the relevant nucleic acids herein. The vector is optionally a plasmid, a viral particle, a phage, a naked nucleic acid, etc. The engineered host cells can be cultured in conventional nutrient media modified as appropriate for activating promoters, selecting transformants, or amplifying the relevant gene. The culture conditions, such as temperature, pH and the like, are those previously used with the host cell selected for expression, and will be apparent to those skilled in the art and in the references cited herein, including, Sambrook and Ausubel.

The host cell can be a eukaryotic cell, such as a yeast cell, or a plant cell, or the host cell can be a prokaryotic cell, such as a bacterial cell. Plant protoplasts are also suitable for some applications. For example, the DNA fragments are introduced into plant tissues, cultured plant cells or plant protoplasts by standard methods including electroporation (Fromm et al., (1985) Proc. Natl. Acad. Sci. USA 82, 5824, infection by viral vectors such as cauliflower mosaic virus (CaMV) (Hohn et al., (1982) Molecular Biology of Plant Tumors, (Academic Press, New York) pp. 549-560; U.S. Pat. No. 4,407,956), high velocity ballistic penetration by small particles with the nucleic acid either within the matrix of small beads or particles, or on the surface (Klein et al., (1987) Nature 327, 70-73), use of pollen as vector (WO 85/01856), or use of Agrobacterium tumefaciens or A. rhizogenes carrying a T-DNA plasmid in which DNA fragments are cloned. The T-DNA plasmid is transmitted to plant cells upon infection by Agrobacterium tumefaciens, and a portion is stably integrated into the plant genome (Horsch et al. (1984) Science 233:496-498; Fraley et al. (1983) Proc. Natl. Acad. Sci. USA 80, 4803).

The cell can include a nucleic acid of the invention which encodes a polypeptide, wherein the cells expresses a polypeptide of the invention. The cell can also include vector sequences, or the like. Furthermore, cells and transgenic plants that include any polypeptide or nucleic acid above or throughout this specification, e.g., produced by transduction of a vector of the invention, are an additional feature of the invention.

For long-term, high-yield production of recombinant proteins, stable expression can be used. Host cells transformed with a nucleotide sequence encoding a polypeptide of the invention are optionally cultured under conditions suitable for the expression and recovery of the encoded protein from cell culture. The protein or fragment thereof produced by a recombinant cell may be secreted, membrane-bound, or contained intracellularly, depending on the sequence and/or the vector used. As will be understood by those of skill in the art, expression vectors containing polynucleotides encoding mature proteins of the invention can be designed with signal sequences which direct secretion of the mature polypeptides through a prokaryotic or eukaryotic cell membrane.

XI. MODIFIED AMINO ACID RESIDUES

Polypeptides of the invention may contain one or more modified amino acid residues. The presence of modified amino acids may be advantageous in, for example, increasing polypeptide half-life, reducing polypeptide antigenicity or toxicity, increasing polypeptide storage stability, or the like. Amino acid residue(s) are modified, for example, co-translationally or post-translationally during recombinant production or modified by synthetic or chemical means.

Non-limiting examples of a modified amino acid residue include incorporation or other use of acetylated amino acids, glycosylated amino acids, sulfated amino acids, prenylated (e.g., farnesylated, geranylgeranylated) amino acids, PEG modified (e.g., “PEGylated”) amino acids, biotinylated amino acids, carboxylated amino acids, phosphorylated amino acids, etc. References adequate to guide one of skill in the modification of amino acid residues are replete throughout the literature.

The modified amino acid residues may prevent or increase affinity of the polypeptide for another molecule, including, but not limited to, polynucleotide, proteins, carbohydrates, lipids and lipid derivatives, and other organic or synthetic compounds.

XII. IDENTIFICATION OF ADDITIONAL FACTORS

A transcription factor provided by the present invention can also be used to identify additional endogenous or exogenous molecules that can affect a phentoype or trait of interest. On the one hand, such molecules include organic (small or large molecules) and/or inorganic compounds that affect expression of (i.e., regulate) a particular transcription factor. Alternatively, such molecules include endogenous molecules that are acted upon either at a transcriptional level by a transcription factor of the invention to modify a phenotype as desired. For example, the transcription factors can be employed to identify one or more downstream gene with which is subject to a regulatory effect of the transcription factor. In one approach, a transcription factor or transcription factor homologue of the invention is expressed in a host cell, e.g., a transgenic plant cell, tissue or explant, and expression products, either RNA or protein, of likely or random targets are monitored, e.g., by hybridization to a microarray of nucleic acid probes corresponding to genes expressed in a tissue or cell type of interest, by two-dimensional gel electrophoresis of protein products, or by any other method known in the art for assessing expression of gene products at the level of RNA or protein. Alternatively, a transcription factor of the invention can be used to identify promoter sequences (i.e., binding sites) involved in the regulation of a downstream target. After identifying a promoter sequence, interactions between the transcription factor and the promoter sequence can be modified by changing specific nucleotides in the promoter sequence or specific amino acids in the transcription factor that interact with the promoter sequence to alter a plant trait. Typically, transcription factor DNA-binding sites are identified by gel shift assays. After identifying the promoter regions, the promoter region sequences can be employed in double-stranded DNA arrays to identify molecules that affect the interactions of the transcription factors with their promoters (Bulyk et al. (1999) Nature Biotechnology 17:573-577).

The identified transcription factors are also useful to identify proteins that modify the activity of the transcription factor. Such modification can occur by covalent modification, such as by phosphorylation, or by protein-protein (homo or-heteropolymer) interactions. Any method suitable for detecting protein-protein interactions can be employed. Among the methods that can be employed are co-immunoprecipitation, cross-linking and co-purification through gradients or chromatographic columns, and the two-hybrid yeast system.

The two-hybrid system detects protein interactions in vivo and is described in Chien et al. ((1991), Proc. Natl. Acad. Sci. USA 88:9578-9582) and is commercially available from Clontech (Palo Alto, Calif.). In such a system, plasmids are constructed that encode two hybrid proteins: one consists of the DNA-binding domain of a transcription activator protein fused to the TF polypeptide and the other consists of the transcription activator protein's activation domain fused to an unknown protein that is encoded by a cDNA that has been recombined into the plasmid as part of a cDNA library. The DNA-binding domain fusion plasmid and the cDNA library are transformed into a strain of the yeast Saccharomyces cerevisiae that contains a reporter gene (e.g., lacZ) whose regulatory region contains the transcription activator's binding site. Either hybrid protein alone cannot activate transcription of the reporter gene. Interaction of the two hybrid proteins reconstitutes the functional activator protein and results in expression of the reporter gene, which is detected by an assay for the reporter gene product. Then, the library plasmids responsible for reporter gene expression are isolated and sequenced to identify the proteins encoded by the library plasmids. After identifying proteins that interact with the transcription factors, assays for compounds that interfere with the TF protein-protein interactions can be preformed.

XIII. IDENTIFICATION OF MODULATORS

In addition to the intracellular molecules described above, extracellular molecules that alter activity or expression of a transcription factor, either directly or indirectly, can be identified. For example, the methods can entail first placing a candidate molecule in contact with a plant or plant cell. The molecule can be introduced by topical administration, such as spraying or soaking of a plant, and then the molecule's effect on the expression or activity of the TF polypeptide or the expression of the polynucleotide monitored. Changes in the expression of the TF polypeptide can be monitored by use of polyclonal or monoclonal antibodies, gel electrophoresis or the like. Changes in the expression of the corresponding polynucleotide sequence can be detected by use of microarrays, Northerns, quantitative PCR, or any other technique for monitoring changes in mRNA expression. These techniques are exemplified in Ausubel et al. (eds) Current Protocols in Molecular Biology, John Wiley & Sons (1998, and supplements through 2001). Such changes in the expression levels can be correlated with modified plant traits and thus identified molecules can be useful for soaking or spraying on fruit, vegetable and grain crops to modify traits in plants.

Essentially any available composition can be tested for modulatory activity of expression or activity of any nucleic acid or polypeptide herein. Thus, available libraries of compounds such as chemicals, polypeptides, nucleic acids and the like can be tested for modulatory activity. Often, potential modulator compounds can be dissolved in aqueous or organic (e.g., DMSO-based) solutions for easy delivery to the cell or plant of interest in which the activity of the modulator is to be tested. Optionally, the assays are designed to screen large modulator composition libraries by automating the assay steps and providing compounds from any convenient source to assays, which are typically run in parallel (e.g., in microtiter formats on microtiter plates in robotic assays).

In one embodiment, high throughput screening methods involve providing a combinatorial library containing a large number of potential compounds (potential modulator compounds). Such “combinatorial chemical libraries” are then screened in one or more assays, as described herein, to identify those library members (particular chemical species or subclasses) that display a desired characteristic activity. The compounds thus identified can serve as target compounds.

A combinatorial chemical library can be, e.g., a collection of diverse chemical compounds generated by chemical synthesis or biological synthesis. For example, a combinatorial chemical library such as a polypeptide library is formed by combining a set of chemical building blocks (e.g., in one example, amino acids) in every possible way for a given compound length (i.e., the number of amino acids in a polypeptide compound of a set length). Exemplary libraries include peptide libraries, nucleic acid libraries, antibody libraries (see, e.g., Vaughn et al. (1996) Nature Biotechnology, 14(3):309-314 and PCT/US96/10287), carbohydrate libraries (see, e.g., Liang et al. Science (1996) 274:1520-1522 and U.S. Pat. No. 5,593,853), peptide nucleic acid libraries (see, e.g., U.S. Pat. No. 5,539,083), and small organic molecule libraries (see, e.g., benzodiazepines, Baum C&EN January 18, page 33 (1993); isoprenoids, U.S. Pat. No. 5,569,588; thiazolidinones and metathiazanones, U.S. Pat. No. 5,549,974; pyrrolidines, U.S. Pat. Nos. 5,525,735 and 5,519,134; morpholino compounds, U.S. Pat. No. 5,506,337) and the like.

Preparation and screening of combinatorial or other libraries is well known to those of skill in the art. Such combinatorial chemical libraries include, but are not limited to, peptide libraries (see, e.g., U.S. Pat. No. 5,010,175; Furka, (1991) Int. J. Pept. Prot. Res. 37:487-493; and Houghton et al. (1991) Nature 354:84-88). Other chemistries for generating chemical diversity libraries can also be used.

In addition, as noted, compound screening equipment for high-throughput screening is generally available, e.g., using any of a number of well known robotic systems that have also been developed for solution phase chemistries useful in assay systems. These systems include automated workstations including an automated synthesis apparatus and robotic systems utilizing robotic arms. Any of the above devices are suitable for use with the present invention, e.g., for high-throughput screening of potential modulators. The nature and implementation of modifications to these devices (if any) so that they can operate as discussed herein will be apparent to persons skilled in the relevant art.

Indeed, entire high throughput screening systems are commercially available. These systems typically automate entire procedures including all sample and reagent pipetting, liquid dispensing, timed incubations, and final readings of the microplate in detector(s) appropriate for the assay. These configurable systems provide high throughput and rapid start up as well as a high degree of flexibility and customization. Similarly, microfluidic implementations of screening are also commercially available.

The manufacturers of such systems provide detailed protocols the various high throughput. Thus, for example, Zymark Corp. provides technical bulletins describing screening systems for detecting the modulation of gene transcription, ligand binding, and the like. The integrated systems herein, in addition to providing for sequence alignment and, optionally, synthesis of relevant nucleic acids, can include such screening apparatus to identify modulators that have an effect on one or more polynucleotides or polypeptides according to the present invention.

In some assays it is desirable to have positive controls to ensure that the components of the assays are working properly. At least two types of positive controls are appropriate. That is, known transcriptional activators or inhibitors can be incubated with cells/plants/etc. in one sample of the assay, and the resulting increase/decrease in transcription can be detected by measuring the resulting increase in RNA/protein expression, etc., according to the methods herein. It will be appreciated that modulators can also be combined with transcriptional activators or inhibitors to find modulators that inhibit transcriptional activation or transcriptional repression. Either expression of the nucleic acids and proteins herein or any additional nucleic acids or proteins activated by the nucleic acids or proteins herein, or both, can be monitored.

In an embodiment, the invention provides a method for identifying compositions that modulate the activity or expression of a polynucleotide or polypeptide of the invention. For example, a test compound, whether a small or large molecule, is placed in contact with a cell, plant (or plant tissue or explant), or composition comprising the polynucleotide or polypeptide of interest and a resulting effect on the cell, plant, (or tissue or explant) or composition is evaluated by monitoring, either directly or indirectly, one or more of: expression level of the polynucleotide or polypeptide, activity (or modulation of the activity) of the polynucleotide or polypeptide. In some cases, an alteration in a plant phenotype can be detected following contact of a plant (or plant cell, or tissue or explant) with the putative modulator, e.g., by modulation of expression or activity of a polynucleotide or polypeptide of the invention. Modulation of expression or activity of a polynucleotide or polypeptide of the invention may also be caused by molecular elements in a signal transduction second messenger pathway and such modulation can affect similar elements in the same or another signal transduction second messenger pathway.

XIV. SUBSEQUENCES

Also contemplated are uses of polynucleotides, also referred to herein as oligonucleotides, typically having at least 12 bases, preferably at least 15, more preferably at least 20, 30, or 50 bases, which hybridize under at least highly stringent (or ultra-high stringent or ultra-ultra-high stringent conditions) conditions to a polynucleotide sequence described above. The polynucleotides may be used as probes, primers, sense and antisense agents, and the like, according to methods as noted supra.

Subsequences of the polynucleotides of the invention, including polynucleotide fragments and oligonucleotides are useful as nucleic acid probes and primers. An oligonucleotide suitable for use as a probe or primer is at least about 15 nucleotides in length, more often at least about 18 nucleotides, often at least about 21 nucleotides, frequently at least about 30 nucleotides, or about 40 nucleotides, or more in length. A nucleic acid probe is useful in hybridization protocols, e.g., to identify additional polypeptide homologues of the invention, including protocols for microarray experiments. Primers can be annealed to a complementary target DNA strand by nucleic acid hybridization to form a hybrid between the primer and the target DNA strand, and then extended along the target DNA strand by a DNA polymerase enzyme. Primer pairs can be used for amplification of a nucleic acid sequence, e.g., by the polymerase chain reaction (PCR) or other nucleic-acid amplification methods. See Sambrook and Ausubel, supra.

In addition, the invention includes an isolated or recombinant polypeptide including a subsequence of at least about 15 contiguous amino acids encoded by the recombinant or isolated polynucleotides of the invention. For example, such polypeptides, or domains or fragments thereof, can be used as immunogens, e.g., to produce antibodies specific for the polypeptide sequence, or as probes for detecting a sequence of interest. A subsequence can range in size from about 15 amino acids in length up to and including the full length of the polypeptide.

To be encompassed by the present invention, an expressed polypeptide which comprises such a polypeptide subsequence performs at least one biological function of the intact polypeptide in substantially the same manner, or to a similar extent, as does the intact polypeptide. For example, a polypeptide fragment can comprise a recognizable structural motif or functional domain such as a DNA binding domain that binds to a specific DNA promoter region, an activation domain or a domain for protein-protein interactions.

XV. PRODUCTION OF TRANSGENIC PLANTS

Modification of Traits

The polynucleotides of the invention are favorably employed to produce transgenic plants with various traits, or characteristics, that have been modified in a desirable manner, e.g., to improve the seed characteristics of a plant. For example, alteration of expression levels or patterns (e.g., spatial or temporal expression patterns) of one or more of the transcription factors (or transcription factor homologues) of the invention, as compared with the levels of the same protein found in a wild type plant, can be used to modify a plant's traits. An illustrative example of trait modification, improved characteristics, by altering expression levels of a particular transcription factor is described further in the Examples and the Sequence Listing.

Arabidopsis as a model system

Arabidopsis thaliana is the object of rapidly growing attention as a model for genetics and metabolism in plants. Arabidopsis has a small genome, and well documented studies are available. It is easy to grow in large numbers and mutants defining important genetically controlled mechanisms are either available, or can readily be obtained. Various methods to introduce and express isolated homologous genes are available (see Koncz, et al., eds. Methods in Arabidopsis Research. et al. (1992), World Scientific, New Jersey, N.J., in “Preface”). Because of its small size, short life cycle, obligate autogamy and high fertility, Arabidopsis is also a choice organism for the isolation of mutants and studies in morphogenetic and development pathways, and control of these pathways by transcription factors (Koncz, supra, p. 72). A number of studies introducing transcription factors into A. thaliana have demonstrated the utility of this plant for understanding the mechanisms of gene regulation and trait alteration in plants. See, for example, Koncz, supra, and U.S. Pat. No. 6,417,428).

Arabidopsis Genes in Transgenic Plants.

Expression of genes which encode transcription factors modify expression of endogenous genes, polynucleotides, and proteins are well known in; the art. In addition, transgenic plants comprising isolated polynucleotides encoding transcription factors may also modify expression of endogenous genes, polynucleotides, and proteins. Examples include Peng et al. (1997, Genes and Development 11:3194-3205) and Peng et al. (1999, Nature, 400:256-261). In addition, many others have demonstrated that an Arabidopsis transcription factor expressed in an exogenous plant species elicits the same or very similar phenotypic response. See, for example, Fu et al. (2001, Plant Cell 13:1791-1802); Nandi et al. (2000, Curr. Biol. 10:215-218); Coupland (1995, Nature 377:482-483); and Weigel and Nilsson (1995, Nature 377:482-500).

Homologous Genes Introduced into Transgenic Plants.

Homologous genes that may be derived from any plant, or from any source whether natural, synthetic, semi-synthetic or recombinant, and that share significant sequence identity or similarity to those provided by the present invention, may be introduced into plants, for example, crop plants, to confer desirable or improved traits. Consequently, transgenic plants may be produced that comprise a recombinant expression vector or cassette with a promoter operably linked to one or more sequences homologous to presently disclosed sequences. The promoter may be, for example, a plant or viral promoter.

The invention thus provides for methods for preparing transgenic plants, and for modifying plant traits. These methods include introducing into a plant a recombinant expression vector or cassette comprising a functional promoter operably linked to one or more sequences homologous to presently disclosed sequences. Plants and kits for producing these plants that result from the application of these methods are also encompassed by the present invention.

Traits of Interest

Examples of some of the traits that may be desirable in plants, and that may be provided by transforming the plants with the presently disclosed sequences, are listed in Table 6. TABLE 6 Genes, traits and utilities that affect plant characteristics Transcription factor genes that Utility Trait Category Traits impact traits Gene effect on: Resistance and Salt stress resistance G22; G196; G226; G303; G312; Germination rate, tolerance G325; G353; G482; G545; G801; survivability, yield; G867; G884; G922; G926; G1452; extended growth G1794; G1820; G1836; G1843; range G1863; G2053; G2110; G2140; G2153; G2379; G2701; G2713; G2719; G2789 Osmotic stress G47; G175; G188; G303; G325; Germination rate, resistance G353; G489; G502; G526; G921; survivability, yield G922; G926; G1069; G1089; G1452; G1794; G1930; G2140; G2153; G2379; G2701; G2719; G2789; Cold stress resistance; G256; G394; G664; G864; G1322; Germination, cold germination G2130 growth, earlier planting Tolerance to freezing G303; G325; G353; G720; G912; Survivability, yield, G913; G1794; G2053; G2140; appearance, G2153; G2379; G2701; G2719; extended range G2789 Heat stress resistance G3; G464; G682; G864; G964; Germination, G1305; G1645; G2130; G2430 growth, later planting Drought, low humidity G303; G325; G353; G720; G912; Survivability, yield, resistance G926; G1452; G1794; G1820; extended range G1843; G2053; G2140; G2153; G2379; G2583; G2701; G2719; G2789 Radiation resistance G1052 Survivability, vigor, appearance Decreased herbicide G343; G2133; G2517 Resistant to sensitivity increased herbicide use Increased herbicide G374; G877; G1519 Use as a herbicide sensitivity target Oxidative stress G477; G789; G1807; G2133; Improved yield, G2517 appearance, reduced senescence Light response G183; G354; G375; G1062; Germination, G1322; G1331; G1488; G1494; growth, G1521; G1786; G1794; G2144; development, G2555; flowering time Development, Overall plant G24; G27; G31; G33; G47; G147; Vascular tissues, morphology architecture G156; G160; G182; G187; G195; lignin content; cell G196; G211; G221; G237; G280; wall content; G342; G352; G357; G358; G360; appearance G362; G364; G365; G367; G373; G377; G396; G431; G447; G479; G546; G546; G551; G578; G580; G596; G615; G617; G620; G625; G638; G658; G716; G725; G727; G730; G740; G770; G858; G865; G869; G872; G904; G910; G912; G920; G939; G963; G977; G979; G987; G988; G993; G1007; G1010; G1014; G1035; G1046; G1049; G1062; G1069; G1070; G1076; G1089; G1093; G1127; G1131; G1145; G1229; G1246; G1304; G1318; G1320; G1330; G1331; G1352; G1354; G1360; G1364; G1379; G1384; G1399; G1415; G1417; G1442; G1453; G1454; G1459; G1460; G1471; G1475; G1477; G1487; G1487; G1492; G1499; G1499; G1531; G1540; G1543; G1543; G1544; G1548; G1584; G1587; G1588; G1589; G1636; G1642; G1747; G1749; G1749; G1751; G1752; G1763; G1766; G1767; G1778; G1789; G1790; G1791; G1793; G1794; G1795; G1800; G1806; G1811; G1835; G1836; G1838; G1839; G1843; G1853; G1855; G1865; G1881; G1882; G1883; G1884; G1891; G1896; G1898; G1902; G1904; G1906; G1913; G1914; G1925; G1929; G1930; G1954; G1958; G1965; G1976; G2057; G2107; G2133; G2134; G2151; G2154; G2157; G2181; G2290; G2299; G2340; G2340; G2346; G2373; G2376; G2424; G2465; G2505; G2509; G2512; G2513; G2519; G2520; G2533; G2534; G2573; G2589; G2687; G2720; G2787; G2789; G2893 Size: increased stature G189; G1073; G1435; G2430 Size: reduced stature G3; G5; G21; G23; G39; G165; Ornamental; small or dwarfism G184; G194; G258; G280; G340; stature provides G343; G353; G354; G362; G363; wind resistance; G370; G385; G396; G439; G440; creation of dwarf G447; G450; G550; G557; G599; varieties G636; G652; G670; G671; G674; G729; G760; G804; G831; G864; G884; G898; G900; G912; G913; G922; G932; G937; G939; G960; G962; G977; G991; G1000; G1008; G1020; G1023; G1053; G1067; G1075; G1137; G1181; G1198; G1228; G1266; G1267; G1275; G1277; G1309; G1311; G1314; G1317; G1322; G1323; G1326; G1332; G1334; G1367; G1381; G1382; G1386; G1421; G1488; G1494; G1537; G1545; G1560; G1586; G1641; G1652; G1655; G1671; G1750; G1756; G1757; G1782; G1786; G1794; G1839; G1845; G1879; G1886; G1888; G1933; G1939; G1943; G1944; G2011; G2094; G2115; G2130; G2132; G2144; G2145; G2147; G2156; G2294; G2313; G2344; G2431; G2510; G2517; G2521; G2893; G2893 Fruit size and number G362 Biomass, yield, cotton boll fiber density Flower structure, G47; G259; G353; G354; G671; Ornamental inflorescence G732; G988; G1000; G1063; horticulture; G1140; G1326; G1449; G1543; production of G1560; G1587; G1645; G1947; saffron or other G2108; G2143; G2893 edible flowers Number and G225; G226; G247; G362; G585; Resistance to pests development of G634; G676; G682; G1014; and desiccation; trichomes G1332; G1452; G1795; G2105 essential oil production Seed size, color, and G156; G450; G584; G652; G668; Yield number G858; G979; G1040; G1062; G1145; G1255; G1494; G1531; G1534; G1594; G2105; G2114; Root development, G9; G1482; G1534; G1794; modifications G1852; G2053; G2136; G2140 Modifications to root G225; G226 Nutrient, water hairs uptake, pathogen resistance Apical dominance G559; G732; G1255; G1275; Ornamental G1411; G1488; G1635; G2452; horticulture G2509 Branching patterns G568; G988; G1548 Ornamental horticulture, knot reduction, improved windscreen Leaf shape, color, G375; G377; G428; G438; G447; Appealing shape or modifications G464; G557; G577; G599; G635; shiny leaves for G671; G674; G736; G804; G903; ornamental G977; G921; G922; G1038; agriculture, G1063; G1067; G1073; G1075; increased biomass G1146; G1152; G1198; G1267; or photosynthesis G1269; G1452; G1484; G1586; G1594; G1767; G1786; G1792; G1886; G2059; G2094; G2105; G2113; G2117; G2143; G2144; G2431; G2452; G2465; G2587; G2583; G2724; Silique G1134 Ornamental Stem morphology G47; G438; G671; G748; G988; Ornamental; G1000 digestibility Shoot modifications G390; G391 Ornamental stem bifurcations Disease, Bacterial G211; G347; G367; G418; G525; Yield, appearance, Pathogen G545; G578; G1049 survivability, Resistance extended range Fungal G19; G28; G28; G28; G147; Yield, appearance, G188; G207; G211; G237; G248; survivability, G278; G347; G367; G371; G378; extended range G409; G477; G545; G545; G558; G569; G578; G591; G594; G616; G789; G805; G812; G865; G869; G872; G881; G896; G940; G1047; G1049; G1064; G1084; G1196; G1255; G1266; G1363; G1514; G1756; G1792; G1792; G1792; G1792; G1880; G1919; G1919; G1927; G1927; G1936; G1936; G1950; G2069; G2130; G2380; G2380; G2555 Nutrients Increased tolerance to G225; G226; G1792 nitrogen-limited soils Increased tolerance to G419; G545; G561; G1946 phosphate-limited soils Increased tolerance to G561; G911 potassium-limited soils Hormonal Hormone sensitivity G12; G546; G926; G760; G913; Seed dormancy, G926; G1062; G1069; G1095; drought tolerance; G1134; G1330; G1452; G1666; plant form, fruit G1820; G2140; G2789 ripening Seed Production of seed G214; G259; G490; G652; G748; Antioxidant activity, biochemistry prenyl lipids, including G883; G1052; G1328; G1930; vitamin E tocopherol G2509; G2520 Production of seed G20 Precursors for sterols human steroid hormones; cholesterol modulators Production of seed G353; G484; G674; G1272; Defense against glucosinolates G1506; G1897; G1946; G2113; insects; putative G2117; G2155; G2290; G2340 anticancer activity; undesirable in animal feeds Modified seed oil G162; G162; G180; G192; G241; Vegetable oil content G265; G286; G291; G427; G509; production; G519; G561; G567; G590; G818; increased caloric G849; G892; G961; G974; G1063; value for animal G1143; G1190; G1198; G1226; feeds; lutein content G1229; G1323; G1451; G1471; G1478; G1496; G1526; G1543; G1640; G1644; G1646; G1672; G1677; G1750; G1765; G1777; G1793; G1838; G1902; G1946; G1948; G2059; G2123; G2138; G2139; G2343; G2792; G2830 Modified seed oil G217; G504; G622; G778; G791; Heat stability, composition G861; G869; G938; G965; G1417; digestibility of seed G2192 oils Modified seed protein G162; G226; G241; G371; G427; Reduced caloric content G509; G567; G597; G732; G849; value for humans G865; G892; G963; G988; G1323; G1323; G1419; G1478; G1488; G1634; G1637; G1641; G1644; G1652; G1677; G1777; G1777; G1818; G1820; G1903; G1909; G1946; G1946; G1958; G2059; G2117; G2417; G2509 Leaf Production of G1666* Ornamental pigment biochemistry flavonoids production; pathogen resistance; health benefits Production of leaf G264; G353; G484; G652; G674; Defense against glucosinolates G681; G1069; G1198; G1322; insects; putative G1421; G1657; G1794; G1897; anticancer activity; G1946; G2115; G2117; G2144; undesirable in G2155; G2155; G2340; G2512; animal feeds G2520; G2552 Production of G229 Induction of diterpenes enzymes involved in alkaloid biosynthesis Production of G546 Ornamental pigment anthocyanin Production of leaf G561; G2131; G2424 Precursors for phytosterols, inc. human steroid stigmastanol, hormones; campesterol cholesterol modulators Leaf fatty acid G214; G377; G861; G962; G975; Nutritional value; composition G987; G1266; G1337; G1399; increase in waxes G1465; G1512; G2136; G2147; for disease G2192 resistance Production of leaf G214; G259; G280; G652; G987; Antioxidant activity, prenyl lipids, including G1543; G2509; G2520 vitamin E tocopherol Biochemistry, Production of G229; G663 general miscellaneous secondary metabolites Sugar, starch, G158; G211; G211; G237; G242; Food digestibility, hemicellulose G274; G598; G1012; G1266; hemicellulose & composition, G1309; G1309; G1641; G1765; pectin content; fiber G1865; G2094; G2094; G2589; content; plant G2589 tensile strength, wood quality, pathogen resistance, pulp production; tuber starch content Sugar sensing Plant response G26; G38; G43; G207; G218; Photosynthetic rate, to sugars G241; G254; G263; G308; G536; carbohydrate G567; G567; G680; G867; G912; accumulation, G956; G996; G1068; G1225; biomass production, G1314; G1314; G1337; G1759; source-sink G1804; G2153; G2379 relationships, senescence Growth, Plant growth rate and G447; G617; G674; G730; G917; Faster growth, Reproduction development G937; G1035; G1046; G1131; increased biomass G1425; G1452; G1459; G1492; or yield, improved G1589; G1652; G1879; G1943; appearance; delay in G2430; G2431; G2465; G2521 bolting Embryo development G167 Seed germination rate G979; G1792; G2130 Yield Plant, seedling vigor G561; G2346 Survivability, yield Senescence; cell death G571; G636; G878; G1050; Yield, appearance; G1463; G1749; G1944; G2130; response to G2155; G2340; G2383 pathogens; Modified fertility G39; G340; G439; G470; G559; Prevents or G615; G652; G671; G779; G962; minimizes escape of G977; G988; G1000; G1063; the pollen of GMOs G1067; G1075; G1266; G1311; G1321; G1326; G1367; G1386; G1421; G1453; G1471; G1453; G1560; G1594; G1635; G1750; G1947; G2011; G2094; G2113; G2115; G2130; G2143; G2147; G2294; G2510; G2893 Early flowering G147; G157; G180; G183; G183; Faster generation G184; G185; G208; G227; G294; time; synchrony of G390; G390; G390; G391; G391; flowering; potential G427; G427; G490; G565; G590; for introducing new G592; G720; G789; G865; G898; traits to single G898; G989; G989; G1037; variety G1037; G1142; G1225; G1225; G1226; G1242; G1305; G1305; G1380; G1380; G1480; G1480; G1488; G1494; G1545; G1545; G1649; G1706; G1760; G1767; G1767; G1820; G1841; G1841; G1842; G1843; G1843; G1946; G1946; G2010; G2030; G2030; G2144; G2144; G2295; G2295; G2347; G2348; G2348; G2373; G2373; G2509; G2509; G2555; G2555 Delayed flowering G8; G47; G192; G214; G234; Delayed time to G361; G362; G562; G568; G571; pollen production of G591; G680; G736; G748; G859; GMO plants; G878; G910; G912; G913; G971; synchrony of G994; G1051; G1052; G1073; flowering; increased G1079; G1335; G1435; G1452; yield G1478; G1789; G1804; G1865; G1865; G1895; G1900; G2007; G2133; G2155; G2291; G2465 Extended flowering G1947 phase Flower and leaf G259; G353; G377; G580; G638; Ornamental development G652; G858; G869; G917; G922; applications; G932; G1063; G1075; G1140; decreased fertility G1425; G1452; G1499; G1548; G1645; G1865; G1897; G1933; G2094; G2124; G2140; G2143; G2535; G2557 Flower abscission G1897 Ornamental: longer retention of flowers *When co-expressed with G669 and G663 Significance of Modified Plant Traits

Currently, the existence of a series of maturity groups for different latitudes represents a major barrier to the introduction of new valuable traits. Any trait (e.g. disease resistance) has to be bred into each of the different maturity groups separately, a laborious and costly exercise. The availability of single strain, which could be grown at any latitude, would therefore greatly increase the potential for introducing new traits to crop species such as soybean and cotton.

For many of the traits, listed in Table 6 and below, that may be conferred to plants, a single transcription factor gene may be used to increase or decrease, advance or delay, or improve or prove deleterious to a given trait. For example, overexpression of a transcription factor gene that naturally occurs in a plant may cause early flowering relative to non-transformed or wild-type plants. By knocking out the gene, or suppressing the gene (with, for example, antisense suppression) the plant may experience delayed flowering. Similarly, overexpressing or suppressing one or more genes can impart significant differences in production of plant products, such as different fatty acid ratios. Thus, suppressing a gene that causes a plant to be more sensitive to cold may improve a plant's tolerance of cold.

Salt stress resistance. Soil salinity is one of the more important variables that determines where a plant may thrive. Salinity is especially important for the successful cultivation of crop plants, particular in many parts of the world that have naturally high soil salt concentrations, or where the soil has been over-utilized. Thus, presently disclosed transcription factor genes that provide increased salt tolerance during germination, the seedling stage, and throughout a plant's life cycle would find particular value for imparting survivability and yield in areas where a particular crop would not normally prosper.

Osmotic stress resistance. Presently disclosed transcription factor genes that confer resistance to osmotic stress may increase germination rate under adverse conditions, which could impact survivability and yield of seeds and plants.

Cold stress resistance. The potential utility of presently disclosed transcription factor genes that increase tolerance to cold is to confer better germination and growth in cold conditions. The germination of many crops is very sensitive to cold temperatures. Genes that would allow germination and seedling vigor in the cold would have highly significant utility in allowing seeds to be planted earlier in the season with a high rate of survivability. Transcription factor genes that confer better survivability in cooler climates allow a grower to move up planting time in the spring and extend the growing season further into autumn for higher crop yields.

Tolerance to freezing. The presently disclosed transcription factor genes that impart tolerance to freezing conditions are useful for enhancing the survivability and appearance of plants conditions or conditions that would otherwise cause extensive cellular damage. Thus, germination of seeds and survival may take place at temperatures significantly below that of the mean temperature required for germination of seeds and survival of non-transformed plants. As with salt tolerance, this has the added benefit of increasing the potential range of a crop plant into regions in which it would otherwise succumb. Cold tolerant transformed plants may also be planted earlier in the spring or later in autumn, with greater success than with non-transformed plants.

Heat stress tolerance. The germination of many crops is also sensitive to high temperatures. Presently disclosed transcription factor genes that provide increased heat tolerance are generally useful in producing plants that germinate and grow in hot conditions, may find particular use for crops that are planted late in the season, or extend the range of a plant by allowing growth in relatively hot climates.

Drought, low humidity tolerance. Strategies that allow plants to survive in low water conditions may include, for example, reduced surface area or surface oil or wax production. A number of presently disclosed transcription factor genes increase a plant's tolerance to low water conditions and provide the benefits of improved survivability, increased yield and an extended geographic and temporal planting range.

Radiation resistance. Presently disclosed transcription factor genes have been shown to increase lutein production. Lutein, like other xanthophylls such as zeaxanthin and violaxanthin, are important in the protection of plants against the damaging effects of excessive light. Lutein contributes directly or indirectly, to the rapid rise of non-photochemical quenching in plants exposed to high light. Increased tolerance of field plants to visible and ultraviolet light impacts survivability and vigor, particularly for recent transplants. Also affected are the yield and appearance of harvested plants or plant parts. Crop plants engineered with presently disclosed transcription factor genes that cause the plant to produce higher levels of lutein therefore would have improved photoprotection, leading to less oxidative damage and increase vigor, survivability and higher yields under high light and ultraviolet light conditions.

Decreased herbicide sensitivity. Presently disclosed transcription factor genes that confer resistance or tolerance to herbicides (e.g., glyphosate) may find use in providing means to increase herbicide applications without detriment to desirable plants. This would allow for the increased use of a particular herbicide in a local environment, with the effect of increased detriment to undesirable species and less harm to transgenic, desirable cultivars.

Increased herbicide sensitivity. Knockouts of a number of the presently disclosed transcription factor genes have been shown to be lethal to developing embryos. Thus, these genes are potentially useful as herbicide targets.

Oxidative stress. In plants, as in all living things, abiotic and biotic stresses induce the formation of oxygen radicals, including superoxide and peroxide radicals. This has the effect of accelerating senescence, particularly in leaves, with the resulting loss of yield and adverse effect on appearance. Generally, plants that have the highest level of defense mechanisms, such as, for example, polyunsaturated moieties of membrane lipids, are most likely to thrive under conditions that introduce oxidative stress (e.g., high light, ozone, water deficit, particularly in combination). Introduction of the presently disclosed transcription factor genes that increase the level of oxidative stress defense mechanisms would provide beneficial effects on the yield and appearance of plants. One specific oxidizing agent, ozone, has been shown to cause significant foliar injury, which impacts yield and appearance of crop and ornamental plants. In addition to reduced foliar injury that would be found in ozone resistant plant created by transforming plants with some of the presently disclosed transcription factor genes, the latter have also been shown to have increased chlorophyll fluorescence (Yu-Sen Chang et al. Bot. Bull. Acad. Sin. (2001) 42: 265-272).

Heavy metal tolerance. Heavy metals such as lead, mercury, arsenic, chromium and others may have a significant adverse impact on plant respiration. Plants that have been transformed with presently disclosed transcription factor genes that confer improved resistance to heavy metals, through, for example, sequestering or reduced uptake of the metals will show improved vigor and yield in soils with relatively high concentrations of these elements. Conversely, transgenic transcription factors may also be introduced into plants to confer an increase in heavy metal uptake, which may benefit efforts to clean up contaminated soils.

Light response. Presently disclosed transcription factor genes that modify a plant's response to light may be useful for modifying a plant's growth or development, for example, photomorphogenesis in poor light, or accelerating flowering time in response to various light intensities, quality or duration to which a non-transformed plant would not similarly respond. Examples of such responses that have been demonstrated include leaf number and arrangement, and early flower bud appearances.

Overall plant architecture. Several presently disclosed transcription factor genes have been introduced into plants to alter numerous aspects of the plant's morphology. For example, it has been demonstrated that a number of transcription factors may be used to manipulate branching, such as the means to modify lateral branching, a possible application in the forestry industry. Transgenic plants have also been produced that have altered cell wall content, lignin production, flower organ number, or overall shape of the plants. Presently disclosed transcription factor genes transformed into plants may be used to affect plant morphology by increasing or decreasing internode distance, both of which may be advantageous under different circumstances. For example, for fast growth of woody plants to provide more biomass, or fewer knots, increased internode distances are generally desirable. For improved wind screening of shrubs or trees, or harvesting characteristics of, for example, members of the Gramineae family, decreased internode distance may be advantageous. These modifications would also prove useful in the ornamental horticulture industry for the creation of unique phenotypic characteristics of ornamental plants.

Increased stature. For some ornamental plants, the ability to provide larger varieties may be highly desirable. For many plants, including t fruit-bearing trees or trees and shrubs that serve as view or wind screens, increased stature provides obvious benefits. Crop species may also produce higher yields on larger cultivars.

Reduced stature or dwarfism. Presently disclosed transcription factor genes that decrease plant stature can be used to produce plants that are more resistant to damage by wind and rain, or more resistant to heat or low humidity or water deficit. Dwarf plants are also of significant interest to the ornamental horticulture industry, and particularly for home garden applications for which space availability may be limited.

Fruit size and number. Introduction of presently disclosed transcription factor genes that affect fruit size will have desirable impacts on fruit size and number, which may comprise increases in yield for fruit crops, or reduced fruit yield, such as when vegetative growth is preferred (e.g., with bushy ornamentals, or where fruit is undesirable, as with ornamental olive trees).

Flower structure, inflorescence, and development. Presently disclosed transgenic transcription factors have been used to create plants with larger flowers or arrangements of flowers that are distinct from wild-type or non-transformed cultivars. This would likely have the most value for the ornamental horticulture industry, where larger flowers or interesting presentations generally are preferred and command the highest prices. Flower structure may have advantageous effects on fertility, and could be used, for example, to decrease fertility by the absence, reduction or screening of reproductive components. One interesting application for manipulation of flower structure, for example, by introduced transcription factors could be in the increased production of edible flowers or flower parts, including saffron, which is derived from the stigmas of Crocus sativus.

Number and development of trichomes. Several presently disclosed transcription factor genes have been used to modify trichome number and amount of trichome products in plants. Trichome glands on the surface of many higher plants produce and secrete exudates that give protection from the elements and pests such as insects, microbes and herbivores. These exudates may physically immobilize insects and spores, may be insecticidal or ant-microbial or they may act as allergens or irritants to protect against herbivores. Trichomes have also been suggested to decrease transpiration by decreasing leaf surface air flow, and by exuding chemicals that protect the leaf from the sun.

Seed size, color and number. The introduction of presently disclosed transcription factor genes into plants that alter the size or number of seeds may have a significant impact on yield, both when the product is the seed itself, or when biomass of the vegetative portion of the plant is increased by reducing seed production. In the case of fruit products, it is often advantageous to modify a plant to have reduced size or number of seeds relative to non-transformed plants to provide seedless or varieties with reduced numbers or smaller seeds. Presently disclosed transcription factor genes have also been shown to affect seed size, including the development of larger seeds. Seed size, in addition to seed coat integrity, thickness and permeability, seed water content and by a number of other components including antioxidants and oligosaccharides, may affect seed longevity in storage. This would be an important utility when the seed of a plant is the harvested crops, as with, for example, peas, beans, nuts, etc. Presently disclosed transcription factor genes have also been used to modify seed color, which could provide added appeal to a seed product.

Root development, modifications. By modifying the structure or development of roots by transforming into a plant one or more of the presently disclosed transcription factor genes, plants may be produced that have the capacity to thrive in otherwise unproductive soils. For example, grape roots that extend further into rocky soils, or that remain viable in waterlogged soils, would increase the effective planting range of the crop. It may be advantageous to manipulate a plant to produce short roots, as when a soil in which the plant will be growing is occasionally flooded, or when pathogenic fungi or disease-causing nematodes are prevalent.

Modifications to root hairs. Presently disclosed transcription factor genes that increase root hair length or number potentially could be used to increase root growth or vigor, which might in turn allow better plant growth under adverse conditions such as limited nutrient or water availability.

Apical dominance. The modified expression of presently disclosed transcription factors that control apical dominance could be used in ornamental horticulture, for example, to modify plant architecture.

Branching patterns. Several presently disclosed transcription factor genes have been used to manipulate branching, which could provide benefits in the forestry industry. For example, reduction in the formation of lateral branches could reduce knot formation. Conversely, increasing the number of lateral branches could provide utility when a plant is used as a windscreen, or may also provide ornamental advantages.

Leaf shape, color and modifications. It has been demonstrated in laboratory experiments that overexpression of some of the presently disclosed transcription factors produced marked effects on leaf development. At early stages of growth, these transgenic seedlings developed narrow, upward pointing leaves with long petioles, possibly indicating a disruption in circadian-clock controlled processes or nyctinastic movements. Other transcription factor genes can be used to increase plant biomass; large size would be useful in crops where the vegetative portion of the plant is the marketable portion.

Siliques. Genes that later silique conformation in brassicates may be used to modify fruit ripening processes in brassicates and other plants, which may positively affect seed or fruit quality.

Stem morphology and shoot modifications. Laboratory studies have demonstrated that introducing several of the presently disclosed transcription factor genes into plants can cause stem bifurcations in shoots, in which the shoot meristems split to form two or three separate shoots. This unique appearance would be desirable in ornamental applications.

Diseases, pathogens and pests. A number of the presently disclosed transcription factor genes have been shown to or are likely to confer resistance to various plant diseases, pathogens and pests. The offending organisms include fungal pathogens Fusarium oxysporum, Botrytis cinerea, Sclerotinia scierotiorum, and Erysiphe orontii. Bacterial pathogens to which resistance may be conferred include Pseudomonas syringae. Other problem organisms may potentially include nematodes, mollicutes, parasites, or herbivorous arthropods. In each case, one or more transformed transcription factor genes may provide some benefit to the plant to help prevent or overcome infestation. The mechanisms by which the transcription factors work could include increasing surface waxes or oils, surface thickness, local senescence, or the activation of signal transduction pathways that regulate plant defense in response to attacks by herbivorous pests (including, for example, protease inhibitors).

Increased tolerance of plants to nutrient-limited soils. Presently disclosed transcription factor genes introduced into plants may provide the means to improve uptake of essential nutrients, including nitrogenous compounds, phosphates, potassium, and trace minerals. The effect of these modifications is to increase the seedling germination and range of ornamental and crop plants. The utilities of presently disclosed transcription factor genes conferring tolerance to conditions of low nutrients also include cost savings to the grower by reducing the amounts of fertilizer needed, environmental benefits of reduced fertilizer runoff; and improved yield and stress tolerance. In addition, this gene could be used to alter seed protein amounts and/or composition that could impact yield as well as the nutritional value and production of various food products.

Hormone sensitivity. One or more of the presently disclosed transcription factor genes have been shown to affect plant abscisic acid (ABA) sensitivity. This plant hormone is likely the most important hormone in mediating the adaptation of a plant to stress. For example, ABA mediates conversion of apical meristems into dormant buds. In response to increasingly cold conditions, the newly developing leaves growing above the meristem become converted into stiff bud scales that closely wrap the meristem and protect it from mechanical damage during winter. ABA in the bud also enforces dormancy; during premature warm spells, the buds are inhibited from sprouting. Bud dormancy is eliminated after either a prolonged cold period of cold or a significant number of lengthening days. Thus, by affecting ABA sensitivity, introduced transcription factor genes may affect cold sensitivity and survivability. ABA is also important in protecting plants from drought tolerance.

Several other of the present transcription factor genes have been used to manipulate ethylene signal transduction and response pathways. These genes can thus be used to manipulate the processes influenced by ethylene, such as seed germination or fruit ripening, and to improve seed or fruit quality.

Production of seed and leaf prenyl lipids, including tocopherol. Prenyl lipids play a role in anchoring proteins in membranes or membranous organelles. Thus modifying the prenyl lipid content of seeds and leaves could affect membrane integrity and function. A number of presently disclosed transcription factor genes have been shown to modify the tocopherol composition of plants. Tocopherols have both anti-oxidant and vitamin E activity.

Production of seed and leaf phytosterols: Presently disclosed transcription factor genes that modify levels of phytosterols in plants may have at least two utilities. First, phytosterols are an important source of precursors for the manufacture of human steroid hormones. Thus, regulation of transcription factor expression or activity could lead to elevated levels of important human steroid precursors for steroid semi-synthesis. For example, transcription factors that cause elevated levels of campesterol in leaves, or sitosterols and stigmasterols in seed crops, would be useful for this purpose. Phytosterols and their hydrogenated derivatives phytostanols also have proven cholesterol-lowering properties, and transcription factor genes that modify the expression of these compounds in plants would thus provide health benefits.

Production of seed and leaf glucosinolates. Some glucosinolates have anti-cancer activity; thus, increasing the levels or composition of these compounds by introducing several of the presently disclosed transcription factors might be of interest from a nutraceutical standpoint. (3) Glucosinolates form part of a plants natural defense against insects. Modification of glucosinolate composition or quantity could therefore afford increased protection from predators. Furthermore, in edible crops, tissue specific promoters might be used to ensure that these compounds accumulate specifically in tissues, such as the epidermis, which are not taken for consumption.

Modified seed oil content. The composition of seeds, particularly with respect to seed oil amounts and/or composition, is very important for the nutritional value and production of various food and feed products. Several of the presently disclosed transcription factor genes in seed lipid saturation that alter seed oil content could be used to improve the heat stability of oils or to improve the nutritional quality of seed oil, by, for example, reducing the number of calories in seed, increasing the number of calories in animal feeds, or altering the ratio of saturated to unsaturated lipids comprising the oils.

Seed and leaf fatty acid composition. A number of the presently disclosed transcription factor genes have been shown to alter the fatty acid composition in plants, and seeds in particular. This modification may find particular value for improving the nutritional value of, for example, seeds or whole plants. Dietary fatty acids ratios have been shown to have an effect on, for example, bone integrity and remodeling (see, for example, Weiler, H. A., Pediatr Res (2000) 47:5 692-697). The ratio of dietary fatty acids may alter the precursor pools of long-chain polyunsaturated fatty acids that serve as precursors for prostaglandin synthesis. In mammalian connective tissue, prostaglandins serve as important signals regulating the balance between resorption and formation in bone and cartilage. Thus dietary fatty acid ratios altered in seeds may affect the etiology and outcome of bone loss.

Modified seed protein content. As with seed oils, the composition of seeds, particularly with respect to protein amounts and/or composition, is very important for the nutritional value and production of various food and feed products. A number of the presently disclosed transcription factor genes modify the protein concentrations in seeds would provide nutritional benefits, and may be used to prolong storage, increase seed pest or disease resistance, or modify germination rates.

Production of flavonoids in leaves and other plant parts. Expression of presently disclosed transcription factor genes that increase flavonoid production in plants, including anthocyanins and condensed tannins, may be used to alter in pigment production for horticultural purposes, and possibly increasing stress resistance. Flavonoids have antimicrobial activity and could be used to engineer pathogen resistance. Several flavonoid compounds have health promoting effects such as the inhibition of tumor growth and cancer, prevention of bone loss and the prevention of the oxidation of lipids. Increasing levels of condensed tannins, whose biosynthetic pathway is shared with anthocyanin biosynthesis, in forage legumes is an important agronomic trait because they prevent pasture bloat by collapsing protein foams within the rumen. For a review on the utilities of flavonoids and their derivatives, refer to Dixon et al. (1999) Trends Plant Sci. 4:394-400.

Production of diterpenes in leaves and other plant parts. Depending on the plant species, varying amounts of diverse secondary biochemicals (often lipophilic terpenes) are produced and exuded or volatilized by trichomes. These exotic secondary biochemicals, which are relatively easy to extract because they are on the surface of the leaf, have been widely used in such products as flavors and aromas, drugs, pesticides and cosmetics. Thus, the overexpression of genes that are used to produce diterpenes in plants may be accomplished by introducing transcription factor genes that induce said overexpression. One class of secondary metabolites, the diterpenes, can effect several biological systems such as tumor progression, prostaglandin synthesis and tissue inflammation. In addition, diterpenes can act as insect pheromones, termite allomones, and can exhibit neurotoxic, cytotoxic and antimitotic activities. As a result of this functional diversity, diterpenes have been the target of research several pharmaceutical ventures. In most cases where the metabolic pathways are impossible to engineer, increasing trichome density or size on leaves may be the only way to increase plant productivity.

Production of anthocyanin in leaves and other plant parts. Several presently disclosed transcription factor genes can be used to alter anthocyanin production in numerous plant species. The potential utilities of these genes include alterations in pigment production for horticultural purposes, and possibly increasing stress resistance in combination with another transcription factor.

Production of miscellaneous secondary metabolites. Microarray data suggests that flux through the aromatic amino acid biosynthetic pathways and primary and secondary metabolite biosynthetic pathways are up-regulated. Presently disclosed transcription factors have been shown to be involved in regulating alkaloid biosynthesis, in part by up-regulating the enzymes indole-3-glycerol phosphatase and strictosidine synthase. Phenylalanine ammonia lyase, chalcone synthase and trans-cinnamate mono-oxygenase are also induced, and are involved in phenylpropenoid biosynthesis.

Sugar, starch, hemicellulose composition. Overexpression of the presently disclosed transcription factors that affect sugar content resulted in plants with altered leaf insoluble sugar content. Transcription factors that alter plant cell wall composition have several potential applications including altering food digestibility, plant tensile strength, wood quality, pathogen resistance and in pulp production. The potential utilities of a gene involved in glucose-specific sugar sensing are to alter energy balance, photosynthetic rate, carbohydrate accumulation, biomass production, source-sink relationships, and senescence.

Hemicellulose is not desirable in paper pulps because of its lack of strength compared with cellulose. Thus modulating the amounts of cellulose vs. hemicellulose in the plant cell wall is desirable for the paper/lumber industry. Increasing the insoluble carbohydrate content in various fruits, vegetables, and other edible consumer products will result in enhanced fiber content. Increased fiber content would not only provide health benefits in food products, but might also increase digestibility of forage crops. In addition, the hemicellulose and pectin content of fruits and berries affects the quality of jam and catsup made from them. Changes in hemicellulose and pectin content could result in a superior consumer product.

Plant response to sugars and sugar composition. In addition to their important role as an energy source and structural component of the plant cell, sugars are central regulatory molecules that control several aspects of plant physiology, metabolism and development. It is thought that this control is achieved by regulating gene expression and, in higher plants, sugars have been shown to repress or activate plant genes involved in many essential processes such as photosynthesis, glyoxylate metabolism, respiration, starch and sucrose synthesis and degradation, pathogen response, wounding response, cell cycle regulation, pigmentation, flowering and senescence. The mechanisms by which sugars control gene expression are not understood.

Because sugars are important signaling molecules, the ability to control either the concentration of a signaling sugar or how the plant perceives or responds to a signaling sugar could be used to control plant development, physiology or metabolism. For example, the flux of sucrose (a disaccharide sugar used for systemically transporting carbon and energy in most plants) has been shown to affect gene expression and alter storage compound accumulation in seeds. Manipulation of the sucrose signaling pathway in seeds may therefore cause seeds to have more protein, oil or carbohydrate, depending on the type of manipulation. Similarly, in tubers, sucrose is converted to starch which is used as an energy store. It is thought that sugar signaling pathways may partially determine the levels of starch synthesized in the tubers. The manipulation of sugar signaling in tubers could lead to tubers with a higher starch content.

Thus, the presently disclosed transcription factor genes that manipulate the sugar signal transduction pathway may lead to altered gene expression to produce plants with desirable traits. In particular, manipulation of sugar signal transduction pathways could be used to alter source-sink relationships in seeds, tubers, roots and other storage organs leading to increase in yield.

Plant growth rate and development. A number of the presently disclosed transcription factor genes have been shown to have significant effects on plant growth rate and development. These observations have included, for example, more rapid or delayed growth and development of reproductive organs. This would provide utility for regions with short or long growing seasons, respectively. Accelerating plant growth would also improve early yield or increase biomass at an earlier stage, when such is desirable (for example, in producing forestry products).

Embryo development. Presently disclosed transcription factor genes that alter embryo development has been used to alter seed protein and oil amounts and/or composition which is very important for the nutritional value and production of various food products. Seed shape and seed coat may also be altered by these genes, which may provide for improved storage stability.

Seed germination rate. A number of the presently disclosed transcription factor genes have been shown to modify seed germination rate, including when the seeds are in conditions normally unfavorable for germination (e.g., cold, heat or salt stress, or in the presence of ABA), and may thus be used to modify and improve germination rates under adverse conditions.

Plant, seedling vigor. Seedlings transformed with presently disclosed transcription factors have been shown to possess larger cotyledons and appeared somewhat more advanced than control plants. This indicates that the seedlings developed more rapidly that the control plants. Rapid seedling development is likely to reduce loss due to diseases particularly prevalent at the seedling stage (e.g., damping off) and is thus important for survivability of plants germinating in the field or in controlled environments.

Senescence, cell death. Presently disclosed transcription factor genes may be used to alter senescence responses in plants. Although leaf senescence is thought to be an evolutionary adaptation to recycle nutrients, the ability to control senescence in an agricultural setting has significant value. For example, a delay in leaf senescence in some maize hybrids is associated with a significant increase in yields and a delay of a few days in the senescence of soybean plants can have a large impact on yield. Delayed flower senescence may also generate plants that retain their blossoms longer and this may be of potential interest to the ornamental horticulture industry.

Modified fertility. Plants that overexpress a number of the presently disclosed transcription factor genes have been shown to possess reduced fertility. This could be a desirable trait, as it could be exploited to prevent or minimize the escape of the pollen of genetically modified organisms (GMOs) into the environment.

Early and delayed flowering. Presently disclosed transcription factor genes that accelerate flowering could have valuable applications in such programs since they allow much faster generation times. In a number of species, for example, broccoli, cauliflower, where the reproductive parts of the plants constitute the crop and the vegetative tissues are discarded, it would be advantageous to accelerate time to flowering. Accelerating flowering could shorten crop and tree breeding programs. Additionally, in some instances, a faster generation time mignt allow additional harvests of a crop to be made within a given growing season. A number of Arabidopsis genes have already been shown to accelerate flowering when constitutively expressed. These include LEAFY, APETALA1 and CONSTANS (Mandel, M. et al., 1995, Nature 377, 522-524; Weigel, D. and Nilsson, O., 1995, Nature 377, 495-500; Simon et al., 1996, Nature 384, 59-62).

By regulating the expression of potential flowering using inducible promoters, flowering could be triggered by application of an inducer chemical. This would allow flowering to be synchronized across a crop and facilitate more efficient harvesting. Such inducible systems could also be used to tune the flowering of crop varieties to different latitudes. At present, species such as soybean and cotton are available as a series of maturity groups that are suitable for different latitudes on the basis of their flowering time (which is governed by day-length). A system in which flowering could be chemically controlled would allow a single high-yielding northern maturity group to be grown at any latitude. In southern regions such plants could be grown for longer, thereby increasing yields, before flowering was induced: In more northern areas, the induction would be used to ensure that the crop flowers prior to the first winter frosts.

In a sizeable number of species, for example, root crops, where the vegetative parts of the plants constitute the crop and the reproductive tissues are discarded, it would be advantageous to delay or prevent flowering. Extending vegetative development with presently disclosed transcription factor genes could thus bring about large increases in yields. Prevention of flowering might help maximize vegetative yields and prevent escape of genetically modified organism (GMO) pollen.

Extended flowering phase. Presently disclosed transcription factors that extend flowering time have utility in engineering plants with longer-lasting flowers for the horticulture industry, and for extending the time in which the plant is fertile.

Flower and leaf development. Presently disclosed transcription factor genes have been used to modify the development of flowers and leaves. This could be advantageous in the development of new ornamental cultivars that present unique configurations. In addition, some of these genes have been shown to reduce a plant's fertility, which is also useful for helping to prevent development of pollen of GMOs.

Flower abscission. Presently disclosed transcription factor genes introduced into plants have been used to retain flowers for longer periods. This would provide a significant benefit to the ornamental industry, for both cut flowers and woody plant varieties (of, for example, maize), as well as have the potential to lengthen the fertile period of a plant, which could positively impact yield and breeding programs.

A listing of specific effects and utilities that the presently disclosed transcription factor genes have on plants, as determined by direct observation and assay analysis, is provided in Table 4.

XVI. ANTISENSE AND CO-SUPRESSION

In addition to expression of the nucleic acids of the invention as gene replacement or plant phenotype modification nucleic acids, the nucleic acids are also useful for sense and anti-sense suppression of expression, e.g., to down-regulate expression of a nucleic acid of the invention, e.g., as a further mechanism for modulating plant phenotype. That is, the nucleic acids of the invention, or subsequences or anti-sense sequences thereof, can be used to block expression of naturally occurring homologous nucleic acids. A variety of sense and anti-sense technologies are known in the art, e.g., as set forth in Lichtenstein and Nellen (1997) Antisense Technology: A Practical Approach IRL Press at Oxford University Press, Oxford, U.K. In general, sense or anti-sense sequences are introduced into a cell, where they are optionally amplified, e.g., by transcription. Such sequences include both simple oligonucleotide sequences and catalytic sequences such as ribozymes.

For example, a reduction or elimination of expression (i.e., a “knock-out”) of a transcription factor or transcription factor homologue polypeptide in a transgenic plant, e.g., to modify a plant trait, can be obtained by introducing an antisense construct corresponding to the polypeptide of interest as a cDNA. For antisense suppression, the transcription factor or homologue cDNA is arranged in reverse orientation (with respect to the coding sequence) relative to the promoter sequence in the expression vector. The introduced sequence need not be the full length cDNA or gene, and need not be identical to the cDNA or gene found in the plant type to be transformed. Typically, the antisense sequence need only be capable of hybridizing to the target gene or RNA of interest. Thus, where the introduced sequence is of shorter length, a higher degree of homology to the endogenous transcription factor sequence will be needed for effective antisense suppression. While antisense sequences of various lengths can be utilized, preferably, the introduced antisense sequence in the vector will be at least 30 nucleotides in length, and improved antisense suppression will typically be observed as the length of the antisense sequence increases. Preferably, the length of the antisense sequence in the vector will be greater than 100 nucleotides. Transcription of an antisense construct as described results in the production of RNA molecules that are the reverse complement of mRNA molecules transcribed from the endogenous transcription factor gene in the plant cell.

Suppression of endogenous transcription factor gene expression can also be achieved using a ribozyme. Ribozymes are RNA molecules that possess highly specific endoribonuclease activity. The production and use of ribozymes are disclosed in U.S. Pat. No. 4,987,071 and U.S. Pat. No. 5,543,508. Synthetic ribozyme sequences including antisense RNAs can be used to confer RNA cleaving activity on the antisense RNA, such that endogenous mRNA molecules that hybridize to the antisense RNA are cleaved, which in turn leads to an enhanced antisense inhibition of endogenous gene expression.

Vectors in which RNA encoded by a transcription factor or transcription factor homologue cDNA is over-expressed can also be used to obtain co-suppression of a corresponding endogenous gene, e.g., in the manner described in U.S. Pat. No. 5,231,020 to Jorgensen. Such co-suppression (also termed sense suppression) does not require that the entire transcription factor cDNA be introduced into the plant cells, nor does it require that the introduced sequence be exactly identical to the endogenous transcription factor gene of interest. However, as with antisense suppression, the suppressive efficiency will be enhanced as specificity of hybridization is increased, e.g., as the introduced sequence is lengthened, and/or as the sequence similarity between the introduced sequence and the endogenous transcription factorgene is increased.

Vectors expressing an untranslatable form of the transcription factor mRNA, e.g., sequences comprising one or more stop codon, or nonsense mutation) can also be used to suppress expression of an endogenous transcription factor, thereby reducing or eliminating it's activity and modifying one or more traits. Methods for producing such constructs are described in U.S. Pat. No. 5,583,021. Preferably, such constructs are made by introducing a premature stop codon into the transcription factor gene. Alternatively, a plant trait can be modified by gene silencing using double-strand RNA (Sharp (1999) Genes and Development 13: 139-141). Another method for abolishing the expression of a gene is by insertion mutagenesis using the T-DNA of Agrobacterium tumefaciens. After generating the insertion mutants, the mutants can be screened to identify those containing the insertion in a transcription factor or transcription factor homologue gene. Plants containing a single transgene insertion event at the desired gene can be crossed to generate homozygous plants for the mutation. Such methods are well known to those of skill in the art. (See for example Koncz et al. (1992) Methods in Arabidopsis Research, World Scientific.)

Alternatively, a plant phenotype can be altered by eliminating an endogenous gene, such as a transcription factor or transcription factor homologue, e.g., by homologous recombination (Kempin et al. (1997) Nature 389:802-803).

A plant trait can also be modified by using the Cre-lox system (for example, as described in U.S. Pat. No. 5,658,772). A plant genome can be modified to include first and second lox sites that are then contacted with a Cre recombinase. If the lox sites are in the same orientation, the intervening DNA sequence between the two sites is excised. If the lox sites are in the opposite orientation, the intervening sequence is inverted.

The polynucleotides and polypeptides of this invention can also be expressed in a plant in the absence of an expression cassette by manipulating the activity or expression level of the endogenous gene by other means. For example, by ectopically expressing a gene by T-DNA activation tagging (Ichikawa et al. (1997) Nature 390 698-701; Kakimoto et al. (1996) Science 274: 982-985). This method entails transforming a plant with a gene tag containing multiple transcriptional enhancers and once the tag has inserted into the genome, expression of a flanking gene coding sequence becomes deregulated. In another example, the transcriptional machinery in a plant can be modified so as to increase transcription levels of a polynucleotide of the invention (See, e.g., PCT Publications WO 96/06166 and WO 98/53057 which describe the modification of the DNA-binding specificity of zinc finger proteins by changing particular amino acids in the DNA-binding motif).

The transgenic plant can also include the machinery necessary for expressing or altering the activity of a polypeptide encoded by an endogenous gene, for example by altering the phosphorylation state of the polypeptide to maintain it in an activated state.

Transgenic plants (or plant cells, or plant explants, or plant tissues) incorporating the polynucleotides of the invention and/or expressing the polypeptides of the invention can be produced by a variety of well established techniques as described above. Following construction of a vector, most typically an expression cassette, including a polynucleotide, e.g., encoding a transcription factor or transcription factor homologue, of the invention, standard techniques can be used to introduce the polynucleotide into a plant, a plant cell, a plant explant or a plant tissue of interest. Optionally, the plant cell, explant or tissue can be regenerated to produce a transgenic plant.

The plant can be any higher plant, including gymnosperms, monocotyledonous and dicotyledenous plants. Suitable protocols are available for Leguminosae (alfalfa, soybean, clover, etc.), Umbelliferae (carrot, celery, parsnip), Cruciferae (cabbage, radish, rapeseed, broccoli, etc.), Curcurbitaceae (melons and cucumber), Gramineae (wheat, corn, rice, barley, millet, etc.), Solanaceae (potato, tomato, tobacco, peppers, etc.), and various other crops. See protocols described in Ammirato et al. (1984) Handbook of Plant Cell Culture—Crop Species, Macmillan Publ. Co. Shimamoto et al. (1989) Nature 338:274-276; Fromm et al. (1990) Bio/Technology 8:833-839; and Vasil et al. (1990) Bio/Technology 8:429-434.

Transformation and regeneration of both monocotyledonous and dicotyledonous plant cells is now routine, and the selection of the most appropriate transformation technique will be determined by the practitioner. The choice of method will vary with the type of plant to be transformed; those skilled in the art will recognize the suitability of particular methods for given plant types. Suitable methods can include, but are not limited to: electroporation of plant protoplasts; liposome-mediated transformation; polyethylene glycol (PEG) mediated transformation; transformation using viruses; micro-injection of plant cells; micro-projectile bombardment of plant cells; vacuum infiltration; and Agrobacterium tumefaciens mediated transformation. Transformation means introducing a nucleotide sequence into a plant in a manner to cause stable or transient expression of the sequence.

Successful examples of the modification of plant characteristics by transformation with cloned sequences which serve to illustrate the current knowledge in this field of technology, and which are herein incorporated by reference, include: U.S. Pat. Nos. 5,571,706; 5,677,175; 5,510,471; 5,750,386; 5,597,945; 5,589,615; 5,750,871; 5,268,526; 5,780,708; 5,538,880; 5,773,269; 5,736,369 and 5,610,042.

Following transformation, plants are preferably selected using a dominant selectable marker incorporated into the transformation vector. Typically, such a marker will confer antibiotic or herbicide resistance on the transformed plants, and selection of transformants can be accomplished by exposing the plants to appropriate concentrations of the antibiotic or herbicide.

After transformed plants are selected and grown to maturity, those plants showing a modified trait are identified. The modified trait can be any of those traits described above. Additionally, to confirm that the modified trait is due to changes in expression levels or activity of the polypeptide or polynucleotide of the invention can be determined by analyzing mRNA expression using Northern blots, RT-PCR or microarrays, or protein expression using immunoblots or Western blots or gel shift assays.

XVII. Integrated Systems—Sequence Identity

Additionally, the present invention may be an integrated system, computer or computer readable medium that comprises an instruction set for determining the identity of one or more sequences in a database. In addition, the instruction set can be used to generate or identify sequences that meet any specified criteria. Furthermore, the instruction set may be used to associate or link certain functional benefits, such improved characteristics, with one or more identified sequence.

For example, the instruction set can include, e.g., a sequence comparison or other alignment program, e.g., an available program such as, for example, the Wisconsin Package Version 10.0, such as BLAST, FASTA, PILEUP, FINDPATTERNS or the like (GCG, Madison, Wis.). Public sequence databases such as GenBank, EMBL, Swiss-Prot and PIR or private sequence databases such as PHYTOSEQ sequence database (Incyte Genomics, Palo Alto, Calif.) can be searched.

Alignment of sequences for comparison can be conducted by the local homology algorithm of Smith and Waterman (1981) Adv. Appl. Math. 2:482, by the homology alignment algorithm of Needleman and Wunsch (1970) J. Mol. Biol. 48:443-453, by the search for similarity method of Pearson and Lipman (1988) Proc. Natl. Acad. Sci. U.S.A. 85:2444-2448, by computerized implementations of these algorithms. After alignment, sequence comparisons between two (or more) polynucleotides or polypeptides are typically performed by comparing sequences of the two sequences over a comparison window to identify and compare local regions of sequence similarity. The comparison window can be a segment of at least about 20 contiguous positions, usually about 50 to about 200, more usually about 100 to about 150 contiguous positions. A description of the method is provided in Ausubel et al., supra.

A variety of methods for determining sequence relationships can be used, including manual alignment and computer assisted sequence alignment and analysis. This later approach is a preferred approach in the present invention, due to the increased throughput afforded by computer assisted methods. As noted above, a variety of computer programs for performing sequence alignment are available, or can be produced by one of skill.

One example algorithm that is suitable for determining percent sequence identity and sequence similarity is the BLAST algorithm, which is described in Altschul et al. J. Mol. Biol 215:403-410 (1990). Software for performing BLAST analyses is publicly available, e.g., through the National Center for Biotechnology Information (see internet website at ncbi.nlm.nih.gov). This algorithm involves first identifying high scoring sequence pairs (HSPs) by identifying short words of length W in the query sequence, which either match or satisfy some positive-valued threshold score T when aligned with a word of the same length in a database sequence. T is referred to as the neighborhood word score threshold (Altschul et al., supra). These initial neighborhood word hits act as seeds for initiating searches to find longer HSPs containing them. The word hits are then extended in both directions along each sequence for as far as the cumulative alignment score can be increased. Cumulative scores are calculated using, for nucleotide sequences, the parameters M (reward score for a pair of matching residues; always >0) and N (penalty score for mismatching residues; always <0). For amino acid sequences, a scoring matrix is used to calculate the cumulative score. Extension of the word hits in each direction are halted when: the cumulative alignment score falls off by the quantity X from its maximum achieved value; the cumulative score goes to zero or below, due to the accumulation of one or more negative-scoring residue alignments; or the end of either sequence is reached. The BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment. The BLASTN program (for nucleotide sequences) uses as defaults a wordlength (W) of 11, an expectation (E) of 10, a cutoff of 100, M=5, N=−4, and a comparison of both strands. For amino acid sequences, the BLASTP program uses as defaults a wordlength (W) of 3, an expectation (E) of 10, and the BLOSUM62 scoring matrix (see Henikoff & Henikoff (1989) Proc. Natl. Acad. Sci. USA 89:10915). Unless otherwise indicated, “sequence identity” here refers to the % sequence identity generated from a tblastx using the NCBI version of the algorithm at the default settings using gapped alignments with the filter “off” (see, for example, internet website at ncbi.nlm.nih.gov).

In addition to calculating percent sequence identity, the BLAST algorithm also performs a statistical analysis of the similarity between two sequences (see, e.g., Karlin & Altschul (1993) Proc. Natl. Acad. Sci. USA 90:5873-5787). One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance. For example, a nucleic acid is considered similar to a reference sequence (and, therefore, in this context, homologous) if the smallest sum probability in a comparison of the test nucleic acid to the reference nucleic acid is less than about 0.1, or less than about 0.01, and or even less than about 0.001. An additional example of useful sequence alignmnt algorithm is PILEUP. PILEUP creates a multiple sequence alignment from a group of related sequences using progressive, pairwise alignments. The program can align, e.g., up to 300 sequences of a maximum length of 5,000 letters.

The integrated system, or computer typically includes a user input interface allowing a user to selectively view one or more sequence records corresponding to the one or more character strings, as well as an instruction set which aligns the one or more character strings with each other or with an additional character string to identify one or more region of sequence similarity. The system may include a link of one or more character strings with a particular phenotype or gene function. Typically, the system includes a user readable output element that displays an alignment produced by the alignment instruction set.

The methods of this invention can be implemented in a localized or distributed computing environment. In a distributed environment, the methods may implemented on a single computer comprising multiple processors or on a multiplicity of computers. The computers can be linked, e.g. through a common bus, but more preferably the computer(s) are nodes on a network. The network can be a generalized or a dedicated local or wide-area network and, in certain preferred embodiments, the computers may be components of an intra-net or an internet.

Thus, the invention provides methods for identifying a sequence similar or homologous to one or more polynucleotides as noted herein, or one or more target polypeptides encoded by the polynucleotides, or otherwise noted herein and may include linking or associating a given plant phenotype or gene function with a sequence. In the methods, a sequence database is provided (locally or across an inter or intra net) and a query is made against the sequence database using the relevant sequences herein and associated plant phenotypes or gene functions.

Any sequence herein can be entered into the database, before or after querying the database. This provides for both expansion of the database and, if done before the querying step, for insertion of control sequences into the database. The control sequences can be detected by the query to ensure the general integrity of both the database and the query. As noted, the query can be performed using a web browser based interface. For example, the database can be a centralized public database such as those noted herein, and the querying can be done from a remote terminal or computer across an internet or intranet.

XVIII. EXAMPLES

The following examples are intended to illustrate but not limit the present invention. The complete descriptions of the traits associated with each polynucleotide of the invention is fully disclosed in Table 4 and Table 6.

Example I

Full Length Gene Identification and Cloning

Putative transcription factor sequences (genomic or ESTs) related to known transcription factors were identified in the Arabidopsis thaliana GenBank database using the tblastn sequence analysis program using default parameters and a P-value cutoff threshold of −4 or −5 or lower, depending on the length of the query sequence. Putative transcription factor sequence hits were then screened to identify those containing particular sequence strings. If the sequence hits contained such sequence strings, the sequences were confirmed as transcription factors.

Alternatively, Arabidopsis thaliana cDNA libraries derived from different tissues or treatments, or genomic libraries were screened to identify novel members of a transcription family using a low stringency hybridization approach. Probes were synthesized using gene specific primers in a standard PCR reaction (annealing temperature 60° C.) and labeled with ³²P dCTP using the High Prime DNA Labeling Kit (Boehringer Mannheim). Purified radiolabelled probes were added to filters immersed in Church hybridization medium (0.5 M NaPO₄ pH 7.0, 7% SDS, 1% w/v bovine serum albumin) and hybridized overnight at 60° C. with shaking. Filters were washed two times for 45 to 60 minutes with 1×SCC, 1% SDS at 60° C.

To identify additional sequence 5′ or 3+ of a partial cDNA sequence in a cDNA library, 5′ and 3′ rapid amplification of cDNA ends (RACE) was performed using the Marathon™ cDNA amplification kit (Clontech, Palo Alto, Calif.). Generally, the method entailed first isolating poly(A) mRNA, performing first and second strand cDNA synthesis to generate double stranded cDNA, blunting cDNA ends, followed by ligation of the Marathon™ Adaptor to the cDNA to form a library of adaptor-ligated ds cDNA.

Gene-specific primers were designed to be used along with adaptor specific primers for both 5′ and 3′ RACE reactions. Nested primers, rather than single primers, were used to increase PCR specificity. Using 5′ and 3′ RACE reactions, 5′ and 3′ RACE fragments were obtained, sequenced and cloned. The process can be repeated until 5′ and 3′ ends of the full-length gene were identified. Then the full-length cDNA was generated by PCR using primers specific to 5′ and 3′ ends of the gene by end-to-end PCR.

Example II

Construction of Expression Vectors

The sequence was amplified from a genomic or cDNA library using primers specific to sequences upstream and downstream of the coding region. the expression vector was pMEN20 or pMEN65, which are both derived from pMON316 (Sanders et al, (1987) Nucleic Acids Research 15:1543-1558) and contain the caMV 35s promoter to express transgenes. To clone the sequence into the vector, both pmen20 and the amplified DNA fragment were digested separately with Sali and Noti restriction enzymes at 37° C. for 2 hours. The digestion products were subject to electrophoresis in a 0.8% agarose gel and visualized by ethidium bromide staining. The DNA fragments containing the sequence and the linearized plasmid were excised and purified by using a Qiaquick gel extraction kit (Qiagen, Valencia Calif.). The fragments of interest were ligated at a ratio of 3:1 (vector to insert). Ligation reactions using t4 DNA ligase (New England Biolabs, Beverly, Mass.) were carried out at 16° C. for 16 hours. The ligated DNAs were transformed into competent cells of the E. coli strain DH5alpha by using the heat shock method. The transformations were plated on LB plates containing 50 mg/l kanamycin (Sigma, St. Louis, Mo.). Individual colonies were grown overnight in five milliliters of LB broth containing 50 mg/l kanamycin at 37° C. Plasmid DNA was purified by using Qiaquick Mini Prep kits (Qiagen).

Example III

Transformation of Agrobacterium with the Expression Vector

After the plasmid vector containing the gene was constructed, the vector was used to transform Agrohacterin tumnefaciens cells expressing the gene products. The stock of Agrobacterium tumefaciens cells for transformation were made as described by Nagel et al. (1990) FEMS Microbiol Letts. 67: 325-328. Agrobacterium strain ABI was grown in 250 ml LB medium (Sigma) overnight at 28° C. with shaking until an absorbance (A₆₀₀) of 0.5-1.0 was reached. Cells were harvested by centrifugation at 4,000×g for 15 min at 4° C. Cells were then resuspended in 250 μl chilled buffer (1 mM HEPES, pH adjusted to 7.0 with KOH). Cells were centrifuged again as described above and resuspended in 125 μl chilled buffer. Cells were then centrifuged and resuspended two more times in the same HEPES buffer as described above at a volume of 100 μl and 750 μl, respectively. Resuspended cells were then distributed into 40 μl aliquots quickly frozen in liquid nitrogen, and stored at −80° C.

Agrobacterium cells were transformed with plasmids prepared as described above following the protocol described by Nagel et al. For each DNA construct to be transformed, 50-100 ng DNA (generally resuspended in 10 mM Tris-HCl, 1 mM EDTA, pH 8.0) was mixed with 40 μl of Agrohacterium cells. The DNA/cell mixture was then transferred to a chilled cuvette with a 2 mm electrode gap and subject to a 2.5 kV charge dissipated at 25 μF and 200 μF using a Gene Pulser II apparatus (Bio-Rad, Hercules, Calif.). After electroporation, cells were immediately resuspended in 1.0 ml LB and allowed to recover without antibiotic selection for 2-4 hours at 28° C. in a shaking incubator. After recovery, cells were plated onto selective medium of LB broth containing 100 μg/ml spectinomycin (Sigma) and incubated for 24-48 hours at 28° C. Single colonies were then picked and inoculated in fresh medium. The presence of the plasmid construct was verified by PCR amplification and sequence analysis.

Example IV

Transformation of Arabidopsis Plants with Agrobacterium tumefaciens with Expression Vector

After transformation of Agrobacterium tumefaciens with plasmid vectors containing the gene, single Agrohacterium colonies were identified, propagated, and used to transform Arabidopsis plants. Briefly, 500 ml cultures of LB medium containing 50 mg/l kanamycin were inoculated with the colonies and grown at 28° C. with shaking for 2 days until an optical absorbance at 600 nm wavelength over 1 cm (A₆₀₀) of >2.0 is reached. Cells were then harvested by centrifugation at 4,000×g for 10 min, and resuspended in infiltration medium (½×Murashige and Skoog salts (Sigma), 1×Gamborg's B-5 vitamins (Sigma), 5.0% (w/v) sucrose (Sigma), 0.044 μM benzylamino purine (Sigma), 200 μl/l Silwet L-77 (Lehle Seeds) until an A₆₀₀ of 0.8 was reached.

Prior to transformation, Arabidopsis thaliana seeds (ecotype Columbia) were sown at a density of ˜10 plants per 4″ pot onto Pro-Mix BX potting medium (Hummert International) covered with fiberglass mesh (18 mm×16 mm). Plants were grown under continuous illumination (50-75 μE/m²/sec) at 22-23° C. with 65-70% relative humidity. After about 4 weeks, primary inflorescence stems (bolts) are cut off to encourage growth of multiple secondary bolts. After flowering of the mature secondary bolts, plants were prepared for transformation by removal of all siliques and opened flowers.

The pots were then immersed upside down in the mixture of Agrobacterium infiltration medium as described above for 30 sec, and placed on their sides to allow draining into a 1′×2′ flat surface covered with plastic wrap. After 24 h, the plastic wrap was removed anu pots are turned upright. The immersion procedure was repeated one week later, for a total of two immersions per pot. Seeds were then collected from each transformation pot and analyzed following the protocol described below.

Example V

Identification of Arabidopsis Primary Transformants

Seeds collected from the transformation pots were sterilized essentially as follows. Seeds were dispersed into in a solution containing 0.1% (v/v) Triton X-100 (Sigma) and sterile H₂O and washed by shaking the suspension for 20 min. The wash solution was then drained and replaced with fresh wash solution to wash the seeds for 20 min with shaking. After removal of the second wash solution, a solution containing 0.1% (v/v) Triton X-100 and 70% ethanol (Equistar) was added to the seeds and the suspension was shaken for 5 min. After removal of the ethanol/detergent solution, a solution containing 0.1% (v/v) Triton X-100 and 30% (v/v) bleach (Clorox) was added to the seeds, and the suspension was shaken for 10 min. After removal of the bleach/detergent solution, seeds were then washed five times in sterile distilled H₂O. The seeds were stored in the last wash water at 4° C. for 2 days in the dark before being plated onto antibiotic selection medium (1×Murashige and Skoog salts (pH adjusted to 5.7 with 1M KOH), 1×Gamborg's B-5 vitamins, 0.9% phytagar (Life Technologies), and 50 mg/l kanamycin). Seeds were germinated under continuous illumination (50-75 μE/m²/sec) at 22-23° C. After 7-10 days of growth under these conditions, kanamycin resistant primary transformants (T₁ generation) were visible and obtained. These seedlings were transferred first to fresh selection plates where the seedlings continued to grow for 3-5 more days, and then to soil (Pro-Mix BX potting medium).

Primary transformants were crossed and progeny seeds (T₂) collected; kanamycin resistant seedlings were selected and analyzed. The expression levels of the recombinant polynucleotides in the transformants varies from about a 5% expression level increase to a least a 100% expression level increase. Similar observations are made with respect to polypeptide level expression.

Example VI

Identification of Arabidopsis Plants with Transcription Factor Gene Knockouts

The screening of insertion mutagenized Arabidopsis collections for null mutants in a known target gene was essentially as described in Krysan et al (1999) Plant Cell 11:2283-2290. Briefly, gene-specific primers, nested by 5-250 base pairs to each other, were designed from the 5′ and 3′ regions of a known target gene. Similarly, nested sets of primers were also created specific to each of the T-DNA or transposon ends (the “right” and “left” borders). All possible combinations of gene specific and T-DNA/transposon primers were used to detect by PCR an insertion event within or close to the target gene. The amplified DNA fragments were then sequenced which allows the precise determination of the T-DNA/transposon insertion point relative to the target gene. Insertion events within the coding or intervening sequence of the genes were deconvoluted from a pool comprising a plurality of insertion events to a single unique mutant plant for functional characterization. The method is described in more detail in Yu and Adam, U.S. application Ser. No. 09/177,733 filed Oct. 23, 1998.

Example VII

Identification of Modified Phenotypes in Overexpression or Gene Knockout Plants

Experiments were performed to identify those transformants or knockouts that exhibited modified biochemical characteristics. Among the biochemicals that were assayed were insoluble sugars, such as arabinose, fucose, galactose, mannose, rhamnose or xylose or the like; prenyl lipids, such as lutein, beta-carotene, xanthophyll-1, xanthophyll-2, chlorophylls A or B, or alpha-, delta- or gamma-tocopherol or the like; fatty acids, such as 16:0 (palmitic acid), 16:1 (palmitoleic acid), 18:0 (stearic acid), 18:1 (oleic acid), 18:2 (linoleic acid), 20:0 , 18:3 (linolenic acid), 20:1 (eicosenoic acid), 20:2, 22:1 (erucic acid) or the like; waxes, such as by altering the levels of C29, C31, or C33 alkanes; sterols, such as brassicasterol, campesterol, stigmasterol, sitosterol or stigmastanol or the like, glucosinolates, protein or oil levels.

Fatty acids were measured using two methods depending on whether the tissue was from leaves or seeds. For leaves, lipids were extracted and esterified with hot methanolic H₂SO₄ and partitioned into hexane from methanolic brine. For seed fatty acids, seeds were pulverized and extracted in methanol:heptane:toluene:2,2-dimethoxypropane:H₂SO₄ (39:34:20:5:2) for 90 minutes at 80° C. After cooling to room temperature the upper phase, containing the seed fatty acid esters, was subjected to GC analysis. Fatty acid esters from both seed and leaf tissues were analyzed with a Supelco SP-2330 column.

Glucosinolates were purified from seeds or leaves by first heating the tissue at 95° C. for 10 minutes. Preheated ethanol:water (50:50) is and after heating at 95° C. for a further 10 minutes, the extraction solvent is applied to a DEAE Sephadex column which had been previously equilibrated with 0.5 M pyridine acetate. Desulfoglucosinolates were eluted with 300 ul water and analyzed by reverse phase HPLC monitoring at 226 nm.

For wax alkanes, samples were extracted using an identical method as fatty acids and extracts were analyzed on a HP 5890 GC coupled with a 5973 MSD. Samples were chromatographically isolated on a J&W DB35 mass spectrometer (J&W Scientific).

To measure prenyl lipids levels, seeds or leaves were pulverized with 1 to 2% pyrogallol as an antioxidant. For seeds, extracted samples were filtered and a portion removed for tocopherol and carotenoid/chlorophyll analysis by HPLC. The remaining material was saponified for sterol determination. For leaves, an aliquot was removed and diluted with methanol and chlorophyll A, chlorophyll B, and total carotenoids measured by spectrophotometry by determining optical absorbance at 665.2 nm, 652.5 nm, and 470 nm. An aliquot was removed for tocopherol and carotenoid/chlorophyll composition by HPLC using a Waters uBondapak C18 column (4.6 mm×150 mm). The remaining methanolic solution was saponified with 10% KOH at 80° C. for one hour. The samples were cooled and diluted with a mixture of methanol and water. A solution of 2% methylene chloride in hexane was mixed in and the samples were centrifuged. The aqueous methanol phase was again re-extracted 2% methylene chloride in hexane and, after centrifugation, the two upper phases were combined and evaporated. 2% methylene chloride in hexane was added to the tubes and the samples were then extracted with one ml of water. The upper phase was removed, dried, and resuspended in 400 ul of 2% methylene chloride in hexane and analyzed by gas chromatography using a 50 m DB-5 ms (0.25 mm ID, 0.25 um phase, J&W Scientific).

Insoluble sugar levels were measured by the method essentially described by Reiter et al., (1999) Plant Journal 12:335-345. This method analyzes the neutral sugar composition of cell wall polymers found in Arabidopsis leaves. Soluble sugars were separated from sugar polymers by extracting leaves with hot 70% ethanol. The remaining residue containing the insoluble polysaccharides was then acid hydrolyzed with allose added as an internal standard. Sugar monomers generated by the hydrolysis were then reduced to the corresponding alditols by treatment with NaBH4, then were acetylated to generate the volatile alditol acetates which were then analyzed by GC-FID. Identity of the peaks was determined by comparing the retention times of known sugars converted to the corresponding aIditol acetates with the retention times of peaks from wild-type plant extracts. Alditol acetates were analyzed on a Supelco SP-2330 capillary column (30 m ×250 um×0.2 um) using a temperature program beginning at 180° C. for 2 minutes followed by an increase to 220° C. in 4 minutes. After holding at 220° C. for 10 minutes, the oven temperature is increased to 240° C. in 2 minutes and held at this temperature for 10 minutes and brought back to room temperature.

To identify plants with alterations in total seed oil or protein content, 150 mg of seeds from T2 progeny plants were subjected to analysis by Near Infrared Reflectance Spectroscopy (NIRS) using a Foss NirSystems Model 6500 with a spinning cup transport system. NIRS is a non-destructive analytical method used to determine seed oil and protein composition. Infrared is the region of the electromagnetic spectrum located after the visible region in the direction of longer wavelengths. ‘Near infrared’ owns its name for being the infrared region near to the visible region of the electromagnetic spectrum. For practical purposes, near infrared comprises wavelengths between 800 and 2500 nm. NIRS is applied to organic compounds rich in O—H bonds (such as moisture, carbohydrates, and fats), C—H bonds (such as organic compounds and petroleum derivatives), and N—H bonds (such as proteins and amino acids). The NIRS analytical instruments operate by statistically correlating NIRS signals at several wavelengths with the characteristic or property intended to be measured. All biological substances contain thousands of C—H, O—H, and N—H bonds. Therefore, the exposure to near infrared radiation of a biological sample, such as a seed, results in a complex spectrum which contains qualitative and quantitative information about the physical and chemical composition of that sample.

The numerical value of a specific analyte in the sample, such as protein content or oil content, is mediated by a calibration approach known as chemometrics. Chemometrics applies statistical methods such as multiple linear regression (MLR), partial least squares (PLS), and principle component analysis (PCA) to the spectral data and correlates them with a physical property or other factor, that property or factor is directly determined rather than the analyte concentration itself. The method first provides “wet chemistry” data of the samples required to develop the calibration.

Calibration for Arabidopsis seed oil composition was performed using accelerated solvent extraction using 1 g seed sample size and was validated against certified canola seed. A similar wet chemistry approach was performed for seed protein composition calibration.

Data obtained from NIRS analysis was analyzed statistically using a nearest-neighbor (N—N) analysis. The N—N analysis allows removal of within-block spatial variability in a fairly flexible fashion which does not require prior knowledge of the pattern of variability in the chamber. Ideally, all hybrids are grown under identical experimental conditions within a block (rep). In reality, even in many block designs, significant within-block variability exists. Nearest-neighbor procedures are based on assumption that environmental effect of a plot is closely related to that of its neighbors. Nearest-neighbor methods use information from adjacent plots to adjust for within-block heterogeneity and so provide more precise estimates of treatment means and differences. If there is within-plot heterogeneity on a spatial scale that is larger than a single plot and smaller than the entire block, then yields from adjacent plots will be positively correlated. Information from neighboring plots can be used to reduce or remove the unwanted effect of the spatial heterogeneity, and hence improve the estimate of the treatment effect. Data from neighboring plots can also be used to reduce the influence of competition between adjacent plots. The Papadakis N—N analysis can be used with designs to remove within-block variability that would not be removed with the standard split plot analysis (Papadakis, 1973, Inst. d'Amelior. Plantes Thessaloniki (Greece) Bull. Scientif., No. 23; Papadakis, 1984, Proc. Acad. Athens, 59, 326-342).

Experiments were performed to identify those transformants or knockouts that exhibited an improved pathogen tolerance. For such studies, the transformants were exposed to biotropic fungal pathogens, such as Erysiphe orontii, and necrotropic fungal pathogens, such as Fusarium oxysporum. Fusarium oxysporum isolates cause vascular wilts and damping off of various annual vegetables, perennials and weeds (Mauch-Mani and Slusarenko (1994) Molecular Plant-Microbe Interactions 7: 378-383). For Fusarium oxysporum experiments, plants grown on Petri dishes were sprayed with a fresh spore suspension of F. oxysporum. The spore suspension was prepared as follows: A plug of fungal hyphae from a plate culture was placed on a fresh potato dextrose agar plate and allowed to spread for one week. 5 ml sterile water was then added to the plate, swirled, and pipetted into 50 ml Armstrong Fusarium medium. Spores were grown overnight in Fusarium medium and then sprayed onto plants using a Preval paint sprayer. Plant tissue was harvested and frozen in liquid nitrogen 48 hours post infection.

Erysiphe orontii is a causal agent of powdery mildew. For Erysiphe orontii experiments, plants were grown approximately 4 weeks in a greenhouse under 12 hour light (20° C., ˜30% relative humidity (rh)). Individual leaves were infected with E. orontii spores from infected plants using a camel's hair brush, and the plants were transferred to a Percival growth chamber (20° C., 80% rh.). Plant tissue was harvested and frozen in liquid nitrogen 7 days post infection.

Botrytis cinerea is a necrotrophic pathogen. Botrytis cinerea was grown on potato dextrose agar in the light. A spore culture was made by spreading 10 ml of sterile water on the fungus plate, swirling and transferring spores to 10 ml of sterile water. The spore inoculum (approx. 105 spores/ml) was used to spray 10 day-old seedlings grown under sterile conditions on MS (minus sucrose) media. Symptoms were evaluated every day up to approximately 1 week.

Infection with bacterial pathogens Pseudomonas syringae pv maculicola (Psm) strain 4326 and pv maculicola strain 4326 was performed by hand inoculation at two doses. Two inoculation doses allows the differentiation between plants with enhanced susceptibility and plants with enhanced resistance to the pathogen. Plants were grown for 3 weeks in the greenhouse, then transferred to the growth chamber for the remainder of their growth. Psm ES4326 was hand inoculated with 1 ml syringe on 3 fully-expanded leaves per plant (4½ wk old), using at least 9 plants per overexpressing line at two inoculation doses, OD=0.005 and OD=0.0005. Disease scoring occurred at day 3 post-inoculation with pictures of the plants and leaves taken in parallel.

In some instances, expression patterns of the pathogen-induced genes (such as defense genes) was monitored by microarray experiments. cDNAs were generated by PCR and resuspended at a final concentration of ˜100 ng/ul in 3×SSC or 150 mM Na-phosphate (Eisen and Brown (1999) Methods Enzymol. 303:179-205). The cDNAs were spotted on microscope glass slides coated with polylysine. The prepared cDNAs were aliquoted into 384 well plates and spotted on the slides using an x-y-z gantry (OmniGrid) purchased from GeneMachines (Menlo Park, Calif.) outfitted with quill type pins purchased from Telechem International (Sunnyvale, Calif.). After spotting, the arrays were cured for a minimum of one week at room temperature, rehydrated and blocked following the protocol recommended by Eisen and Brown (1999; supra).

Sample total RNA (10 ug) samples were labeled using fluorescent Cy3 and Cy5 dyes. Labeled samples were resuspended in 4×SSC/0.03% SDS/4 ug salmon sperm DNA/2 ug tRNA/50 mM Na-pyrophosphate, heated for 95° C. for 2.5 minutes, spun down and placed on the array. The array was then covered with a glass coverslip and placed in a sealed chamber. The chamber was then kept in a water bath at 62° C. overnight. The arrays were washed as described in Eisen and Brown (1999) and scanned on a General Scanning 3000 laser scanner. The resulting files are subsequently quantified using Imagene, a software purchased from BioDiscovery (Los Angeles, Calif.).

Experiments were performed to identify those transformants or knockouts that exhibited an improved environmental stress tolerance. For such studies, the transformants were exposed to a variety of environmental stresses. Plants were exposed to chilling stress (6 hour exposure to 4-8° C.), heat stress (6 hour exposure to 32-37° C.), high salt stress (6 hour exposure to 200 mM NaCl), drought stress (168 hours after removing water from trays), osmotic stress (6 hour exposure to 3 M mannitol), or nutrient limitation (nitrogen, phosphate, and potassium) (Nitrogen: all components of MS medium remained constant except N was reduced to 20 mg/l of NH₄NO₃, or Phosphate: All components of MS medium except KH₂PO₄, which was replaced by K₂SO₄, Potassium: All components of MS medium except removal of KNO₃ and KH₂PO₄, which were replaced by NaH₄PO₄).

Experiments were performed to identify those transformants or knockouts that exhibited a modified structure and development characteristics. For such studies, the transformants were observed by eye to identify novel structural or developmental characteristics associated with the ectopic expression of the polynucleotides or polypeptides of the invention.

Experiments were performed to identify those transformants or knockouts that exhibited modified sugar-sensing. For such studies, seeds from transformants were germinated on media containing 5% glucose or 9.4% sucrose which normally partially restrict hypocotyl elongation. Plants with altered sugar sensing may have either longer or shorter hypocotyls than normal plants when grown on this media. Additionally, other plant traits may be varied such as root mass.

Flowering time was measured by the number of rosette leaves present when a visible inflorescence of approximately 3 cm is apparent Rosette and total leaf number on the progeny stem are tightly correlated with the timing of flowering (Koornneef et al (1991) Mol. Gen. Genet 229:57-66. The vernalization response was measured. For vernalization treatments, seeds were sown to MS agar plates, sealed with micropore tape, and placed in a 4° C. cold room with low light levels for 6-8 weeks. The plates were then transferred to the growth rooms alongside plates containing freshly sown non-vernalized controls. Rosette leaves were counted when a visible inflorescence of approximately 3 cm was apparent.

Modified phenotypes observed for particular overexpressor or knockout plants are provided in Table 4. For a particular overexpressor that shows a less beneficial characteristic, it may be more useful to select a plant with a decreased expression of the particular transcription factor. For a particular knockout that shows a less beneficial characteristic, it may be more useful to select a plant with an increased expression of the particular transcription factor.

The sequences of the Sequence Listing or those in Tables 4, Table 5 or those disclosed here can be used to prepare transgenic plants and plants with altered traits. The specific transgenic plants listed below are produced from the sequences of the Sequence Listing, as noted. Table 4 provides exemplary polynucleotide and polypeptide sequences of the invention. Table 4 includes, from left to right for each sequence: the first column shows the polynucleotide SEQ ID NO; the second column shows the Mendel Gene ID No., GID; the third column shows the trait(s) resulting from the knock out or overexpression of the polynucleotide in the transgenic plant; the fourth column shows the category of the trait; the fifth column shows the transcription factor family to which the polynucleotide belongs; the sixth column (“Comment”), includes specific effects and utilities conferred by the polynucleotide of the first column; the seventh column shows the SEQ ID NO of the polypeptide encoded by the polynucleotide; and the eighth column shows the amino acid residue positions of the conserved domain in amino acid (AA) co-ordinates.

Seed of plants overexpressing sequences G265 (SEQ ID NOs: 871 and 872), G715 (SEQ ID NOs: 925 and 926), G1471 (SEQ ID NOs: 311 and 312), G1793 (SEQ ID NOs: 365 and 366), G1838 (SEQ ID NOs: 381 and 382), G1902 (SEQ ID NOs: 405 and 406), G286 (SEQ ID NOs: 877 and 878), G2138 (SEQ ID NOs: 865 and 866) and G2830 (SEQ ID NOs: 875 and 876) was subjected to NIR analysis and a significant increase in seed oil content compared with seed from control plants was identified.

G192: G192 (SEQ ID NO: 859) was expressed in all plant tissues and under all conditions examined. Its expression was slightly induced upon infection by Fusarium. G192 was analyzed using transgenic plants in which this gene was expressed under the control of the 35S promoter. G192 overexpressors were late flowering under 12 hour light and had more leaves than control plants. This phenotype was manifested in the three T2 lines analyzed. Results of one experiment suggest that G192 overexpressor was more susceptible to infection with a moderate dose of the fungal pathogen Erysiphe orontii. The decrease in seed oil observed for one line was replicated in an independent experiment. G192 overexpression delayed flowering. A wide variety of applications exist for systems that either lengthen or shorten the time to flowering, or for systems of inducible flowering time control. In particular, in species where the vegetative parts of the plants constitute the crop and the reproductive tissues are discarded, it will be advantageous to delay or prevent flowering. Extending vegetative development can bring about large increases in yields. G192 can be used to manipulate the defense response in order to generate pathogen-resistant plants. G192 can be used to manipulate seed oil content, which can be of nutritional value.

Closely Related Genes from Other Species

G192 had some similarity within the conserved WRKY domain to non-Arabidopsis plant proteins.

G1946: G1946 (SEQ ID NO: 801) was studied using transgenic plants in which the gene was expressed under the control of the 35S promoter. Overexpression of G1946 resulted in accelerated flowering, with 35S::G1946 transformants producing flower buds up to a week earlier than wild-type controls (24-hour light conditions). These effects were seen in 12/20 primary transformants and in two independent plantings of each of the three T2 lines. Unlike many early flowering Arabidopsis transgenic lines, which are dwarfed, 35S::G1946 transformants often reached full-size at maturity, and produced large quantities of seeds, although the plants were slightly pale in coloration and had slightly flat leaves compared to wild-type. In addition, 35S::G1946 plants showed an altered response to phosphate deprivation. Seedlings of G1946 overexpressor plants showed more secondary root growth on phosphate-free media, when compared to wild-type control. In a repeat experiment, all three lines showed the phenotype. Overexpression of G1946 in Arabidopsis also resulted in an increase in seed glucosinolate M39501 in T2 lines 1 and 3. An increase in seed oil and a decrease in seed protein was also observed in these two lines. G1946 was ubiquitously expressed, and does not appear to be significantly induced or repressed by any of the biotic and abiotic stress conditions tested at this time, with the exception of cold, which repressed G1946 expression. G1946 can be used to modify flowering time, as well as to improve the plant's performance in conditions of limited phosphate, and to alter seed oil, protein, and glucosinolate composition.

Closely Related Genes from Other Species

A comparison of the amino acid sequence of G1946 with sequences available from GenBank showed strong similarity with plant HSFs of several species (Lycopersicon peruvianum, Medicago truncatula, Lycopersicon esculentum, Glycine max, Solanum tuberosum, Oryza sativa and Hordeum vulgare subsp. vulgare).

G375: The sequence of G375 (SEQ ID NO: 239) was experimentally determined and G375 was analyzed using transgenic plants in which G375 was expressed under the control of the 35S promoter. Overexpression of G375 produced marked effects on leaf development. At early stages of growth, 35S::G375 seedlings developed narrow, upward pointing leaves with long petioles (possibly indicating a disruption in circadian-clock controlled processes or nyctinastic movements). Additionally, some seedlings were noted to have elongated hypocotyls, and some were rather small compared to wild-type controls. Comparable phenotypes were obtained by overexpression of an AP2 family gene, G2113 (SEQ ID NO: 85). Following the switch to flowering, 35S::G375 plants showed reduced fertility, which possibly arose from a failure of stamens to fully elongate. One of the three T2 lines, (#41) was later flowering than wild-type controls, and also developed large numbers of small secondary rosette leaves in the axils of the primary rosette. Although these effects were not noted in the other two lines, the phenotypes obtained in line 41 were somewhat similar to those produced by overexpression of another Z-dof gene, G736 (SEQ ID NO: 211). G375 was expressed in all tissues, although at different levels. It was expressed at low levels in the root and germinating seed, and expressed at high levels in the embryo. The effects of G375 on leaf architecture are of potential interest to the ornamental horticulture industry.

Closely Related Genes from Other Spceies

G375 showed some homology to non-Arabidopsis plant proteins within the conserved Dof domain.

G1255: The sequence of G1255 (SEQ ID NO: 273) was experimentally determined and G1255 was analyzed using transgenic plants in which G1255 was expressed under the control of the 35S promoter. Plants overexpressing G1255 had alterations in leaf architecture, a reduction in apical dominance, an increase in seed size, and showed more disease symptoms following inoculation with a low dose of the fungal pathogen Botrytis cinerea. G1255 was constitutively expressed and not significantly induced by any conditions tested. On the basis of the phenotypes produced by overexpression of G1255, G1255 can be used to manipulate the plant's defense response to produce pathogen resistance, alter plant architecture, or alter seed size.

Closely Related Genes from Other Species

G1255 showed strong homology to a putative rice zing finger protein represented by sequence AC087181_(—)3. Sequence identity between these two protein extended beyond the conserved domain, and therefore, these genes can be orthologs.

G865: The complete cDNA sequence of G865 (SEQ ID NO: 557) was determined. G865 was ubiquitously expressed in Arabidopsis tissues. G865 was analyzed using transgenic plants in which G865 was expressed under the control of the 35S promoter. Plants overexpressing G865 were early flowering, with numerous secondary inflorescence meristems giving them a bushy appearance. G865 overexpressors were more susceptible to infection with a moderate dose of the fungal pathogens Erysiphe orontii and Botrytis cinerea. In addition, seeds from G865 overexpressing plants showed a trend of increased protein and reduced oil content, although the observed changes were not beyond the criteria used for judging significance except in one line. G865 can be used to control flowering time. G865 can be used to manipulate the defense response in order to generate pathogen-resistant plants. G865 can be used to alter seed oil and protein content of a plant.

Closely Related Genes from Other Species

G865 and other non-Arabidopsis AP2/EREBP proteins were similar within the conserved AP2 domain.

G2509: G2509 (SEQ ID NO: 23) was studied using transgenic plants in which the gene was expressed under the control of the 35S promoter. Overexpression of G2509 caused multiple alterations in plant growth and development, most notably, altered branching patterns, and a reduction in apical dominance, giving the plants a shoier, more bushy stature than wild type. Twenty 35S::G2509 primary transformants were examined; at early stages of rosette development, these plants displayed a wild-type phenotype. However, at the switch to flowering, almost all T1 lines showed a marked loss of apical dominance and large numbers of secondary shoots developed from axils of primary rosette leaves. In the most extreme cases, the shoots had very short internodes, giving the inflorescence a very bushy appearance. Such shoots were often very thin and flowers were relatively small and poorly fertile. At later stages, many plants appeared very small and had a low seed yield compared to wild type. In addition to the effects on branching, a substantial number of 35S::G2509 primary transformants also flowered early and had buds visible several days prior to wild type. Similar effects on inflorescence development were noted in each of three T2 populations examined. The branching and plant architecture phenotypes observed in 35S::G2509 lines resemble phenotypes observed for three other AP2/EREBP genes: G865 (SEQ ID NO: 557), G1411 (SEQ ID NO: 3), and G1794 (SEQ ID NO: 13). G2509, G865, and G1411 fonn a small clade within the large AP2/EREBP family, and G1794, although not belonging to the clade, is one of the AP2/EREBP genes closest to it in the phylogenetic tree. It is thus likely that all these genes share a related function, such as affecting hormone balance. Overexpression of G2509 in Arabidopsis resulted in an increase in alpha-tocopherol in seeds in T2 lines 5 and 11. G2509 was ubiquitously expressed in Arabidopsis plant tissue. G2509 expression levels were altered by a variety of environmental or physiological conditions. G2509 can be used to manipulate plant architecture and development. G2509 can be used to alter tocopherol composition. Tocopherols have anti-oxidant and vitamin E activity. G2509 can be useful in altering flowering tine. A wide variety of applications exist for systems that either lengthen or shorten the time to flowering.

Closely Related Genes from Other Species

G2509 showed some sequence similarity with known genes from other plant species within the conserved AP2/EREBP domain.

G2347: G2347 (SEQ ID NO: 1119) was analyzed using transgenic plants in which G2347 was expressed under the control of the 35S promoter. Overexpression of G2347 markedly reduced the time to flowering in Arabidopsis. This phenotype was apparent in the majority of primary transformants and in all plants from two out of the three T2 lines examined. Under continuous light conditions, 35S::G2347 plants formed flower buds up a week earlier than wild type. Many of the plants were rather small and spindly compared to controls. To demonstrate that overexpression of G2347 could induce flowering under less inductive photoperiods, two T2 lines were re-grown in 12 hour conditions; again, all plants from both lines bolted early, with some initiating flower buds up to two weeks sooner than wild-type. As determined by RT-PCR, G2347 was highly expressed in rosette leaves and flowers, and to much lower levels in embryos and siliques. No expression of G2347 was detected in the other tissues tested. G2347 expression was repressed by cold, and by auxin treatments and by infection by Erysiphe. G2347 is also highly similar to the Arabidopsis protein G2010 (SEQ ID NO: 1121). The level of homology between these two proteins suggested they could have similar, overlapping, or redundant functions in Arabidopsis. In support of this hypothesis, overexpression of both G2010 and G2347 resulted in early flowering phenotypes in transgenic plants.

Closely Related Genes from Other Species

The closest relative to G2347 is the Antirrhinum protein, SBP2 (CAA63061). The similarity between these two proteins is extensive enough to suggest they might have similar functions in a plant.

G988: G988 (SEQ ID NO: 43) was analyzed using transgenic plants in which G988 was expressed under the control of the 35S promoter. Plants overexpressing G988 had multiple morphological phenotypes. The transgenic plants were generally smaller than wild-type plants, had altered leaf, inflorescence and flower development, altered plant architecture, and altered vasculature. In one transgenic line overexpressing G988 (line 23), an increase in the seed glucosinolate M39489 was observed. The phenotype of plants overexpressing G988 was wild-type in all other assays performed. In wild-type plants, G988 was expressed primarily in flower and silique tissue, but was also present at detectable levels in all other tissues tested. Expression of G988 was induced in response to heat treatment, and repressed in response to infection with Erysiphe. Based on the observed morphological phenotypes of the transgenic plants, G988 can be used to create plants with larger flowers. This can have value in the ornamental horticulture industry. The reduction in the formation of lateral branches suggests that G988 can have utility on the forestry industry. The Arabidopsis plants overexpressing G988 also had reduced fertility. This could actually be a desirable trait in some instances, as it can be exploited to prevent or minimize the escape of GMO (genetically modified organism) pollen into the environment.

Closely Related Genes from Other Species

The amino acid sequence for the Capsella rubella hypothetical protein represented by GenBank accession number CRU303349 was significantly identical to G988 outside of the SCR conserved domains. The Capsella rubella hypothetical protein is 90% identical to G988 over a stretch of roughly 450 amino acids. Therefore, it is likely that the Capsella rubella gene is an ortholog of G988.

G2346: G2346 (SEQ ID NO: 459) was analyzed using transgenic plants in which the gene was expressed under the control of the 35S promoter. 35S::G2346 seedlings from all three T2 populations had slightly larger cotyledons and appeared somewhat more advanced than controls. This indicated that the seedlings developed more rapidly that the control plants. At later stages, however, G2346 overexpressing plants showed no consistent differences from control plants. The phenotype of these transgenic plants was wild-type in all other assays performed. According to RT-PCR analysis, G2346 is expressed ubiquitously.

Closely Related Genes from Other Species

G2346 shows some sequence similarity with known genes from other plant species within the conserved SBP domain.

G1354: The complete sequence ofG1354 (SEQ ID NO: 285) was determined. G1354 was analyzed using transgenic plants in which G1354 was expressed under the control of the 35S promoter. Overexpression of G1354 produced highly deleterious effects on growth and development. Only three 35S::G1354 T1 plants were obtained; all were extremely tiny and slow developing. After three weeks of growth, each of the plants comprised a completely disorganized mass of leaves and root that had no clear axis of growth. Since these individuals would not have survived transplantation to soil, they were harvested for RT-PCR analysis; all three plants showed moderate levels of G1354 overexpression compared to whole wild-type seedlings of an equivalent size. Only a very small number of transformants were obtained from two selection attempts on separate batches of T0 seed. Usually between 15 and 120 transformants are obtained from each aliquot of 300 mg T0 seed from wild-type plants. The low transformation frequency obtained in this experiment suggests that high levels of G1354 overexpression might have completely lethal effects and prevent transformed seeds from germinating. As determined by RT-PCR, G1354 was uninformly expressed in all tissues and under all conditions tested in RT-PCR. However, the gene was repressed in leaf tissue in response to Erysiphe infection.

Closely Related Genes from Other Species

G 1354 is closely related to a NAM protein encoded by polynucleotide from rice (AC005310). Similarity between G1354 and this rice protein extends beyond the signature motif of the family to a level that would suggest the genes are orthologs.

G1063: G1063 (SEQ ID NO: 119) is a member of a clade of highly related HLH/MYC proteins that also includes G779 (SEQ ID NO: 113), G1499 (SEQ ID NO: 7), G2143 (SEQ ID NO: 129), and G2557 (SEQ ID NO: 133). All of these genes caused similar pleiotropic phenotypic effects when overexpressed, the most striking of which was the production of ectopic carpelloid tissue. These genes can be considered key regulators of carpel development. A spectrum of developmental alterations was observed amongst 35S::G1063 primary transformants and the majority were markedly small, dark green, and had narrow curled leaves. The most severely affected individuals were completely sterile and formed highly abnormal inflorescences; shoots often terminated in pin-like structures, and flowers were replaced by filamentous carpelloid structures. In other cases, flowers showed internode elongation between floral whorls, with a central carpel protruding on a pedicel-like organ. Additionally, lateral branches sometimes failed to develop and tiny patches of carpelloid tissue formed at axillary nodes of the inflorescence. In lines with an intermediate phenotype, flowers contained defined whorls of organs, but sepals were converted to carpelloid structures or displayed patches of carpelloid tissue. In contrast, lines with a weak phenotype developed relatively normal flowers and produced a reasonable quantity of seed. Such plants were still distinctly smaller than wild-type controls. Since the strongest 35S::G1063 lines were sterile, three lines with a relatively weak phenotype, that had produced sufficient seed for biochemical and physiological analysis, were selected for further study. Two of the T2 populations (T2-28, 37) were clearly small, darker green and possessed narrow leaves compared to wild type. Plants from one of these populations (T2-28) also produced occasional branches with abnormal flowers like those seen in the T1. The final T2 population (T2-30) displayed a very mild phenotype. Overexpression of G1063 in Arabidopsis resulted in a decrease in seed oil content in T2 lines 28 and 37. No altered phenotypes were detected in any of the physiological assays, except that the plants were noted to be somewhat small and produce anthocyanin when grown in Petri plates. G1063 was expressed at low to moderate levels in roots, flowers, rosette leaves, embryos, and germinating seeds, but was not detected in shoots or siliques. It was induced by auxin. G1063 can be used to manipulate flower form and structure or plant fertility. One application for manipulation of flower structure can be in the production of saffron, which is derived from the stigmas of Crocus sativus. G1063 has utility in manipulating seed oil and protein content.

Closely Related Genes from Other Species

G1063 protein shared extensive homology in the basic helix loop helix region with a protein sequence encoded by Glycine max cDNA clone (AW832545) as well as a tomato root, plants pre-anthesis Lycopersicon sculentum cDNA (BE451174).

G2143: G2143 (SEQ ID NO: 129) is a member of a clade of highly related HLH/MYC proteins that also includes G779 (SEQ ID NO: 113), G1063 (SEQ ID NO: 119), G1499 (SEQ ID NO: 7), and G2557 (SEQ ID NO: 133). All of these genes caused similar pleiotropic phenotypic effects when overexpressed, the most striking of which was the production of ectopic carpelloid tissue. These genes can be considered key regulators of carpel development. Twelve out of twenty 35S::G2143 T1 lines showed a very severe phenotype; these plants were markedly small and had narrow, curled, dark-green leaves. Such individuals were completely sterile and formed highly abnormal inflorescences; shoots often terminated in pin-like structures, and flowers were replaced by filamentous carpelloid structures, or a fused mass of carpelloid tissue. Furthermore, lateral branches usually failed to develop, and tiny patches of stigmatic tissue often formed at axillary nodes of the inflorescence. Strongly affected plants displayed the highest levels of transgene expression (determined by RT-PCR). The remaining T1 lines showed lower levels of G2143 overexpression; these plants were still distinctly smaller than wild type, but had relatively normal inflorescences and produced seed. Since the strongest 35S::G2143 lines were sterile, three lines with a relatively weak phenotype, that had produced sufficient seed for biochemical analysis, were selected for further study. T2-11 plants displayed a very mild phenotype and had somewhat small, narrow, dark green leaves. The other two T2 populations, however, appeared wild-type, suggesting that transgene activity might have been reduced between the generations. Reduced seedling vigor was noted in the physiological assays. G2143 expression was detected at low levels in flowers and siliques, and at higher levels in germinating seed. G2143 can be used to manipulate flower form and structure or plant fertility. One application for manipulation of flower structure can be in the production of saffron, which is derived from the stigmas of Crocus sativus.

Closely Related Genes from Other Species

G2143 protein shared extensive homology in the basic helix loop helix region with a protein encoded by Glycine max cDNA clones (AW832545, BG726819 and BG154493) and a Lycopersicon esculentum cDNA clone (BE451174). There was lower homology outside of the region.

G2557: G2557 (SEQ ID NO: 133) is a member of a clade of highly related HLH/MYC proteins that also includes G779 (SEQ ID NO: 113), G1063 (SEQ ID NO: 119), G1499 (SEQ ID NO: 7), and G2143 (SEQ ID NO: 129). All of these genes caused similar pleiotropic phenotypic effects when overexpressed, the most striking of which was the production of ectopic carpelloid tissue. These genes can be considered key regulators of carpel development. The flowers of 35S::G2557 primary transformants displayed patches of stigmatic papillae on the sepals, and often had rather narrow petals and poorly developed stamens. Additionally, carpels were also occasionally held outside of the flower at the end of an elongated pedicel like structure. As a result of such defects, 35S::G2557 plants often showed very poor fertility and formed small wrinkled siliques. In addition to such floral abnormalities, the majority of primary transformants were also small and darker green in coloration than wild type. Approximately one third of the T1 plants were extremely tiny and completely sterile. Three T1 lines (#7,9,12), that had produced some seeds, and showed a relatively weak phenotype, were chosen for further study. All three of the T2 populations from these lines contained plants that were distinctly small, had abnormal flowers, and were poorly fertile compared to controls. Stigmatic tissue was not noted on the sepals of plants from these three T2 lines. Another line (#4) that had shown a moderately strong phenotype in the T1 was sown for only morphological analysis in the T2 generation. T2-4 plants were small, dark green, and produced abnormal flowers with ectopic stigmatic tissue on the sepals, as had been seen in the parental plant. G2557 expression was detected at low to moderate levels in all tissues tested except shoots. It was induced by cold, heat, and salt, and repressed by pathogen infection. G1063 can be used to manipulate flower form and structure or plant fertility. One application for manipulation of flower structure can be in the production of saffron, which is derived from the stigmas of Crocus sativus.

Closely Related Genes from Other Species

G2557 protein shows extensive sequence similarity in the region of basic helix loop helix with a protein encoded by Glycine max cDNA clone (BE34781 1).

G2430: The complete sequence of G2430 (SEQ ID NO: 697) was determined. G2430 is a member of the response regulator class of GARP proteins (ARR genes), although one of the two conserved aspartate residues characteristic of response regulators is not present. The second aspartate, the putative phosphorylated site, is retained so G2430 can have response regulator function. G2430 is specifically expressed in embryo and silique tissue. In morphological analyses, plants overexpressing G2430 showed more rapid growth than control plants at early stages, and in two of three lines examined produced large, flat leaves. Early flowering was observed for some lines, but this effect was inconsistent between plantings. G2430 can regulate plant growth. Overexpression of G2430 in Arabidopsis also resulted in seedlings that are slightly more tolerant to heat in a germination assay. Seedlings from G2430 overexpressing transgenic plants were slightly greener than the control seedlings under high temperature conditions. In a repeat experiment on individual lines, G2430 line 15 showed the strongest heat tolerant phenotype. G2430 can be useful to promote faster development and reproduction in plants.

Closely Related Genes from Other Species

G2430 had some similarity within of the conserved GARP and response-regulator domains to non-Arabidopsis proteins.

G1478: The sequence of G1478 (SEQ ID NO: 831) was determined and G1478 was analyzed using transgenic plants in which G1478 was expressed under the control of the 35S promoter. Plants overexpressing G1478 had a general delay in progression through the life cycle, in particular a delay in flowering time. G1478 is expressed at higher levels in flowers, rosettes and embryos but otherwise expression is constitutive. Based on the phenotypes produced through G1478 overexpression, G1478 can be used to manipulate the rate at which plants grow, and flowering time.

Closely Related Genes from Other Species

G1478 shows some homology to non-Arabidopsis proteins within the conserved domain.

G681: G681 (SEQ ID NO: 579) was analyzed using transgenic plants in which the gene was expressed under the control of the 35S promoter. Approximately half of the 35S::6681 primary transformants were markedly small and formed narrow leaves compared to controls. These plants often produced thin inflorescence stems, had rather poorly formed flowers with low pollen production, and set few seeds. Three T1 lines with relatively weak phenotypes, which had produced reasonable quantities of seed, were selected for further study. Piants from one of the T2 populations were noted to be slightly small, but otherwise the T2 lines displayed no consistent differences in morphology from controls. In leaves of two of the T2 lines, overexpression of G681 resulted in an increase in the percentage of the glucosinolate M39480. According to RT-PCR analysis, G681 expression was detected at very low levels in flower and rosette leaf tissues. G681 was induced by drought stress. G681 can be used to alter glucosinolate composition in plants. Increases or decreases in specific glucosinolates or total glucosinolate content are desirable depending upon the particular application. For example: (1) Glucosinolates are undesirable components of the oilseeds used in animal feed, since they produce toxic effects. Low-glucosinolate varieties of canola have been developed to combat this problem. (2) Some glucosinolates have anti-cancer activity; thus, increasing the levels or composition of these compounds might be of interest from a nutraceutical standpoint. (3) Glucosinolates form part of a plants natural defense against insects. Modification of glucosinolate composition or quantity could therefore afford increased protection from predators. Furthermore, in edible crops, tissue specific promoters can be used to ensure that these compounds accumulate specifically in tissues, such as the epidermis, which are not taken for consumption.

Closely Related Genes from Other Species

G681 shows some sequence similarity with known genes from other plant species within the conserved Myb domain.

G878: G878 (SEQ ID NO: 611) was studied using transgenic plants in which the gene was expressed under the control of the 35S promoter. Analysis of primary transformants revealed that overexpression of G878 delays the onset of flowering in Arabidopsis. 11/20 of the 35S::G878 T1 plants flowered approximately one week later than wild type under continuous light conditions. These plants were also darker green, had shorter stems, and senesced later than controls. G878 was ubiquitously expressed. G878 can be used to modify flowering time and senescence, and a wide variety of applications exist for systems that either lengthen or shorten the time to flowering.

Closely Related Genes from Other Species

G878 was highly related to other WRKY proteins from a variety of plant species, such as the Nicotiana tabacum DNA-binding protein 2 (WRKY2) (AF096299), and a Cucumis sativus SPFI-like DNA-binding protein (L44134).

G374: G374 (SEQ ID NO: 47) was expressed at low levels throughout the plant and was induced by salicylic acid. G374 was investigated using lines carrying a T-DNA insertion in this gene. The T-DNA insertion was approximately three quarters of the way into the protein coding sequence and should result in a null mutation. Homozygosity for a T-DNA insertion within G374 caused lethality at early stages of embryo development. In an initial screen for G374 knockouts, heterozygous plants were identified. Seed from those individuals was sown to soil and eleven plants were PCR-screened to identify homozygotes. No homozygotes were obtained; 6 of the progeny were heterozygous whilst the other 5 were wild type. This raised the prospect that homozygosity for the G374 insertion was lethal. To examine this possibility further, heterozygous KO.G374 plants were re-grown. These individuals looked wild type, but their siliques were examined for seed abnormalities. When green siliques were dissected, around 25% of developing seeds were white or aborted. Embryos from these siliques were cleared using Hoyers solution, and examined under the microscope. It was apparent that embryos from the white seeds had arrested at early (globular or heart) stages of development, whilst embryos from the normal seeds were fully developed. Such arrested or aborted seeds most likely represented homozygotes for the G374 insertion. To support this conclusion, seed was collected from heterozygous plants and sown to kanamycin plates (the T-DNA insertion carried the NPT marker gene). Of the seedlings that germinated, 160 were kanamycin resistant and 107 were kanamycin sensitive. These data more closely fitted a 2:1 (chi-sq., 1df,=5.5, 0.05>P>0.01) than a 3:1 (chi-sq., 1df,=32, P<0.001) ratio. Such a segregation ratio suggested that a homozygous class of kanamycin resistant seedlings was absent from the progeny of KO.G374 plant. G374 can be a herbicide target.

Closely Related Genes from Other Species

Similar sequences to G374 are present in tomato and Medicago truncatula, and these sequences can be orthologs.

Example VIII

Identification of Homologous Sequences

Homologous sequences from Arabidopsis and plant species other than Arabidopsis were identified using database sequence search tools, such as the Basic Local Alignment Search Tool (BLAST) (Altschul et al. (1990) J. Mol. Biol. 215:403-410; and Altschul et al. (1997) Nucl. Acid Res. 25: 3389-3402). The tblastx sequence analysis programs were employed using the BLOSUM-62 scoring matrix (Henikoff, S. and Henikoff, J. G. (1992) Proc. Natl. Acad. Sci. USA 89: 10915-10919).

Identified non-Arabidopsis sequences homologous to the Arabidopsis sequences are provided in Table 5. The percent sequence identity among these sequences can be as low as 47%, or even lower sequence identity. The entire NCBI GenBank database was filtered for sequences from all plants except Arabidopsis thaliana by selecting all entries in the NCBI GenBank database associated with NCBI taxonomic ID 33090 (Viridiplantae; all plants) and excluding entries associated with taxonomic ID 3701 (Arabidopsis thaliana). These sequences are compared to sequences representing genes of SEQ IDs NOs: 2-2N, where N=2-561, using the Washington University TBLASTX algorithm (version 2.0a19MP) at the default settings using gapped alignments with the filter “off”. For each gene of SEQ IDs NOs: 2-2N, where N=2-561, individual comparisons were ordered by probability score (P-value), where the score reflects the probability that a particular alignment occurred by chance. For example, a score of 3.6e-40 is 3.6×10 ⁻⁴⁰. In addition to P-values, comparisons were also scored by percentage identity. Percentage identity reflects the degree to which two segments of DNA or protein are identical over a particular length. Examples of sequences so identified are presented in Table 5. Homologous or orthologous sequences are readily identified and available in GenBank by Accession number (Table 5; Test sequence ID)The identified homologous polynucleotide and polypeptide sequences and homologues of the Arabidopsis polynucleotides and polypeptides may be orthologs of the Arabidopsis polynucleotides and polypeptides. (TBD: to be determined.)

Example IX

Introduction of Polynucleotides into Dicotyledonous Plants

SEQ ID NOs: 1−(2N −1), wherein N=2-561, paralogous, orthologous, and homologous sequences recombined into pMEN20 or pMEN65 expression vectors are transformed into a plant for the purpose of modifying plant traits. The cloning vector may be introduced into a variety of cereal plants by means well-known in the art such as, for example, direct DNA transfer or Agrobacterium tumefaciens-mediated transformation. It is now routine to produce transgenic plants using most dicot plants (see Weissbach and Weissbach, (1989) supra; Gelvin et al., (1990) supra; Herrera-Estrella et al. (1983) supra; Bevan (1984) supra; and Klee (1985) supra). Methods for analysis of traits are routine in the art and examples are disclosed above.

Example X

Transformation of Cereal Plants with an Expression Vector

Cereal plants such as corn, wheat, rice, sorghum or barley, may also be transformed with the present polynucleotide sequences in pMEN20 or pMEN65 expression vectors for the purpose of modifying plant traits. For example, pMEN020 may be modified to replace the NptII coding region with thie BAR gene of Streptomyces hygroscopicus that confers resistance to phosphinothricin. The KpnI and BgIII sites of the Bar gene are removed by site-directed mutagenesis with silent codon changes.

The cloning vector may be introduced into a variety of cereal plants by means well-known in the art such as, for example, direct DNA transfer or Agrobacterium tumefaciens-mediated transformation. It is now routine to produce transgenic plants of most cereal crops (Vasil, I., Plant Molec. Biol. 25: 925-937 (1994)) such as corn, wheat, rice, sorghum (Cassas, A. et al., Proc. Natl. Acad Sci USA 90: 11212-11216 (1993) and barley (Wan, Y. and Lemeaux, P. Plant Physiol. 104:37-48 (1994). DNA transfer methods such as the microprojectile can be used for corn (Fromm. et al. Bio/Technology 8: 833-839 (1990); Gordon-Kamm et al. Plant Cell 2: 603-618 (1990); Ishida, Y., Nature Biotechnology 14:745-750 (1990)), wheat (Vasil, et al. Bio/Technology 10:667-674 (1992); Vasil et al., Bio/Technology 11:1553-1558 (1993); Weeks et al., Plant Physiol. 102:1077-1084 (1993)), rice (Christou Bio/Technology 9:957-962 (1991); Hiei et al. Plant J. 6:271-282 (1994); Aldemita and Hodges, Planta 199:612-617; Hiei et al., Plant Mol Biol. 35:205-18 (1997)). For most cereal plants, embryogenic cells derived from immature scutellum tissues are the preferred cellular targets for transformation (Hiei et al., Plant Mol Biol. 35:205-18 (1997); Vasil, Plant Molec. Biol. 25: 925-937 (1994)).

Vectors according to the present invention may be transformed into corn embryogenic cells derived from immature scutellar tissue by using microprojectile bombardment, with the A188XB73 genotype as the preferred genotype (Fromm, et al., Bio/Technology 8: 833-839 (1990); Gordon-Kamm et al., Plant Cell 2: 603-618 (1990)). After microprojectile bombardment the tissues are selected on phosphinothricin to identify the transgenic embryogenic cells (Gordon-Kamm et al., Plant Cell 2: 603-618 (1990)). Transgenic plants are regenerated by standard corn regeneration techniques (Fromm, et al., Bio/Technology 8: 833-839 (1990); Gordon-Kamm et al., Plant Cell 2: 603-618 (1990)).

The plasmids prepared as described above can also be used to produce transgenic wheat and rice plants (Christou, Bio/Technology 9:957-962 (1991); Hiei et al., Plant J. 6:271-282 (1994); Aldemita and Hodges, Planta 199:612-617 (1996); Hici et al., Plant Mol Biol. 35:205-18 (1997)) that coordinately express genes of interest by following standard transformation protocols known to those skilled in the art for rice and wheat Vasil, et al. Bio/Technology 10:667-674 (1992); Vasil et al., Bio/Technology 11:1553-1558 (1993); Weeks et al., Plant Physiol. 102:1077-1084 (1993)), where the bar gene is used as the selectable marker.

All references, publications, patent documents, web pages, and other documents cited or mentioned herein are hereby incorporated by reference in their entirety for all purposes. Although the invention has been described with reference to specific embodiments and examples, it should be understood that one of ordinary skill can make various modifications without departing from the spirit of the invention. The scope of the invention is not limited to the specific embodiments and examples provided. TABLE 4 Poly nu- Poly- cleo- pep- tide tide SEQ SEQ ID ID Conserved NO: GID No. Trait Category Family Comment NO: domains 1 G1275 Architecture; Dev and morph WRKY Reduced apical dominance; small plant 2 (113-169) size 3 G1411 Architecture Dev and morph AP2 Loss of apical dominance 4 (87-154) 5 G1488 Architecture; Dev and GATA/Zn Reduced apical dominance, shorter stems; constitutive 6 (221-246) light response; morph; seed photomorphogenesis; reduced size; altered seed protein size; seed biochemistry content protein content 7 G1499 Architecture; Dev and morph HLH/MYC Altered plant architecture; altered floral organ identity 8 (118-181) flower; and development; dark green color morphology: other 9 G1543 Architecture; Dev and HB Altered plant architecture; altered carpel shape; dark 10 (135-195) flower; morph; seed green color; decreased seed oil morphology: biochemistry other; seed oil 11 G1635 Architecture; Dev and morph MYB-related Reduced apical dominance; pale green, smaller plants; 12 (44-104) morphology: reduced fertility other; fertility 13 G1794 Architecture; Dev and AP2 Altered plant architecture; constitutive 14 (182-248) light response; morph; seed photomorphogenesis; altered seed oil and protein seed oil and biochemistry content protein content 15 G1839 Architecture; Dev and morph AP2 Altered plant architecture; reduced size 16 (118-184) size 17 G2108 Architecture Dev and morph AP2 Altered inflorescence structure 18 (18-85) 19 G2291 Architecture; Dev and AP2 Altered plant architecture; late flowering 20 (TBD) flowering time morph; flowering time 21 G2452 Architecture; Dev and morph MYB-related Reduced apical dominance; pale green color 22 (27-213) leaf 23 G2509 Architecture; Dev and AP2 Reduced apical dominance; altered seed oil and protein 24 (89-156) seed oil and morph; seed content protein content biochemistry 25 G390 Architecture Dev and morph HB Altered shoot development 26 (18-81) 27 G391 Architecture Dev and morph HB Altered shoot development 28 (25-85) 1 G1275 Architecture; Dev and morph WRKY Reduced apical dominance; small plant 2 (113-169) size 3 G1411 Architecture Dev and morph AP2 Loss of apical dominance 4 (87-154) 5 G1488 Architecture; Dev and GATA/Zn Reduced apical dominance, shorter stems; constitutive 6 (221-246) light response; morph; seed photomorphogenesis; reduced size; altered seed protein size; seed biochemistry content protein content 7 G1499 Architecture; Dev and morph HLH/MYC Altered plant architecture; altered floral organ identity 8 (118-181) flower; and development; dark green color morphology: other 9 G1543 Architecture; Dev and HB Altered plant architecture; altered carpel shape; dark 10 (135-195) flower; morph; seed green color; decreased seed oil morphology: biochemistry other; seed oil 11 G1635 Architecture; Dev and morph MYB-related Reduced apical dominance; pale green, smaller plants; 12 (44-104) morphology: reduced fertility other; fertility 13 G1794 Architecture; Dev and AP2 Altered plant architecture; constitutive 14 (182-248) light response; morph; seed photomorphogenesis; altered seed oil and protein seed oil and biochemistry content protein content 15 G1839 Architecture; Dev and morph AP2 Altered plant architecture; reduced size 16 (118-184) size 17 G2108 Architecture Dev and morph AP2 Altered inflorescence structure 18 (18-85) 19 G2291 Architecture; Dev and AP2 Altered plant architecture; late flowering 20 (TBD) flowering time morph; flowering time 21 G2452 Architecture; Dev and morph MYB-related Reduced apical dominance; pale green color 22 (27-213) leaf 23 G2509 Architecture; Dev and AP2 Reduced apical dominance; altered seed oil and protein 24 (89-156) seed oil and morph; seed content protein content biochemistry 25 G390 Architecture Dev and morph HB Altered shoot development 26 (18-81) 27 G391 Architecture Dev and morph HB Altered shoot development 28 (25-85) 29 G438 Architecture; Dev and morph HB Reduced branching; reduced lignin 30 (22-85) stem 31 G47 Architecture; Dev and AP2 Altered architecture and inflorescence development, 32 (11-80) stem; flowering morph; structure of vascular tissues; late flowering; altered seed time; altered flowering time; oil content seed oil content seed biochemistry 33 G559 Architecture; Dev and morph bZIP Loss of apical dominance; reduced fertility 34 (203-264) fertility 35 G568 Architecture; Dev and bZIP Altered branching; late flowering 36 (215-265) flowering time morph; 37 G580 Architecture; Dev and morph bZIP Altered inflorescences; altered flower development 38 (162-218) flower 39 G615 Architecture; Dev and morph TEO Altered plant architecture; little or no pollen production, 40 (88-147) fertility poor filament elongation 41 G732 Architecture; Dev and bZIP Reduced apical dominance; abnormal flowers; altered 42 (31-91) flower; seed oil morph; seed seed oil and protein content and protein biochemistry 43 G988 Architecture; Dev and SCR Reduced lateral branching; reduced fertility; enlarged 44 (178-195) fertility; morph; seed floral organs, short pedicels; thicker stem, altered flower; stem; biochemistry distribution of vacular bundles; altered seed oil and seed oil and protein content protein content 45 G1519 Embryo lethal Dev and morph RING/C3HC4 Embryo lethal 46 (327-364) 47 G374 Embryo lethal Dev and morph Z-ZPF Embryo lethal 48 (35-67, 245-277) 49 G877 Embryo lethal Dev and morph WRKY Embryo lethal 50 (272-328, 487-603) 51 G1000 Fertility; size; Dev and morph MYB-(R1)R2R3 Reduced fertility; small plant; reduced or absent petals 52 (14-117) flower; stem and sepals; reduced inflorescence, stem elongation 53 G1067 Fertility; leaf; Dev and morph AT-hook Reduced fertility; altered leaf shape; small plant 54 (86-93) size 55 G1075 Fertility; flower; Dev and morph AT-hook Reduced fertility; reduced or absent petals, sepals and 56 (78-85) leaf; size stamens; altered leaf shape; small plant 57 G1266 Fertility; size Dev and morph AP2 Reduced fertility; small plant 58 (79-147) 59 G1311 Fertility; size Dev and morph MYB-(R1)R2R3 Reduced fertility; small plant 60 (11-112) 61 G1321 Fertility; flower Dev and morph MYB-(R1)R2R3 Poor fertility; altered flower morphology 62 (4-106) 63 G1326 Fertility; flower; Dev and morph MYB-(R1)R2R3 Reduced fertility; petals and sepals are smaller; small 64 (18-121) size plant 65 G1367 Fertility; size Dev and morph AT-hook Reduced fertility; reduced size 66 (179-201, 262-285, 298-319, 335-357) 67 G1386 Fertility; size; Dev and AP2 Reduced fertility; reduced size; altered seed oil and 68 (TBD) seed oil and morph; seed Protein content protein content biochemistry 69 G1421 Fertility; size; Dev and AP2 Reduced fertility; small plant; altered seed oil content 70 (74-151) seed oil content morph; seed biochemistry 71 G1453 Fertility; Dev and morph NAC Reduced fertility; altered inflorescence development 72 (13-160) morphology: other 73 G1560 Fertility; flower; Dev and morph HS Reduced fertility; altered flower development; reduced 74 (62-151) size size 75 G1594 Fertility; leaf; Dev and morph HB Reduced fertility; altered leaf shape and development; 76 (343-308) seed large pale seed 77 G1750 Fertility; size; Dev and AP2 Reduced fertility; reduced size; increased seed oil 78 (107-173) seed oil content morph; seed content biochemistry 79 G1947 Fertility; flower; Dev and HS Reduced fertility; extended period of flowering; altered 80 (37-120) seed protein morph; seed seed protein content content biochemistry 81 G2011 Fertility; size; Dev and HS Reduced fertility; reduced size; altered seed oil and 82 (56-147) seed oil and morph; seed protein content protein content biochemistry 83 G2094 Fertility; leaf; Dev and morph GATA/Zn Reduced fertility; altered leaf development; reduced size 84 (43-68) size 85 G2113 Fertility; leaf; Dev and AP2 Reduced fertility; long petioles, altered orientation; 86 (TBD) seed protein morph; seed altered seed protein content content biochemistry 87 G2115 Fertility; size Dev and morph AP2 Reduced fertility; reduced size 88 (46-115) 89 G2130 Fertility; size; Dev and morph AP2 Reduced fertility; reduced size; early senescence 90 (93-160) senescence 91 G2147 Fertility; size Dev and morph HLH/MYC Reduced fertility; reduced size 92 (160-234) 93 G2156 Fertility; size; Dev and AT-hook Reduced fertility; reduced size; altered seed protein 94 (66-86) seed protein morph; seed content content biochemistry 95 G2294 Fertility; size Dev and morph AP2 Reduced fertility; reduced size 96 (32-102) 97 G2510 Fertility; size Dev and morph AP2 Reduced fertility; reduced size 98 (41-108) 99 G2893 Fertility; flower; Dev and morph MYB-(R1)R2R3 Reduced fertility; altered flower development; reduced 100 (19-120) size size 101 G340 Fertility; size Dev and morph Z-C3H Reduced fertility, size 102 (37-154) 103 G39 Fertility; size Dev and morph AP2 Reduced fertility, small plant 104 (24-90) 105 G439 Fertility; size Dev and morph AP2 Reduced fertility; small plant 106 (110-177) 107 G470 Fertility Dev and morph ARF Short stamen filaments 108 (61-393) 109 G652 Fertility; seed; Dev and Z-CLDSH Reduced fertility; irregular shaped seed; altered flower 110 (28-49, flower; size; morph; seed development; reduced size, slow growth; altered seed oil 137-151, seed oil content biochemistry content 182-196) 111 G671 Fertility; flower; Dev and morph MYB-(R1)R2R3 Reduced fertility; reduced petal abscission; altered leaf 112 (15-115) leaf; size; stem shape; small plant; altered inflorescence stem structure 113 G779 Fertility; flower Dev and morph HLH/MYC Reduced fertility, homeotic transformations 114 (126-182) 115 G962 Fertility; size Dev and morph NAC Reduced fertility; small plant 116 (53-175) 117 G977 Fertility; leaf; Dev and morph AP2 Reduced fertility; altered leaf shape; dark green; small 118 (5-72) morphology: plant other; size 119 G1063 Flower, leaf; Dev and HLH/MYC Altered flower development, ectopic carpel tissue; 120 (131-182) inflorescence; morph; seed altered leaf shape, dark green color; altered seed oil and biochemistry inflorescence development; altered seed oil and protein protein content content 121 G1140 Flower Dev and morph MADS Altered flower development 122 (2-57) 123 G1425 Flower Dev and morph NAC Altered flower and inflorescence development 124 (20-173) 125 G1449 Flower Dev and morph IAA Altered flower structure 126 (48-53, 74-107, 122-152) 127 G1897 Flower; leaf; Dev and Z-Dof Altered flower development; altered leaf development; 128 (34-62) seed protein morph; seed altered seed protein content content biochemistry 129 G2143 Flower; leaf; Dev and morph HLH/MYC Altered flower development, ectopic carpel tissue; 130 (128-179) inflorescence altered leaf shape, dark green color; altered inflorescence development 131 G2535 Flower; seed Dev and NAC Altered flower development; altered seed protein content 132 (11-114) protein content morph; seed biochemistry 133 G2557 Flower; leaf Dev and morph HLH/MYC Altered flower development, ectopic carpel tissue; 134 (278-328) altered leaf shape, dark green color 135 G259 Flower; leaf Dev and morph HS Altered flower development; altered leaf development 136 (27-131) 137 G353 Flower; leaf; Dev and Z-C2H2 Short pedicels, downward pointing siliques; altered leaf 138 (41-61, size; seed morph; seed development; reduced size; altered seed protein content 84-104) protein content biochemistry 139 G354 Flower; light Dev and morph Z-C2H2 Short pedicels, downward pointing siliques, constitutive 140 (42-62, response; size morphogenesis; reduced size 88-109) 141 G638 Flower; Dev and morph TH Altered flower development; multiple developmental 142 (119-206) morphology: defects other 143 G869 Flower; Dev and AP2 Abnormal anther development; small and spindly plant; 144 (109-177) morphology: morph; seed altered seed fatty acids other; seed oil biochemistry 145 G1645 Inflorescence; Dev and morph MYB-(R1)R2R3 Altered inflorescence structure; altered leaf development 146 (90-210) leaf 147 G1038 Leaf Dev and morph GARP Altered leaf shape 148 (198-247) 149 G1073 Leaf; size; Dev and AT-hook Serrated leaves; increased plant size; flowering appears 150 (33-42, flowering time morph; to be slightly delayed 78-175) flowering time 151 G1146 Leaf Dev and morph PAZ Altered leaf development 152 (886-896) 153 G1267 Leaf; size Dev and morph WRKY Dark green shiny leaves; small plant 154 (70-127) 155 G1269 Leaf Dev and morph MYB-related Long petioles, upturned leaves 156 (27-83) 157 G1452 Leaf; trichome; Dev and NAC Altered leaf shape, dark green color; reduced trichome 158 (30-177) flowering time morph; density; late flowering flowering time 159 G1494 Leaf; size; light Dev and morph HLH/MYC Pale green leaves, altered leaf shape; reduced size; long 160 (261-311) response; seed hypocotyls; large, pale seeds 161 G1548 Leaf Dev and morph HB Altered leaf development 162 (17-77) 163 G1574 Leaf Dev and morph SWI/SNF Altered leaf development 164 (28-350) 165 G1586 Leaf; size Dev and morph HB Narrow leaves; small plants 166 (21-81) 167 G1786 Leaf; light Dev and morph MYB-(R1)R2R3 Dark green, small leaves with short petioles; 168 (TBD) response; size photomorphogensis in the dark; small plant 169 G1792 Leaf; seed oil Dev and AP2 Dark green, shiny leaves; altered seed oil and protein 170 (17-85) and protein morph; seed content content biochemistry 171 G1865 Leaf; seed oil Dev and GRF-like Altered leaf development; altered seed oil and protein 172 (124-149) and protein morph; seed content content biochemistry 173 G1886 Leaf; size Dev and morph Z-Dof Chlorotic patches in leaves; reduced size 174 (17-59) 175 G1933 Leaf; size; seed Dev and WRKY Altered leaf development; reduced size; altered seed 176 (205-263, protein content morph; seed protein content 344-404) biochemistry 177 G2059 Leaf; seed oil Dev and AP2 Smaller, curled leaves; altered seed oil, protein content 178 (184-254) and protein morph; seed content biochemistry 179 G2105 Leaf; seed Dev and morph TH Alterations in leaf surface; large, pale seeds 180 (100-153) 181 G2117 Leaf; seed oil Dev and bZIP Small, dark green leaves; altered seed oil and protein 182 (46-106) and protein morph; seed content content biochemistry 183 G2124 Leaf; seed Dev and TEO Altered leaf development; altered seed protein content 184 (75-132) protein content morph; seed biochemistry 185 G2140 Leaf; root Dev and morph HLH/MYC Altered leaf development; short roots 186 (167-242) 187 G2144 Leaf; light Dev and HLH/MYC Pale green leaves, altered leaf shape; long hypocotyls; 188 (203-283) response; size; morph; seed reduced size; altered seed oil content seed oil content biochemistry 189 G2431 Leaf Dev and morph GARP Dark green leaves; reduced size 190 (38-88) 191 G2465 Morphology: Dev and morph GARP Slowed development; altered leaf color and shape 192 (219-269) other; leaf 193 G2583 Leaf; seed oil Dev and AP2 Glossy, shiny leaves; altered seed oil and protein 194 (4-71) and protein morph; seed content content biochemistry 195 G2724 Leaf Dev and morph MYB-(R1)R2R3 Dark green leaves 196 (7-113) 197 G377 Leaf; Dev and morph RING/C3H2C3 Altered leaf development; slow growth 198 (85-128) morphology: other 199 G428 Leaf Dev and morph HB Altered leaf shape 200 (229-292) 201 G447 Leaf; Dev and morph ARF Dark green leaves; altered cotyledon shape; reduced 202 (22-356) morphology: size other; size 203 G464 Leaf Dev and morph IAA Altered leaf shape 204 (20-28, 71-82, 126-142 187-224) 205 G557 Leaf; size Dev and morph bZIP Dark green color; small plant 206 (90-150) 207 G577 Leaf Dev and morph BZIPT2 Reduced size, increased anthocyanins 208 (TBD) 209 G674 Leaf; size Dev and morph MYB-(R1)R2R3 Dark green leaves, upwardly oriented; reduced size 210 (20-120) 211 G736 Leaf; flowering Dev and Z-Dof Altered leaf shape; later flowering 212 (54-111) time morph; flowering time 213 G903 Leaf Dev and morph Z-C2H2 Altered leaf morphology 214 (68-92) 215 G917 Leaf; seed oil Dev and MADS Altered leaf development; altered seed oil and protein 216 (2-57) and protein morph; seed content content biochemistry 217 G921 Leaf Dev and morph WRKY Serrated leaves 218 (146-203) 219 G922 Leaf; size Dev and morph SCR Altered development, dark green color; reduced size 220 (225-242) 221 G932 Leaf; size Dev and morph MYB-(R1)R2R3 Altered development, dark green color; reduced size 222 (12-118) 223 G599 Leaf; size Dev and morph DBP Altered leaf shape; small plant 224 (187-219, 264-300) 225 G804 Leaf; size Dev and morph PCF Altered leaf shape, small plant 226 (54-117) 227 G1062 Light response; Dev and morph HLH/MYC Constitutive photomorphogenesis; slow growth; altered 228 (308-359) morphology; seed shape other; seed 229 G1322 Light response; Dev and morph MYB-(R1)R2R3 Photomorphogenesis in the dark; reduced size 230 (26-130) size 231 G1331 Light response; Dev and MYB-(R1)R2R3 Constitutive photomorphogenesis; multiple 232 (8-109) morphology. morph; seed developmental alterations; altered seed oil and protein other; seed oil biochemistry content and protein content 233 G1521 Light response Dev and morph RING/C3HC4 Constitutive photomorphogenesis 234 (39-80) 235 G183 Light response; Dev and WRKY Constitutive photomorphogenesis; altered seed protein 236 (307-363) seed protein morph; seed content content biochemistry 237 G2555 Light response Dev and morph HLH/MYC Constitutive photomorphogenesis 238 (175-245) 239 G375 Light response Dev and morph Z-Dof Upward pointing leaves 240 (75-103) 241 G1007 Morphology: Dev and morph AP2 Multiple developmental alterations 242 (TBD) other 243 G1010 Morphology: Dev and morph ABI3/VP-1 Multiple developmental alterations 244 (33-122) other 245 G1014 Morphology: Dev and morph ABI3/VP-1 Multiple developmental defects; reduced trichomes 246 (90-172) other; trichome 247 G1035 Morphology: Dev and morph bZIP Multiple developmental alterations 248 (39-91) other 249 G1046 Morphology: Dev and morph bZIP Multiple developmental alterations 250 (79-138) other 251 G1049 Morphology: Dev and bZIP Multiple developmental alterations; altered seed protein 252 (77-132) other; seed morph; seed content protein content biochemistry 253 G1069 Morphology: Dev and AT-hook Multiple developmental alterations; altered seed oil 254 (67-74) other; seed oil morph; seed content content biochemistry 255 G1070 Morphology: Dev and morph AT-hook Several developmental defects 256 (98-120) other 257 G1076 Morphology: Dev and morph AT-hook Lethal when overexpressed 258 (82-89) other 259 G1089 Morphology: Dev and morph BZIPT2 Developmental defects at seedling stage 260 (425-500) other 261 G1093 Morphology: Dev and morph RING/C3H2C3 Multiple morphological alterations 262 (105-148) other 263 G1127 Morphology: Dev and morph AT-hook Multiple developmental alterations 264 (103-110, other 155-162) 265 G1131 Morphology: Dev and HLH/MYC Multiple developmental alterations altered seed protein 266 (173-220) other; seed morph; seed content protein content biochemistry 267 G1145 Morphology: Dev and bZIP Multiple developmental alterations; reduced seed size, 268 (227-270) other; seed oil morph; seed altered seed shape; altered seed oil and protein content and protein biochemistry 269 G1229 Morphology: Dev and HLH/MYC Several developmental defects; altered seed oil and 270 (102-160) other; seed oil morph; seed protein content and protein biochemistry content 271 G1246 Morphology: Dev and MYB-(R1)R2R3 Multiple developmental alterations; altered seed protein 272 (27-139) other; seed morph; seed content protein content biochemistry 273 G1255 Morphology: Dev and morph Z-CO-like Reduced apical dominance; increased seed size 274 (18-56) other; seed 275 G1304 Morphology: Dev and morph MYB-(R1)R2R3 Lethal when overexpressed 276 (13-118) other 277 G1318 Morphology: Dev and morph MYB-(R1)R2R3 Multiple developmental alterations 278 (20-123) other 279 G1320 Morphology: Dev and morph MYB-(R1)R2R3 Multiple developmental alterations 280 (5-108) other 281 G1330 Morphology: Dev and morph MYB-(R1)R2R3 Multiple developmental alterations 282 (28-134) other 283 G1352 Morphology: Dev and morph Z-C2H2 Multiple developmental alterations 284 (108-129, other 167-188) 285 G1354 Morphology: Dev and morph NAC Multiple developmental alterations 286 (TBD) other 287 G1360 Morphology: Dev and morph NAC Lethal when overexpressed 288 (18-174) other 289 G1364 Morphology: Dev and morph CAAT Lethal when overexpressed 290 (29-120) other 291 G1379 Morphology: Dev and morph AP2 Multiple developmental alterations 292 (18-85) other 293 G1384 Morphology: Dev and morph AP2 Abnormal inflorescence and flower development 294 (TBD) other 295 G1399 Morphology: Dev and morph AT-hook Multiple developmental alterations 296 (86-93) other 297 G1415 Morphology: Dev and morph AP2 Multiple developmental alterations 298 (TBD) other 299 G1417 Morphology: Dev and WRKY Reduced seedling germination and vigor; increase in 300 (239-296) other; seed oil morph; seed 18:2, decrease in 18:3 biochemistry 301 G1442 Morphology: Dev and morph GRF-like Multiple developmental alterations 302 (172-223) other 303 G1454 Morphology: Dev and NAC Multiple developmental alterations; altered seed oil and 304 (9-178) other; seed oil morph; seed protein content and protein biochemistry content 305 G1459 Morphology: Dev and morph NAC Multiple developmental alterations 306 (10-152) other 307 G1460 Morphology: Dev and NAC Multiple developmental alterations; altered seed protein 308 (TBD) other; seed morph; seed content protein content biochemistry 309 G147 Morphology: Dev and morph MADS Multiple developmental defects 310 (2-57) other 311 G1471 Morphology: Dev and Z-C2H2 Multiple developmental alterations; increased seed oil 312 (49-70) other; seed oil morph; seed content biochemistry 313 G1475 Morphology: Dev and morph Z-C2H2 Multiple developmental alterations 314 (51-73) other 315 G1477 Morphology: Dev and morph Z-C2H2 Multiple developmental alterations 316 (29-48) other 317 G1487 Morphology: Dev and GATA/Zn Multiple developmental alterations; altered seed oil and 318 (251-276) other; seed oil morph: seed protein content and protein biochemistry content 319 G1492 Morphology: Dev and morph GARP Multiple developmental alterations 320 (34-83) other 321 G1531 Morphology: Dev and RING/C3HC4 Multiple developmental alterations; pale seed; altered 322 (41-77) other; seed; morph; seed seed protein content seed protein biochemistry content 323 G1540 Morphology: Dev and morph HB Reduced cell differentiation in meristem 324 (35-98) other 325 G1544 Morphology: Dev and morph HB Multiple developmental alterations 326 (64-124) other 327 G156 Morphology: Dev and morph MADS Multiple developmental defects; seed color alteration 328 (2-57) other; seed 329 G1584 Morphology: Dev and morph HB Multiple developmental alterations 330 (TBD) other 331 G1587 Morphology: Dev and morph HB Multiple developmental alterations 332 (61-121) other 333 G1588 Morphology: Dev and morph HB Multiple developmental alterations 334 (66-124) other 335 G1589 Morphology: Dev and HB Multiple developmental alterations; altered seed protein 336 (384-448) other; seed morph; seed content protein content biochemistry 337 G160 Morphology: Dev and morph MADS Multiple developmental defects 338 (7-62) other 339 G1636 Morpholgy: Dev and morph MYB-related Pale green, smaller plants 340 (100-165) other 341 G1642 Morphology: Dev and morph MYB-(R1)R2R3 Multiple developmental alterations 342 (TBD) other 343 G1747 Morphology: Dev and MYB-(R1)R2R3 Multiple developmental alterations; altered seed protein 344 (11-114) other; seed morph; seed content protein content biochemistry 345 G1749 Morphology: Dev and morph AP2 Multiple developmental alterations; formation of necrotic 346 (84-155) other lesions 347 G1751 Morphology: Dev and morph AP2 Multiple developmental alterations 348 (TBD) other 349 G1752 Morphology: Dev and morph AP2 Multiple developmental alterations 350 (83-151) other 351 G1763 Morphology: Dev and morph AP2 Lethal when overexpressed 352 (140-209) other 353 G1766 Morphology: Dev and morph NAC Multiple developmental alterations 354 (10-153) other 355 G1767 Morphology: Dev and SCR Multiple developmental alterations; altered seed oil 356 (255-272) other; seed oil morph; seed content content biochemistry 357 G1778 Morphology: Dev and morph GATA/Zn Lethal when overexpressed 358 (94-119) other 359 G1789 Morphology: Dev and MYB-related Delayed development; altered seed protein content 360 (1-50) other; seed morph; seed protein content biochemistry 361 G1790 Morphology: Dev and morph MYB-(R1)R2R3 Lethal when overexpressed 362 (217-316) other 363 G1791 Morphology: Dev and morph AP2 Multiple developmental alterations 364 (TBD) other 365 G1793 Morphology: Dev and AP2 Multiple developmental alterations; increased seed oil 366 (179-255, other; seed oil morph; seed content 281-349) biochemistry 367 G1795 Morphology: Dev and morph AP2 Multiple developmental alterations; reduced trichomes 368 (12-80) other trichome 369 G1800 Morphology: Dev and morph AP2 Multiple developmental alterations 370 (TBD) other 371 G1806 Morphology: Dev and morph bZIP Multiple developmental alterations 372 (165-225) other 373 G1811 Morphology: Dev and morph ABI3/VP-1 Multiple developmental alterations 374 (TBD) other 375 G182 Morphology: Dev and morph WRKY Multiple developmental alterations 376 (217-276) other 377 G1835 Morphology: Dev and morph GATA/Zn Small, spindly plant 378 (224-296) other 379 G1836 Morphology: Dev and morph CAAT Pale green 380 (30-164) other 381 G1838 Morphology: Dev and AP2 Multiple developmental alterations; increased seed oil 382 (229-305, other; seed oil morph; seed content 330-400) content biochemistry 383 G1843 Morphology: Dev and morph MADS Multiple developmental alterations 384 (2-57) other 385 G1853 Morphology: Dev and morph AKR Lethal when overexpressed 386 (entire other protein) 387 G1855 Morphology: Dev and morph AKR Slow growth 388 (entire other protein) 389 G187 Morphology: Dev and morph WRKY Variety of morphological alterations 390 (172-228) other 391 G1881 Morphology: Dev and morph Z-CO-like Multiple developmental alterations 392 (5-28, other 56-79) 393 G1882 Morphology: Dev and morph Z-Dof Lethal when overexpressed 394 (97-125) other 395 G1883 Morphology: Dev and morph Z-Dof Multiple developmental alterations 396 (82-124) other 397 G1884 Morphology: Dev and morph Z-Dof Multiple developmental alterations 398 (43-71) other 399 G1891 Morphology: Dev and morph Z-Dof Multiple developmental alterations 400 (27-69) other 401 G1896 Morphology: Dev and morph Z-Dof Multiple developmental alterations 402 (43-85) other 403 G1898 Morphology: Dev and morph Z-Dof Lethal when overexpressed 404 (31-59) other 405 G1902 Morphology: Dev and Z-Dof Multiple developmental alterations; increased seed oil 406 (31-59) other; seed oil morph; seed content content biochemistry 407 G1904 Morphology: Dev and morph Z-Dof Multiple developmental alterations 408 (53-95) other 409 G1906 Morphology: Dev and morph Z-Dof Multiple developmental alterations 410 (19-47) other 411 G1913 Morphology: Dev and morph Z-Dof Lethal when overexpressed 412 (27-55) other 413 G1914 Morphology: Dev and morph Z-C2H2 Multiple developmental alterations 414 (195-216, other 245-266) 415 G1925 Morphology: Dev and morph NAC Multiple developmental alterations 416 (6-150) other 417 G1929 Morphology: Dev and morph Z-CO-like Slow growth, delayed development 418 (31-53) other 419 G1930 Morphology: Dev and morph AP2 Multiple developmental alterations 420 (59-124) other 421 G195 Morphology: Dev and morph WRKY Multiple developmental defects 422 (183-239) other 423 G1954 Morphology: Dev and morph HLH/MYC Lethal when overexpressed 424 (187-259) other 425 G1958 Morphology: Dev and GARP Reduced size and root mass in plates.; altered seed 426 (230-278) other; seed morph; seed protein content protein content biochemistry 427 G196 Morphology Dev and WRKY Multiple developmental alterations; altered seed protein 428 (223-283) other; seed morph; seed content protein content biochemistry 429 G1965 Morphology: Dev and morph Z-Dof Lethal when overexpressed 430 (27-55) other 431 G1976 Morphology: Dev and morph Z-C2H2 Multiple developmental alterations 432 (219-323) other 433 G2057 Morphology: Dev and morph TEO Multiple developmental alterations 434 (TBD) other 435 G2107 Morphology: Dev and morph AP2 Multiple developmental alterations 436 (TBD) other 437 G211 Morphology: Dev and morph MYB-(R1)R2R3 Multiple developmental alterations 438 (24-137) other 439 G2133 Morphology: Dev and AP2 Multiple developmental alterations; late flowering; 440 (11-83) other; flowering morph; altered seed protein content time; seed flowering time protein content 441 G2134 Morphology: Dev and morph AP2 Multiple developmental alterations 442 (TBD) other 443 G2151 Morphology: Dev and AT-hook Multiple developmental alterations; altered seed oil and 444 (93-113, other; seed oil morph; seed protein content 124-144) and protein biochemistry content 445 G2154 Morphology: Dev and morph AT-hook Multiple developmental alterations 446 (97-119) other 447 G2157 Morphology: Dev and morph AT-hook Multiple developmental alterations 448 (82-102, other 164-107) 449 G2181 Morphology: Dev and morph NAC Multiple developmental alterations 450 (22-169) other 451 G221 Morphology: Dev and morph MYB-(R1)R2R3 Multiple developmental alterations 452 (21-125) other 453 G2290 Morphology: Dev and morph WRKY Multiple developmental alterations 454 (147-205) other 455 G2299 Morphology: Dev and morph AP2 Multiple developmental alterations 456 (48-115) other 457 G2340 Morphology: Dev and MYB-(R1)R2R3 Tissue necrosis; multiple developmental alterations; 458 (14-120) other; seed oil morph; seed altered seed oil and protein content and protein biochemistry content 459 G2346 Morphology: Dev and morph SBP Enlarged seedlings 460 (59-135) other 461 G237 Morphology: Dev and morph MYB-(R1)R2R3 Multiple developmental alterations 462 (11-113) other 463 G2373 Morphology: Dev and TH Multiple developmental alterations; altered seed protein 464 (290-350) other; seed morph; seed content protein content biochemistry 465 G2376 Morphology: Dev and TH Seedling lethality; altered seed protein content 466 (79-178, other; seed oil morph; seed 336-408) protein biochemistry 467 G24 Morphology: Dev and morph AP2 Reduced size and necrotic patches 468 (25-93) other 469 G2424 Morphology: Dev and morph MYB-(R1)R2R3 Multiple developmental alterations 470 (107-219) other 471 G2505 Morphology: Dev and morph NAC Lethal when overexpressed 472 (10-159) other 473 G2512 Morphology: Dev and morph AP2 Multiple developmental alterations 474 (79-139) other 475 G2513 Morphology: Dev and morph AP2 Multiple developmental alterations 476 (TBD) other 477 G2519 Morphology: Dev and morph HLH/MYC Multiple developmental alterations 478 (1-65) other 479 G2520 Morphology: Dev and HLH/MYC Multiple developmental alterations; altered seed oil and 480 (135-206) other; seed oil morph; seed protein content and protein biochemistry content 481 G2533 Morphology: Dev and NAC Multiple developmental alterations; altered seed protein 482 (11-186) other; seed morph; seed content protein content biochemistry 483 G2534 Morphology: Dev and morph NAC Lethal when overexpressed 484 (10-157) other 485 G2573 Morphology: Dev and AP2 Multiple developmental alterations; altered seed oil and 486 (31-98) other; seed oil morph; seed protein content and protein biochemistry content 487 G2589 Morphology: Dev and morph MADS Multiple developmental alterations 488 (2-57) other 489 G2687 Morphology: Dev and morph AP2 Multiple developmental alterations 490 (51-120) other 491 G27 Morphology: Dev and morph AP2 Abnormal development, small 492 (37-104) other 493 G2720 Morphology: Dev and MYB-(R1)R2R3 Multiple developmental alterations; altered seed oil and 494 (10-114) other; seed oil morph; seed protein content and protein biochemistry content 495 G2787 Morphology: Dev and AT-hook Multiple developmental alterations; altered seed oil 496 (172-192, other; seed oil morph; seed content 226-247, content biochemistry 256-276, 290-311, 245-366) 497 G2789 Morphology: Dev and morph AT-hook Multiple developmental alterations 498 (53-73, other 121-165) 499 G31 Morphology: Dev and morph AP2 Multiple developmental alterations 500 (TBD) other 501 G33 Morphology: Dev and morph AP2 Multiple developmental defects 502 (50-117) other 503 G342 Morphology: Dev and GATA/Zn Multiple developmental alterations; altered seed oil and 504 (155-190) other; seed oil morph; seed protein content and protein biochemistry content 505 G352 Morphology: Dev and morph Z-C2H2 Multiple developmental alterations 506 (99-119, other 166-186) 507 G357 Morphology: Dev and morph Z-C2H2 Developmental defect 508 (7-29) other 509 G358 Morphology: Dev and morph Z-C2H2 Lethal when overexpressed 510 (124-135, other 188-210) 511 G360 Morphology: Dev and morph Z-C2H2 Multiple developmental alterations 512 (42-62) other 513 G362 Size; Dev and Z-C2H2 Reduced size; increased pigmentation in seed, embryos 514 (62-82) Morphology: morph; and other organs; ectopic trichome formation; increased other; trichome; flowering time; trichome number; late flowering; altered protein content flowering time; seed seed protein biochemistry content 515 G364 Morphology: Dev and morph Z-C2H2 Developmental defect 516 (54-76) other 517 G365 Morphology: Dev and morph Z-C2H2 Multiple developmental alterations 518 (70-90) other 519 G367 Morphology: Dev and morph Z-C2H2 Lethal when overexpressed 520 (63-84) other 521 G373 Morphology: Dev and morph RING/C3HC4 Multiple developmental alterations 522 (129-168) other 523 G396 Morphology: Dev and morph HB Altered leaf coloration and shape, reduced fertility; small 524 (159-220) other; size plant 525 G431 Morphology: Dev and morph HB Developmental defect, sterile 526 (286-335) other 527 G479 Morphology: Dev and morph SBP Multiple developmental alterations 528 (70-149) other 529 G546 Morphology: Dev and morph RING/C3H2C3 Slow growth and development; increased anthocyanin 530 (114-155) other pigmentation 531 G551 Morphology: Dev and morph HB Multiple developmental alterations 532 (73-133) other 533 G578 Morphology: Dev and morph bZIP Lethal when overexpressed 534 (36-96) other 535 G596 Morphology: Dev and morph AT-hook Multiple developmental alterations 536 (89-96) other 537 G617 Morphology: Dev and morph TEO Multiple developmental alterations 538 (64-118) other 539 G620 Morphology: Dev and CAAT Multiple developmental alterations; altered seed protein 540 (20-118) other; seed morph; seed content protein content biochemistry 541 G625 Morphology: Dev and morph AP2 Lethal when overexpressed 542 (52-119) other 543 G658 Morphology: Dev and morph MYB-(R1)R2R3 Developmental defect 544 (2-105) other 545 G716 Morphology: Dev and morph ARF Multiple developmental defects 546 (24-355) other 547 G725 Morphology: Dev and morph GARP Developmental defect 548 (39-87) other 549 G727 Morphology: Dev and morph GARP Multiple morphological alterations 550 (226-269) other 551 G740 Morphology: Dev and morph Z-CLDSH Slow growth 552 (24-42, other 232-268) 553 G770 Morphology: Dev and morph NAC Multiple developmental alterations 554 (19-162) other 555 G858 Morphology: Dev and morph MADS Multiple developmental alterations 556 (2-57) other 557 G865 Morphology: Dev and AP2 Altered morphology; increased seed protein 558 (36-103) other; seed morph; seed protein content biochemistry 559 G872 Morphology: Dev and morph AP2 Multiple developmental alterations 560 (18-85) other 561 G904 Morphology: Dev and morph RING/C3H2C3 Multiple developmental alterations 562 (117-158) other 563 G910 Morphology: Dev and Z-CO-like Multiple developmental alterations; late flowering 564 (14-37, other; flowering morph; 77-103) time flowering time 565 G912 Morphology: Dev and AP2 Dark green color; small plant; reduced cotyledon 566 (51-118) other; size; morph; sugar expansion in glucose; late flowering sugar sensing; sensing; flowering time flowering time 567 G920 Morphology: Dev and morph WRKY Multiple developmental alterations 568 (152-211) other 569 G939 Morphology: Dev and morph EIL Pale seedlings on agar; reduced size 570 (97-106) other; size 571 G963 Morphology: Dev and NAC Slowed growth rate; altered seed protein content 572 (TBD) other; seed morph; seed protein content biochemistry 573 G979 Morphology: Dev and morph AP2 Several developmental defects; altered seed 574 (63-139, other; seed development, ripening and germination 165-233) 575 G987 Morphology: Dev and morph SCR Developmental defects 576 (428-432, other 704-708) 577 G993 Morphology: Dev and AP2 Multiple developmental alterations; altered seed protein 578 (69-134) other; seed morph; seed content protein content biochemistry 579 G681 Morphology: Dev and MYB-(R1)R2R3 Multiple developmental alterations; overexpression 580 (14-120) other; leaf morph; leaf results in an increase in M39480 glucosinolates biochemistry 581 G1482 Root Dev and morph Z-CO-like Increased root growth 582 (5-63) 583 G225 Root; trichome Dev and morph MYB-related Increased root hairs; glabrous, lack of trichomes 584 (39-76) 585 G226 Root; trichome; Dev and MYB-related Increased root hairs; glabrous, lack of trichomes; 586 (28-78) seed protein morph; seed increased seed protein content biochemistry 587 G9 Root Dev and morph AP2 Increased root mass 588 (62-127) 589 G1040 Seed Dev and morph GARP Smaller and more rounded seeds 590 (109-158) 591 G2114 Seed Dev and morph AP2 Increased seed size 592 (221-297, 323-393) 593 G450 Seed; size; Dev and IAA Increased seed size; reduced plant size; altered seed 594 (TBD) seed protein morph; seed protein content content biochemistry 595 G584 Seed Dev and morph HLH/MYC Large seeds 596 (401-494) 597 G668 Seed Dev and morph MYB-(R1)R2R3 Reduced seed color 598 (13-113) 599 G1050 Senescence Dev and morph bZIP Delayed senescence 600 (372-425) 601 G1463 Senescence Dev and morph NAC Premature senescence 602 (9-156) 603 G1944 Senescence; Dev and AT-hook Early senescence; reduced size; altered seed protein 604 (87-100) size; seed morph; seed content protein content biochemistry 605 G2383 Senescence; Dev and TEO Early senescence; altered seed protein content 606 (89-149) seed protein morph; seed content biochemistry 607 G571 Senescence; Dev and bZIP Delayed senescence; late flowering 608 (160-220) flowering time morph; flowering time 609 G636 Senescence; Dev and morph TH Premature senescence; reduced size 610 (55-145, size 405-498) 611 G878 Senescence; Dev and WRKY Delayed senescence; late flowering 612 (250-305, flowering time morph; 415-475) flowering time 613 G1134 Silique Dev and morph HLH/MYC Siliques with altered shape 614 (198-247) 615 G1008 Size Dev and morph AP2 Small plant 616 (96-163) 617 G1020 Size Dev and morph AP2 Very small T1 plants 618 (28-95) 619 G1023 Size Dev and morph AP2 Reduced size 620 (128-195) 621 G1053 Size Dev and morph bZIP Small plant 622 (74-120) 623 G1137 Size Dev and morph HLH/MYC Small T1 plants 624 (264-314) 625 G1181 Size Dev and morph HS Small T1 plants 626 (24-114) 627 G1228 Size Dev and morph HLH/MYC Reduced size 628 (179-233) 629 G1277 Size Dev and morph AP2 Small plant 630 (18-85) 631 G1309 Size Dev and morph MYB-(R1)R2R3 Small plant 632 (9-114) 633 G1314 Size; sugar Dev and MYB-(R1)R2R3 Reduced size, reduced seedling vigor on high glucose; 634 (14-116) sensing; seed morph; sugar altered seed protein content protein content sensing; seed biochemistry 635 G1317 Size Dev and morph MYB-(R1)R2R3 Reduced size 636 (13-118) 637 G1323 Size; seed oil Dev and MYB-(R1)R2R3 Small T1 plants, dark green; decreased seed oil, 638 (15-116) and protein morph; seed increased seed protein content biochemistry 639 G1332 Size; trichome; Dev and MYB-(R1)R2R3 Reduced size; reduced trichome density; altered seed oil 640 (13-116) seed oil and morph; seed and protein content protein content biochemistry 641 G1334 Size Dev and morph CAAT Small, dark green 642 (18-190) 643 G1381 Size Dev and morph AP2 Reduced size 644 (68-135) 645 G1382 Size Dev and morph WRKY Small plant 646 (210-266, 385-437) 647 G1435 Size; flowering Dev and GARP Increased plant size; late flowering 648 (146-194) time morph; flowering time 649 G1537 Size Dev and morph HB Small T1 plants with altered development 650 (14 -74) 651 G1545 Size Dev and morph HB Reduced size 652 (54-117) 653 G1641 Size; seed oil Dev and MYB-related Small plant; altered seed oil and protein content 654 (139-200) and protein morph; seed content biochemistry 655 G165 Size; seed Dev and MADS Reduced size; altered seed protein content 656 (7-62) protein content morph; seed biochemistry 657 G1652 Size; seed oil Dev and HLH/MYC Reduced size; altered seed oil and protein content 658 (l43-215) and protein morph; seed content biochemistry 659 G1655 Size Dev and morph HLH/MYC Small plant 660 (134-192) 661 G1671 Size Dev and morph NAC Reduced size 662 (TBD) 663 G1756 Size; seed Dev and WRKY Reduced size; altered seed protein content 664 (TBD) protein content morph; seed biochemistry 665 G1757 Size; seed Dev and WRKY Small plant; altered seed protein content 666 (158-218) protein content morph; seed biochemistry 667 G1782 Size Dev and morph CAAT Small, spindly plant 668 (166-238) 669 G184 Size Dev and morph WRKY Small plant 670 (295-352) 671 G1845 Size Dev and morph AP2 Small plant 672 (140-207) 673 G1879 Size; seed oil Dev and HLH/MYC Reduced size; altered seed oil and protein content 674 (107-176) and protein morph; seed content biochemistry 675 G1888 Size Dev and morph Z-CO-like Reduced size, dark green leaves 676 (5-50) 677 G189 Size; seed Dev and WRKY Increased leaf size; altered seed protein content 678 (240-297) protein content morph; seed biochemistry 679 G1939 Size Dev and morph PCF Reduced size 680 (40-102) 681 G194 Size Dev and morph WRKY Small plant 682 (174-230) 683 G1943 Size Dev and morph HLH/MYC Reduced size 684 (335-406) 685 G21 Size; seed oil Dev and AP2 Reduced size; altered seed oil and protein content 686 (97-164) and protein morph; seed content biochemistry 687 G2132 Size; seed oil Dev and AP2 Reduced size; altered seed oil and protein content 688 (TBD) and protein morph; seed content biochemistry 689 G2145 Size Dev and morph HLH/MYC Reduced size 690 (166-243) 691 G23 Size Dev and morph AP2 Small T1 plants 692 (61-117) 693 G2313 Size Dev and morph MYB-related Reduced size 694 (TBD) 695 G2344 Size Dev and morph CAAT Reduced size, slow growth 696 (TBD) 697 G2430 Size Dev and morph GARP Increased Icaf size, faster development 698 (425-478) 699 G2517 Size Dev and morph WRKY Reduced size 700 (118-234) 701 G2521 Size Dev and morph HLH/MYC Reduced size 702 (145-213) 703 G258 Size; seed oil Dev and MYB-(R1)R2R3 Reduced size; altered seed oil and protein content 704 (24-124) and protein morph; seed content biochemistry 705 G280 Size; seed Dev and AT-hook Reduced size; altered seed protein content 706 (97-104, protein content morph; seed 130-137, biochemistry 155-162, 185-192) 707 G3 Size Dev and morph AP2 Small plant 708 (28-95) 709 G343 Size Dev and morph GATA/Zn Small plant 710 (178-214) 711 G363 Size Dev and morph Z-C2H2 Small plant 712 (87-108) 713 G370 Size Dev and morph Z-C2H2 Reduced size, shiny leaves 714 (97-117) 715 G385 Size Dev and morph HB Small plant, short inflorescence stems, dark green 716 (60-123) 717 G439 Size Dev and morph AP2 Small plant 718 (110-177) 719 G440 Size Dev and morph AP2 Small plant 720 (122-189) 721 G5 Size Dev and morph AP2 Small plant 722 (149-216) 723 G550 Size Dev and morph Z-Dof Small plant 724 (134-180) 725 G670 Size Dev and morph MYB-(R1)R2R3 Small plant 726 (14-122) 727 G760 Size Dev and morph NAC Reduced size 728 (12-156) 729 G831 Size Dev and morph AKR Reduced size 730 (470-591) 731 G864 Size Dev and morph AP2 Small plant 732 (119-186) 733 G884 Size Dev and morph WRKY Reduced size 734 (227-285, 407-465) 735 G898 Size; seed oil Dev and RING/C3HC4 Reduced size; altered seed oil and protein content 736 (148-185) and protein morph; seed content biochemistry 737 G900 Size Dev and morph Z-CO-like Reduced size 738 (6-28, 48-74) 739 G913 Size; flowering Dev and AP2 Small plant; late flowering 740 (62-128) time morph; flowering time 741 G937 Size Dev and morph GARP Slightly reduced size 742 (197-246) 743 G960 Size Dev and morph NAC Small plant 744 (13-156) 745 G991 Size; seed oil Dev and IAA Slightly reduced size; altered seed oil and protein 746 (7-14, and protein morph; seed content 48-59, content biochemistry 82-115, 128-164) 747 G748 Stem; flowering Dev and Z-Dof More vascular bundles in stem; late flowering 748 (112-140) time morph; flowering time 749 G247 Trichome; seed Dev and MYB-(R1)R2R3 Altered trichome distribution; altered seed protein 750 (15-116) protein content morph; seed content biochemistry 751 G585 Trichome Dev and morph HLH/MYC Reduced trichome density 752 (436-501) 753 G634 Trichome; seed Dev and TH Increased trichome density and size; altered seed 754 (62-147, protein content morph; seed protein content 189-245) biochemistry 755 G676 Trichome Dev and morph MYB-(R1)R2R3 Reduced trichomes 756 (17-119) 757 G682 Trichome Dev and morph MYB-related Glabrous, lack of trichomes 758 (27-63) 759 G635 Variegation Dev and morph TH 760 (239-323) 761 G1068 Sugar sensing Sugar sensing AT-hook Reduced cotyledon expansion in glucose 762 (143-150) 763 G1225 Sugar sensing; Sugar sensing; HLH/MYC Better germination on sucrose and glucose media; 764 (78-147) seed oil and seed altered seed oil and protein content protein content biochemistry 765 G1337 Sugar sensing Sugar sensing Z-CO-like Decreased germination on sucrose medium 766 (9-75) 767 G1759 Sugar sensing Sugar sensing MADS Reduced germination on high glucose 768 (2-57) 769 G1804 Sugar sensing; Sugar sensing; bZIP Altered sugar sensing; late flowering 770 (357-407) flowering time flowering time 771 G207 Sugar sensing Sugar sensing MYB-(R1)R2R3 Decreased germination on glucose medium 772 (6-106) 773 G218 Sugar sensing; Sugar sensing; MYB-(R1)R2R3 Reduced cotyledon expansion in glucose; altered seed 774 (TBD) seed oil content seed oil content biochemistry 775 G241 Sugar sensing; Sugar sensing; MYB-(R1)R2R3 Decreased germination and growth on glucose medium; 776 (14-114) seed oil and seed decreased seed oil, altered protein content protein content biochemistry 777 G254 Sugar sensing Sugar sensing MYB-related Decreased germination and growth on glucose medium 778 (62-106) 779 G26 Sugar sensing Sugar sensing AP2 Decreased germination and growth on glucose medium 780 (67-134) 781 G263 Sugar sensing Sugar sensing HS Decreased root growth on sucrose medium, root specific 782 (TBD) expression 783 G308 Sugar sensing Sugar sensing SCR No germination on glucose medium 784 (270-274) 785 G38 Sugar sensing Sugar sensing AP2 Reduced germination on glucose medium 786 (76-143) 787 G43 Sugar sensing Sugar sensing AP2 Decreased germination and growth on glucose medium 788 (104-172) 789 G536 Sugar sensing Sugar sensing GF14 Decreased germination and growth on glucose medium 790 (226-233) 791 G567 Sugar sensing; Sugar sensing; bZIP Decreased seedling vigor on high glucose; altered seed 792 (210-270) seed oil and seed oil and protein content protein content biochemistry 793 G680 Sugar sensing; Sugar sensing; MYB-related Reduced germination on glucose medium; late flowering 794 (24-70) flowering time flowering time 795 G867 Sugar sensing Sugar sensing AP2 Better seedling vigor on sucrose medium 796 (59-124) 797 G956 Sugar sensing Sugar sensing NAC Reduced germination on glucose medium 798 (TBD) 799 G996 Sugar sensing Sugar sensing MYB-(R1)R2R3 Reduced germination on glucose medium 800 (14-114) 801 G1946 Seed Seed HS Increase in M3950; increased oil content; decreased 802 (32-130) glucosinolates, biochemistry protein content oil, protein content 803 G217 Seed oil Seed MYB-related Increase in 20:2 804 (8-67) composition biochemistry 805 G2192 Seed oil Seed bZIP-NIN Altered composition 806 (600-700) composition biochemistry 807 G504 Seed oil Seed NAC Altered seed oil composition and content; altered seed 808 (TBD) composition; biochemistry protein content 809 G622 Seed oil Seed ABI3/VP-1 Decreased 18:2 fatty acid 810 (TBD) composition biochemistry 811 G778 Seed oil Seed HLH/MYC Increased seed 18:1 fatty acid 812 (220-267) composition biochemistry 813 G791 Seed oil Seed HLH/MYC Altered seed fatty acid composition 814 (75-143) composition biochemistry 815 G861 Seed oil Seed MADS Increase in 16:1; altered seed oil content 816 (2-57) composition; biochemistry seed oil content 817 G938 Seed oil Seed EIL Altered seed fatty acid composition 818 (96-104) composition biochemistry 819 G965 Seed oil Seed HB Increase in 18:1 820 (423-486) composition biochemistry 821 G1143 Seed oil and Seed HLH/MYC Altered seed oil and protein content 822 (33-82) protein content biochemistry 823 G1190 Seed oil content Seed AKR Increased content 824 (entire biochemistry protein) 825 G1198 Seed oil and Seed bZIP Altered seed oil and protein content 826 (173-223) protein content biochemistry 827 G1226 Seed oil and Seed HLH/MYC Altered seed oil and protein content 828 (115-174) protein content biochemistry 829 G1451 Seed oil content Seed ARF Altered seed oil content 830 (22-357) biochemistry 831 G1478 Seed oil and Seed Z-CO-like Altered seed oil, protein content; late flowering 832 (32-76) protein content; biochemistry; flowering time flowering time 833 G1496 Seed oil content Seed HLH/MYC Altered seed oil content 834 (184-248) biochemistry 835 G1526 Seed oil content Seed SWI/SNF Increased seed oil content 836 (493-620, biochemistry 864-1006) 837 G1543 Seed oil content Seed HB Decreased seed oil 838 (135-195) biochemistry 839 G162 Seed oil and Seed MADS Altered seed oil content; altered seed oil and protein 840 (2-57) protein content biochemistry content 841 G1640 Seed oil content Seed MYB-(R1)R2R3 Increased seed oil 842 (14-115) biochemistry 843 G1644 Seed oil and Seed MYB-(R1)R2R3 Altered seed oil, protein content 844 (39-102) protein content biochemistry 845 G1646 Seed oil content Seed CAAT Altered seed oil content 846 (72-162) biochemistry 847 G1672 Seed oil content Seed NAC Altered seed oil content 848 (41-194) biochemistry 849 G1677 Seed oil and Seed NAC Altered seed oil, protein content 850 (17-181) protein content biochemistry 851 G1765 Seed oil and Seed NAC Altered seed oil and protein content 852 (20-140) protein content biochemistry 853 G1777 Seed oil and Seed RING/C3HC4 Increased oil, decreased protein content 854 (124-247) protein content biochemistry 855 G1793 Seed oil content Seed AP2 Increased seed oil content 856 (179-255, biochemistry 281-349) 857 G180 Seed oil content Seed WRKY Decreased seed oil content 858 (118-174) biochemistry 859 G192 Seed oil and Seed WRKY Altered seed oil and protein content; late flowering 860 (128-185) protein content; biochemistry; flowering time flowering time 861 G1948 Seed oil and Seed AKR Altered seed oil and protein content 862 (entire protein content biochemistry protein) 863 G2123 Seed oil and Seed GF14 Altered seed oil and protein content 864 (99-109) protein content biochemistry 865 G2138 Seed oil content Seed AP2 Increased seed oil content 866 (TBD) biochemistry 867 G2139 Seed oil content Seed MADS Increased seed content 868 (14-69) biochemistry 869 G2343 Seed oil content Seed MYB-(R1)R2R3 Altered seed oil content 870 (14-116) biochemistry 871 G265 Seed oil and Seed HS Altered seed oil and protein content 872 (11-105) protein content biochemistry 873 G2792 Seed oil content Seed HLH/MYC Increased seed oil content 874 (190-258) biochemistry 875 G2830 Seed oil and Seed Z-C2H2 Altered seed oil and protein content 876 (245-266) protein content biochemistry 877 G286 Seed oil and Seed ENBP Altered seed oil and protein content 878 (TBD) protein content biochemistry 879 G291 Seed oil content Seed MISC Increased seed oil content 880 (132-160) biochemistry 881 G427 Seed oil and Seed HB Increased oil content; decreased protein content 882 (307-370) protein content biochemistry 883 G509 Seed oil and Seed NAC Altered seed oil and protein content 884 (13-169) protein content biochemistry 885 G519 Seed oil and Seed NAC Altered seed oil and protein content 886 (11-104) protein content biochemistry 887 G561 Seed oil content Seed bZIP Altered seed oil content 888 (248-308) biochemistry 889 G590 Seed oil and Seed HLH/MYC Altered seed oil and protein content 890 (202-254) protein content biochemistry 891 G818 Seed oil content Seed HS Increased content 892 (70-162) biochemistry 893 G849 Seed oil and Seed BPF-1 Increased seed oil, altered protein content 894 (324-413, protein content biochemistry 504-583) 895 G892 Seed oil and Seed RING/C3H2C3 Altered seed oil, protein content 896 (177-270) protein content biochemistry 897 G961 Seed oil content Seed NAC Altered seed oil content 898 (15-140) biochemistry 899 G1465 Seed oil and Seed NAC Altered seed oil and protein content 900 (242-306) protein content biochemistry 901 G425 Seed oil content Seed HB Altered seed oil content 902 (TBD) biochemistry 903 G347 Seed oil and Seed Z-LSDlike Altered seed oil and protein content 904 (9-39, protein content biochemistry 50-70, 80-127) 905 G1512 Seed oil and Seed RING/C3HC4 Altered seed oil and protein content 906 (39-93) protein content biochemistry 907 G2069 Seed oil and Seed bZIP Altered seed oil and protein content 908 (TBD) protein content biochemistry 909 G1852 Seed oil content Seed AKR Altered seed oil content 910 (1-601) biochemistry 911 G1793 Seed oil content Seed AP2 Altered seed oil content 912 (179-255, biochemistry 281-349) 913 G761 Seed oil and Seed NAC Altered seed oil and protein content 914 (10-156) protein content biochemistry 915 G1056 Seed oil content Seed bZIP Altered seed oil content 916 (183-246) biochemistry 917 G1447 Seed oil content Seed MISC Altered seed oil content 918 (3-54, biochemistry 124-156) 919 G323 Seed oil and Seed RING/C3HC4 Altered seed oil and protein content 920 (48-96) protein content biochemistry 921 G176 Seed oil content Seed WRKY Altered seed oil content 922 (117-173, biochemistry 234-290) 923 G174 Seed oil and Seed WRKY Altered seed oil and protein content 924 (111-166, protein content biochemistry 283-339) 925 G715 Seed oil content Seed CAAT Altered seed oil content 926 (60-132) biochemistry 927 G588 Seed oil and Seed HLH/MYC Altered seed oil and protein content 928 (309-376) protein content biochemistry 929 G1758 Seed oil and Seed WRKY Altered seed oil and protein content 930 (109-165) protein content biochemistry 931 G2148 Seed oil content Seed HLH/MYC Altered seed oil content 932 (130-268) biochemistry 933 G2379 Seed oil content Seed TH Altered seed oil content 934 (19-110, biochemistry 173-232) 935 G1462 Seed oil content Seed NAC Altered seed oil content 936 (TBD) biochemistry 937 G1211 Seed oil and Seed MISC Altered seed oil and protein content 938 (123-179) protein content biochemistry 939 G1048 Seed oil content Seed bZIP Altered seed oil content 940 (138-190) biochemistry 941 G986 Seed oil content Seed WRKY Altered seed oil content 942 (146-203) biochemistry 943 G789 Seed oil content Seed HLH/MYC Altered seed oil content 944 (253-313) biochemistry 945 G2085 Seed oil and Seed RING/C3HC4 Altered seed oil and protein content 946 (TBD) protein content biochemistry 947 G1783 Seed oil and Seed MYB-related Altered seed oil and protein content 948 (81-129) protein content biochemistry 949 G2072 Seed oil and Seed bZIP Altered seed oil and protein content 950 (90-149) protein content biochemistry 951 G931 Seed oil and Seed CAAT Altered seed oil and protein content 952 (TBD) protein content biochemistry 953 G278 Seed oil and Seed AKR Altered seed oil and protein content 954 (2-593) protein content biochemistry 955 G2421 Seed oil content Seed MYB-(R1)R2R3 Altered seed oil content 956 (9-110) biochemistry 957 G2032 Seed oil content Seed AKR Altered seed oil content 958 (entire biochemistry protein) 959 G1396 Seed oil and Seed S1FA Altered seed oil and protein content 960 (TBD) protein content biochemistry 961 G619 Seed oil and Seed ARF Altered seed oil and protein content 962 (64-406) protein content biochemistry 963 G2295 Seed oil content Seed MADS Altered seed oil content 964 (2-57) biochemistry 965 G312 Seed oil content Seed SCR Altered seed oil content 966 (320-336) biochemistry 967 G1444 Seed oil and Seed GRF-like Altered seed oil and protein content 968 (168-193) protein content biochemistry 969 G801 Seed oil content Seed PCF Altered seed oil content 970 (32-93) biochemistry 971 G1950 Seed oil content Seed AKR Altered seed oil content 972 (65-228) biochemistry 973 G958 Seed oil and Seed NAC Altered seed oil and protein content 974 (7-156) protein content biochemistry 975 G1037 Seed oil and Seed GARP Altered seed oil and protein content 976 (11-134, protein content biochemistry 200-248) 977 G2065 Seed oil content Seed MADS Altered seed oil content 978 (TBD) biochemistry 979 G2137 Seed oil and Seed WRKY Altered seed oil and protein content 980 (109-168) protein content biochemistry 981 G746 Seed oil content Seed RING/C3HC4 Altered seed oil content 982 (139-178) biochemistry 983 G2701 Seed oil and Seed MYB-related Altered seed oil and protein content 984 (33-81, protein content biochemistry 129-183) 985 G1819 Seed oil content Seed CAAT Altered seed oil content 986 (46-188) biochemistry 987 G1227 Seed oil and Seed HLH/MYC Altered seed oil and protein content 988 (183-244) protein content biochemistry 989 G2417 Seed oil content Seed GARP Altered seed oil content 990 (235-285) biochemistry 991 G2116 Seed oil content Seed bZIP Altered seed oil content 992 (150-210) biochemistry 993 G647 Seed oil content Seed Z-C3H Altered seed oil content 994 (77-192) biochemistry 995 G974 Seed oil and Seed AP2 Altered seed oil and protein content 996 (81-140) protein content biochemistry 997 G1419 Seed protein Seed AP2 Increased seed protein 998 (69-137) content biochemistry 999 G1634 Seed protein Seed MYB-related Altered seed protein content 1000 (129-180) content biochemistry 1001 G1637 Seed protein Seed MYB-related Altered seed protein content 1002 (109-173) content biochemistry 1003 G1818 Seed protein Seed CAAT Increased protein content; late flowering 1004 (36-113) content; biochemistry; flowering time flowering time 1005 G1820 Seed oil and Seed CAAT Altered seed oil, protein content 1006 (70-133) protein content biochemistry 1007 G1903 Seed oil and Seed Z-Dof Altered seed oil and protein content 1008 (134-180) protein content biochemistry 1009 G371 Seed oil and Seed RING/C3HC4 Altered seed oil and protein content 1010 (21-74) protein content biochemistry 1011 G597 Seed protein Seed AT-hook Altered seed protein content 1012 (97-104, content biochemistry 137-144) 1013 G1009 Seed protein Seed AP2 Altered seed protein content 1014 (201-277, content biochemistry 303-371) 1015 G170 Seed protein Seed MADS Altered seed protein content 1016 (2-57) content biochemistry 1017 G1768 Seed protein Seed SCR Altered seed protein content 1018 (54-413) content biochemistry 1019 G185 Seed protein Seed WRKY Altered seed protein content 1020 (113-172) content biochemistry 1021 G1931 Seed protein Seed WRKY Altered seed protein content 1022 (114-170) content biochemistry 1023 G2543 Seed protein Seed HB Altered seed protein content 1024 (31-91) content biochemistry 1025 G264 Seed protein Seed HS Altered seed protein content 1026 (24-114) content biochemistry 1027 G32 Seed protein Seed AP2 Altered seed protein content 1028 (17-84) content biochemistry 1029 G436 Seed protein Seed HB Altered seed protein content 1030 (22-85) content biochemistry 1031 G556 Seed protein Seed bZIP Altered seed protein content 1032 (83-143) content biochemistry 1033 G1420 Seed protein Seed WRKY Altered seed protein content 1034 (221-280) content biochemistry 1035 G1412 Seed protein Seed NAC Altered seed protein content 1036 (17-159) content biochemistry 1037 G738 Seed protein Seed Z-Dof Altered seed protein content 1038 (351-393) content biochemistry 1039 G2426 Seed protein Seed MYB-(R1)R2R3 Altered seed protein content 1040 (14-114) content biochemistry 1041 G1524 Seed protein Seed RING/C3HC4 Altered seed protein content 1042 (49-110) content biochemistry 1043 G1243 Seed protein Seed SWI/SNF Altered seed protein content 1044 (216-609) content biochemistry 1045 G631 Seed protein Seed bZIP Altered seed protein content 1046 (TBD) content biochemistry 1047 G1909 Seed protein Seed Z-Dof Altered seed protein content 1048 (23-51) content biochemistry 1049 G1663 Seed protein Seed PCF Altered seed protein content 1050 (TBD) content biochemistry 1051 G1231 Seed protein Seed Z-C4HC3 Altered seed protein content 1052 (TBD) content biochemistry 1053 G227 Seed protein Seed MYB-(R1)R2R3 Altered seed protein content 1054 (13-112) content biochemistry 1055 G1842 Seed protein Seed MADS Altered seed protein content 1056 (2-57) content biochemistry 1057 G1505 Seed protein Seed GATA/Zn Altered seed protein content 1058 (TBD) content biochemistry 1059 G657 Seed protein Seed MYB-(R1)R2R3 Altered seed protein content 1060 (TBD) content biochemistry 1061 G1959 Seed protein Seed GARP Altered seed protein content 1062 (46-97) content biochemistry 1063 G2180 Seed protein Seed NAC Altered seed protein content 1064 (7-156) content biochemistry 1065 G1817 Seed protein Seed PMR Altered seed protein content 1066 (47-331) content biochemistry 1067 G1649 Seed protein Seed HLH/MYC Altered seed protein content 1068 (225-295) content biochemistry 1069 G2131 Seed protein Seed AP2 Altered seed protein content 1070 (50-186, content biochemistry 112-183) 1071 G215 Seed protein Seed MYB-related Altered seed protein content 1072 (TBD) content biochemistry 1073 G1508 Seed protein Seed GATA/Zn Altered seed protein content 1074 (38-63) content biochemistry 1075 G2110 Seed protein Seed WRKY Altered seed protein content 1076 (239-298) content biochemistry 1077 G2442 Seed protein Seed RING/C3HC4 Altered seed protein content 1078 (220-246) content biochemistry 1079 G1051 Flowering time Flowering time bZIP Late flowering 1080 (189-250) 1081 G1052 Flowering time Flowering time bZIP Late flowering 1082 (201-261) 1083 G1079 Flowering time; Flowering BZIPT2 Late flowering; altered seed protein content 1084 (1-50) time; 1085 G1335 Flowering time Flowering time Z-CLDSH Late flowering, slow growth 1086 (24-43, 131-144, 185-203) 1087 G157 Flowering time Flowering time MADS Altered flowering; significant overexpression delays 1088 (2-57) flowering time 1089 G1895 Flowering time Flowering time Z-Dof Late flowering 1090 (55-110) 1091 G1900 Flowering time Flowering time Z-Dof Late flowering 1092 (54-106) 1093 G2007 Flowering time; Flowering MYB-(R1)R2R3 Late flowering; altered seed protein content 1094 (TBD) seed protein time; seed content biochemistry 1095 G214 Flowering time Flowering time MYB-related Late flowering 1096 (22-71) 1097 G2155 Flowering time Flowering time AT-hook Late flowering 1098 (18-38) 1099 G234 Flowering time Flowering time MYB-(R1)R2R3 Late flowering, small plant 1100 (14-115) 1101 G361 Flowering time Flowering time Z-C2H2 Late flowering 1102 (43-63) 1103 G562 Flowering time Flowering time bZIP Late flowering 1104 (253-315) 1105 G591 Flowering time Flowering time HLH/MYC Late flowering 1106 (143-240) 1107 G8 Flowering time Flowering time AP2 Late flowering 1108 (151-217, 243-296) 1109 G859 Flowering time; Flowering MADS Late flowering; altered seed protein content 1110 (TBD) seed protein time; seed content biochemistry 1111 G878 Flowering time Flowering time WRKY Late flowering 1112 (250-305, 415-475) 1113 G971 Flowering time Flowering time AP2 Late flowering 1114 (120-186) 1115 G975 Flowering time; Flowering AP2 Late flowering; glossy leaves 1116 (4-71) morphology: time; other dev and morph 1117 G994 Flowering time Flowering time MYB-(R1)R2R3 Late flowering, small 1118 (14-123) 1119 G2347 Flowering time Flowering time SBP Late flowering, small 1120 (60-136) 1121 G2010 Flowering time Flowering time SBP Late flowering 1122 (53-127)

TABLE 5 Smallest SEQ ID Test Sequence Sum NO GID ID Probability Test Sequence Species Test Sequence GenBank Annotation 859 G192 AW596933 7.70E−40 [Glycine max] sj84f07.y1 Gm-c1034 Glycine max cDNA clone GENO 859 G192 AV423663 2.40E−39 [Lotus japonicus] AV423663 Lotus japonicus young plants (two- 859 G192 BI422074 4.50E−34 [Lycopersicon esculentum] EST532740 tomato callus, TAMU Lycop 859 G192 AW447931 1.40E−27 [Triticum aestivum] BRY_1082 BRY Triticum aestivum cDNA clone 859 G192 BE998060 2.60E−24 [Medicago truncatula] EST429783 GVSN Medicago truncatula cDNA 859 G192 AC018727 1.70E−23 [Oryza sativa] chromosome 10 clone OSJNBa0056G17, ***SEQUENC 859 G192 BG600477 1.00E−20 [Solanum tuberosum] EST505372 cSTS Solanum tuberosum cDNA clo 859 G192 BG356878 2.80E−16 [Sorghum bicolor] OV2_11_B04.g1_A002 Ovary 2 (OV2) Sorghum bi 859 G192 gi12039364 1.10E−31 [Oryza sativa] putative DNA-binding protein. 859 G192 gi4894963 3.30E−14 [Avena sativa] DNA-binding protein WRKY3. 859 G192 gi1432056 5.80E−14 [Petroselinum crispum] WRKY3. 859 G192 gi4760596 2.60E−13 [Nicotiana tabacum] DNA-binding protein NtWRKY3. 859 G192 gi11993901 1.40E−12 [Dactylis glomerata] somatic embryogenesis related protein. 859 G192 gi927025 7.60E−09 [Cucumis sativus] SPF1-like DNA-binding protein. 859 G192 gi13620227 8.40E−09 [Lycopersicon esculentum] hypothetical protein. 859 G192 gi3420906 2.80E−08 [Pimpinella brachycarpa] zinc finger protein; WRKY1. 859 G192 gi1159877 4.70E−08 [Avena fatua] DNA-binding protein. 859 G192 gi484261 1.60E−07 [Ipomoea batatas] SPF1 protein. 801 G1946 LPHSF8 1.10E−119 [Lycopersicon peruvianum] L. peruvianum Lp-hsf8 mRNA for heat 801 G1946 AC087771 4.10E−112 [Medicago truncatula] clone 8D15, ***SEQUENCING IN PROGRESS 801 G1946 LEHSF8 5.90E−103 [Lycopersicon esculentum] L. esculentum Le-hsf8 gene for heat 801 G1946 AW569138 3.10E−75 [Glycine max] si63g09.y1 Gm-r1030 Glycine max cDNA clone GENO 801 G1946 BG890899 1.30E−70 [Solanum tuberosum] EST516750 cSTD Solanum tuberosum cDNA clo 801 G1946 AC027658 4.60E−53 [Oryza sativa] subsp. japonica BAC nbxb0006I13, chromosome 10 801 G1946 AV833112 4.90E−52 [Hordeum vulgare subsp. vulgare] AV833112 K. Sato unpublished 801 G1946 gi19492 2.80E−121 [Lycopersicon peruvianum] heat shock transcription factor 8 801 G1946 gi19260 5.10E−106 [Lycopersicon esculentum] heat stress transcription factor 801 G1946 gi662924 2.00E−47 [Glycine max] heat shock transcription factor 21. 801 G1946 gi5821138 9.70E−46 [Nicotiana tabacum] heat shock factor. 801 G1946 gi11761077 2.90E−40 [Oryza sativa] putative heat shock factor protein 1 (HSF 1) 801 G1946 gi886742 3.20E−40 [Zea mays] heat shock factor. 801 G1946 gi7158882 2.70E−38 [Medicago sativa] heat shock transcription factor. 801 G1946 gi3550588 1.90E−30 [Pisum sativum] heat shock transcription factor (HSFA). 801 G1946 gi100546 0.46 [Avena sativa] avenin precursor - oat. 801 G1946 gi14190783 1 [Apium graveolens] putative phloem transcription factor M1. 239 G375 AW696439 3.40E−33 [Medicago truncatula] NF106B07ST1F1060 Developing stem Medica 239 G375 BG595870 1.90E−31 [Solanum tuberosum] EST494548 cSTS Solanum tuberosum cDNA clo 239 G375 AI899263 3.70E−31 [Lycopersicon esculentum] EST268706 tomato ovary, TAMU Lycope 239 G375 NTBBF3 4.00E−31 [Nicotiana tabacum] N. tabacum mRNA for zinc finger protein, B 239 G375 BG405482 2.70E−30 [Glycine max] sac44a11.y1 Gm-c1062 Glycine max cDNA clone GEN 239 G375 AB028130 3.30E−30 [Oryza sativa] mRNA for Dof zinc finger protein, complete cds 239 G375 AB026297 7.30E−28 [Pisum sativum] mRNA for elicitor-responsive Dof protein ERDP 239 G375 HVBPBF 1.10E−27 [Hordeum vulgare] mRNA for DNA binding protein BPBF. 239 G375 BG263089 1.70E−27 [Triticum aestivum] WHE2337_A02_A03ZS Wheat pre-anthesis spik 239 G375 ZMU82230 4.20E−27 [Zea mays] endosperm-specific prolamin box binding factor (PB 239 G375 gi4996640 1.90E−37 [Oryza sativa] Dof zinc finger protein. 239 G375 gi3777436 8.10E−35 [Hordeum vulgare] DNA binding protein. 239 G375 gi2393775 1.10E−33 [Zea mays] prolamin box binding factor. 239 G375 gi1360088 2.00E−33 [Nicotiana tabacum] Zn finger protein. 239 G375 gi3790264 4.30E−32 [Triticum aestivum] PBF protein. 239 G375 gi6092016 1.30E−29 [Pisum sativum] elicitor-responsive Dof protein ERDP. 239 G375 gi7688355 5.60E−29 [Solanum tuberosum] Dof zinc finger protein. 239 G375 gi1669341 4.60E−20 [Cucurbita maxima] AOBP (ascorbate oxidase promoter-binding 239 G375 gi3929325 5.50E−18 [Dendrobium grex putative DNA-binding prot Madame Thong-In] 239 G375 gi19547 5.50E−06 [Medicago sativa subsp. falcata] environmental stress and a 273 G1255 AC087181 1.60E−46 [Oryza sativa] chromosome 3 clone OSJNBa0018H01, ***SEQUENCI 273 G1255 BG239774 4.50E−33 [Glycine max] sab74c03.y1 Gm-c1032 Glycine max cDNA clone GEN 273 G1255 BG321336 1.70E−32 [Descurainia sophia] Ds01_06h10_A Ds01_AAFC_ECORC_cold_stress 273 G1255 AI772841 2.90E−30 [Lycopersicon esculentum] EST253941 tomato resistant, Cornell 273 G1255 BF480245 4.60E−29 [Mesembryanthemum crystallinum] L0-2152T3 Ice plant Lambda Un 273 G1255 AW688119 2.10E−28 [Medicago truncatula] NF002E07ST1F1000 Developing stem Medica 273 G1255 BF266327 1.80E−26 [Hordeum vulgare] HV_CEa0014N02f Hordeum vulgare seedling gre 273 G1255 AW671538 5.80E−25 [Sorghum bicolor] LGI_348_B08.b1_A002 Light Grown 1 (LG1) Sor 273 G1255 BI072021 5.30E−20 [Populus tremula x C067P76U Populus stra Populus tremuloides] 273 G1255 BG273908 4.90E−19 [Vitis vinifera] EST 110 Green Grape berries Lambda Zap II Li 273 G1255 gi13702811 3.70E−52 [Oryza sativa] putative zinc finger protein. 273 G1255 gi11037311 4.00E−21 [Brassica nigra] constans-like protein. 273 G1255 gi2303683 1.10E−19 [Brassica napus] unnamed protein product. 273 G1255 gi4091804 2.30E−18 [Malus x domestica] CONSTANS-like protein 1. 273 G1255 gi3341723 4.30E−18 [Raphanus sativus] CONSTANS-like 1 protein. 273 G1255 gi10946337 5.20E−17 [lpomoea nil] CONSTANS-like protein. 273 G1255 gi4557093 3.30E−15 [Pinus radiata] zinc finger protein. 273 G1255 gi8132543 0.97 [Chloroplast Zamia furfuracea] cytochrome b559 alpha subuni 273 G1255 gi11795 0.99 [Nicotiana tabacum] put. psbE protein (aa 1-83). 273 G1255 gi65646 0.99 [Chloroplast Nicotiana tabacum] cytochrome b559 component p 557 G865 BE419451 3.70E−32 [Triticum aestivum] WWS012.C2R000101 ITEC WWS Wheat Scutellum 557 G865 AW560968 1.10E−28 [Medicago truncatula] EST316016 DSIR Medicago truncatula cDNA 557 G865 AW782252 1.20E−26 [Glycine max] sm03d11.y1 Gm-c1027 Glycine max cDNA clone GENO 557 G865 BI421895 3.60E−25 [Lycopersicon esculentum] EST532561 tomato callus, TAMU Lycop 557 G865 BE642320 1.60E−24 [Ceratopteris richardii] Cri2_5_L17_SP6 Ceratopteris Spore Li 557 G865 BE494041 1.60E−24 [Secale cereale] WHE1277_B09_D17ZS Secale cereale anther cDNA 557 G865 D39914 2.60E−24 [Oryza sativa] RICS1576A Rice shoot Oryza sativa cDNA, mRNA s 557 G865 AV428124 9.00E−23 [Lotus japonicus] AV428124 Lotus japonicus young plants (two- 557 G865 TOBBY4D 1.80E−21 [Nicotiana tabacum] Tobacco mRNA for EREBP-2, complete cds. 557 G865 gi1208495 2.40E−23 [Nicotiana tabacum] ERF1. 557 G865 gi8809571 5.10E−23 [Nicotiana sylvestris] ethylene-responsive element binding 557 G865 gi3342211 1.40E−22 [Lycopersicon esculentum] Pti4. 557 G865 gi7528276 1.70E−22 [Mesembryanthemum crystallinum] AP2-related transcription f 557 G865 gi15217291 7.80E−22 [Oryza sativa] Putative AP2 domain containing protein. 557 G865 gi3264767 2.70E−21 [Prunus armeniaca] AP2 domain containing protein. 557 G865 gi8980313 2.10E−20 [Catharanthus roseus] AP2-domain DNA-binding protein. 557 G865 gi8571476 9.30E−20 [Atriplex hortensis] apetala2 domain-containing protein. 557 G865 gi1688233 1.40E−19 [Solanum tuberosum] DNA binding protein homolog. 557 G865 gi6478845 1.80E−19 [Matricaria chamomilla] ethylene-responsive element binding 23 G2509 BH577856 2.50E−29 [Brassica oleracea] BOHOJ67TR BOHO Brassica oleracea genomic 23 G2509 BM269574 5.90E−28 [Glycine max] sak01e08.y1 Gm-c1074 Glycine max cDNA clone SOY 23 G2509 BE419451 2.20E−27 [Triticum aestivum] WWS012.C2R000101 ITEC WWS Wheat Scutellum 23 G2509 AI483636 7.80E−27 [Lycopersicon esculentum] EST249507 tomato ovary, TAMU Lycope 23 G2509 AW560968 8.90E−27 [Medicago truncatula] EST316016 DSIR Medicago truncatula cDNA 23 G2509 BE642320 4.30E−26 [Ceratopteris richardii] Cri2_5_L17_SP6 Ceratopteris Spore Li 23 G2509 AP003286 1.00E−25 [Oryza sativa] chromosome 1 clone P0677H08, ***SEQUENCING IN 23 G2509 BE494041 3.20E−25 [Secale cereale] WHE1277_B09_D17ZS Secale cereale anther cDNA 23 G2509 BE602106 1.10E−24 [Hordeum vulgare] HVSMEh0102I06f Hordeum vulgare 5-45 DAP spi 23 G2509 AV428124 1.00E−23 [Lotus japonicus] AV428124 Lotus japonicus young plants (two- 23 G2509 gi3264767 4.00E−27 [Prunus armeniaca] AP2 domain containing protein. 23 G2509 gi12003376 1.40E−23 [Nicotiana tabacum] Avr9/Cf-9 rapidly elicited protein 1. 23 G2509 gi14140141 2.30E−23 [Oryza sativa] putative AP2-related transcription factor. 23 G2509 gi1688233 5.40E−23 [Solanum tuberosum] DNA binding protein homolog. 23 G2509 gi4099921 2.60E−22 [Stylosanthes hamata] EREBP-3 homolog. 23 G2509 gi8809571 7.80E−22 [Nicotiana sylvestris] ethylene-responsive element binding 23 G2509 gi3342211 1.00E−21 [Lycopersicon esculentum] Pti4. 23 G2509 gi7528276 2.70E−21 [Mesembryanthemum crystallinum] AP2-related transcription f 23 G2509 gi17385636 1.90E−20 [Matricaria chamomilla] ethylene-responsive element binding 23 G2509 gi18496063 3.30E−20 [Fagus sylvatica] ethylene responsive element binding prote 1119 G2347 BI931517 5.30E−31 [Lycopersicon esculentum] EST551406 tomato flower, 8 mm to pr 1119 G2347 BE058432 4.20E−29 [Glycine max] sn16a06.y1 Gm-c1016 Glycine max cDNA clone GENO 1119 G2347 AMSPB1 1.80E−28 [Antirrhinum majus] A.majus RNA for squamosa-promoter bindin 1119 G2347 BG525285 5.70E−28 [Stevia rebaudiana] 48-3 Stevia field grown leaf cDNA Stevia 1119 G2347 L38193 4.60E−27 [Brassica rapa] BNAF1025E Mustard flower buds Brassica rapa c 1119 G2347 BG455868 6.40E−27 [Medicago truncatula] NF068F05PL1F1045 Phosphate starved leaf 1119 G2347 BG097153 1.70E−24 [Solanum tuberosum] EST461672 potato leaves and petioles Sola 1119 G2347 BF482644 1.60E−23 [Triticum aestivum] WHE2301-2304_A21_A21ZS Wheat pre-anthesis 1119 G2347 AW747167 2.30E−23 [Sorghum bicolor] WS1_66_F11.b1_A002 Water-stressed 1 (WS1) S 1119 G2347 BG442540 2.50E−23 [Gossypium arboreum] GA_Ea0017G06f Gossypium arboreum 7-10 d 1119 G2347 gi1183864 1.50E−31 [Antirrhinum majus] squamosa-promoter binding protein 2. 1119 G2347 gi5931786 3.40E−25 [Zea mays] SBP-domain protein 5. 1119 G2347 gi8468036 1.40E−21 [Oryza sativa] Similar to Arabidopsis thaliana chromosome 2 1119 G2347 gi9087308 6.60E−09 [Mitochondrion Beta vulgaris orf102a. var. altissima] 1119 G2347 gi7209500 0.83 [Brassica rapa] S-locus pollen protein. 43 G988 CRU303349 3.10E−208 [Capsella rubella] ORF1, ORF2, ORF3, ORF4, ORF5 and ORF6 (pa 43 G988 A84072 4.50E−86 [Lycopersicon esculentum] Sequence 1 from Patent WO9846759. 43 G988 A84080 3.30E−85 [Solanum tuberosum] Sequence 9 from Patent WO9846759. 43 G988 AP003944 1.30E−57 [Oryza sativa] chromosome 6 clone OJ1126_F05, ***SEQUENCING 43 G988 AX081276 2.80E−43 [Brassica napus] Sequence 1 from Patent WO0109356. 43 G988 ZMA242530 1.50E−40 [Zea mays] partial d8 gene for gibberellin response modulato 43 G988 AX005804 2.50E−37 [Triticum aestivum] Sequence 13 from Patent WO9909174. 43 G988 AB048713 9.10E−33 [Pisum sativum] PsSCR mRNA for SCARECROW, complete cds. 43 G988 AW774515 2.00E−29 [Medicago truncatula] EST333666 KV3 Medicago truncatula cDNA 43 G988 BE822458 1.20E−27 [Glycine max] GM700017A20H12 Gm-r1070 Glycine max cDNA clone 43 G988 gi13620166 8.00E−211 [Capsella rubella] hypothetical protein. 43 G988 gi4160441 1.40E−87 [Lycopersicon esculentum] lateral suppressor protein. 43 G988 gi10178637 2.20E−48 [Zea mays] SCARECROW. 43 G988 gi6970472 1.20E−47 [Oryza sativa] OsGAI. 43 G988 gi5640157 2.80E−45 [Triticum aestivum] gibberellin response modulator. 43 G988 gi13170126 7.10E−45 [Brassica napus] unnamed protein product. 43 G988 gi13365610 1.10E−40 [Pisum sativum] SCARECROW. 43 G988 gi14318115 1.10E−14 [Zea mays subsp. mays] gibberellin response modulator. 43 G988 gi14318165 7.30E−14 [Tripsacum dactyloides] gibberellin response modulator. 43 G988 gi347457 2.40E−05 [Glycine max] hydroxyproline-rich glycoprotein. 459 G2346 AMA011622 3.10E−35 [Antirrhinum majus] mRNA for squamosa promoter binding 459 G2346 AW691786 1.80E−26 [Medicago truncatula] NF044B06ST1F1000 Developing stem Medica 459 G2346 AQ273505 7.00E−25 [Oryza sativa] nbxb0030O03f CUGI Rice BAC Library Oryza sativ 459 G2346 AW932595 7.90E−24 [Lycopersicon esculentum] EST358438 tomato fruit mature green 459 G2346 BG593787 9.50E−24 [Solanum tuberosum] EST492465 cSTS Solanum tuberosum cDNA clo 459 G2346 BG442540 1.00E−23 [Gossypium arboreum] GA_Ea0017G06f Gossypium arboreum 7-10 d 459 G2346 AZ919034 1.90E−23 [Zea mays] 1006013G02.x3 1006-RescueMu Grid G Zea mays geno 459 G2346 BE596165 2.70E−23 [Sorghum bicolor] PI1_50_D04.b1_A002 Pathogen induced 1 (PI1) 459 G2346 AI443033 2.30E−22 [Glycine max] sa31a08.y1 Gm-c1004 Glycine max cDNA clone GENO 459 G2346 BF482644 4.30E−22 [Triticum aestivum] WHE2301-2304_A21_A21ZS Wheat pre-anthesis 459 G2346 gi5931643 6.20E−45 [Antirrhinum majus] squamosa promoter binding protein-homol 459 G2346 gi5931786 4.20E−26 [Zea mays] SBP-domain protein 5. 459 G2346 gi8468036 3.30E−14 [Oryza sativa] Similar to Arabidopsis thaliana chromosome 2 459 G2346 gi9087308 8.30E−08 [Mitochondrion Beta vulgaris orf102a. var. altissima] 285 G1354 BG128374 2.90E−58 [Lycopersicon esculentum] EST474020 tomato shoot/meristem Lyc 285 G1354 BE202831 1.90E−56 [Medicago truncatula] EST402853 KV1 Medicago truncatula cDNA 285 G1354 AI161918 6.60E−55 [Populus tremula x A009P50U Hybrid aspen Populus tremuloides] 285 G1354 AB028186 1.20E−53 [Oryza sativa] mRNA for OsNAC7 protein, complete cds. 285 G1354 BE060921 8.00E−50 [Hordeum vulgare] HVSMEg0013N15f Hordeum vulgare pre-anthesis 285 G1354 AF402603 1.50E−42 [Phaseolus vulgaris] NAC domain protein NAC2 mRNA, complete c 285 G1354 BE357920 1.60E−42 [Sorghum bicolor] DG1_23_F03.b1_A002 Dark Grown 1 (DG1) Sorgh 285 G1354 PHRNANAM 3.60E−42 [Petunia x hybrida] P.hybrida mRNA encoding NAM protein. 285 G1354 AW185617 5.30E−40 [Glycine max] se80b05.y1 Gm-c1023 Glycine max cDNA clone GENO 285 G1354 gi6006373 4.50E−63 [Oryza sativa] Similar to NAM like protein (AC005310). 285 G1354 gi15148914 2.30E−44 [Phaseolus vulgaris] NAC domain protein NAC2. 285 G1354 gi14485513 3.50E−44 [Solanum tuberosum] putative NAC domain protein. 285 G1354 gi1279640 5.90E−44 [Petunia x hybrida] NAM. 285 G1354 gi6175246 5.20E−41 [Lycopersicon esculentum] jasmonic acid 2. 285 G1354 gi4218535 5.10E−39 [Triticum sp.] GRAB1 protein. 285 G1354 gi6732158 5.10E−39 [Triticum monococcum] unnamed protein product. 285 G1354 gi7716952 3.30E−35 [Medicago truncatula] NAC1. 285 G1354 gi4996349 2.50E−26 [Nicotiana tabacum] NAC-domain protein. 285 G1354 gi2982275 3.10E−14 [Picea mariana] ATAF1-like protein. 119 G1063 BH700922 4.50E−90 [Brassica oleracea] BOMMZ07TR BO_2_3_KB Brassica oleracea gen 119 G1063 BE451174 2.40E−41 [Lycopersicon esculentum] EST402062 tomato root, plants pre-a 119 G1063 AW832545 2.00E−40 [Glycine max] sm12e10.y1 Gm-c1027 Glycine max cDNA clone GENO 119 G1063 AP004693 5.90E−37 [Oryza sativa] chromosome 8 clone P0461F06, ***SEQUENCING IN 119 G1063 AP004462 4.40E−32 [Oryza sativa ( ) chromosome 8 clo (japonica cultivar-group)] 119 G1063 AT002234 8.90E−32 [Brassica rapa subsp. pekinensis] AT002234 Flower bud cDNA Br 119 G1063 BF263465 5.40E−25 [Hordeum vulgare] HV_CEa0006N02f Hordeum vulgare seedling gre 119 G1063 BG557011 4.20E−22 [Sorghum bicolor] EM1_41_E02.g1_A002 Embryo 1 (EM1) Sorghum b 119 G1063 BG842856 3.10E−21 [Zea mays] MEST40-H05.T3 ISUM4-TN Zea mays cDNA clone MEST40- 119 G1063 BG559930 1.40E−18 [Sorghum propinquum] RHIZ2_75_D09.g1_A003 Rhizome2 (RHIZ2) So 119 G1063 gi15528743 4.20E−26 [Oryza sativa] contains EST C74560(E31855)˜unknown protein. 119 G1063 gi6166283 8.10E−10 [Pinus taeda] helix-loop-helix protein 1A. 119 G1063 gi11045087 8.80E−09 [Brassica napus] putative protein. 119 G1063 gi10998404 7.10E−08 [Petunia x hybrida] anthocyanin 1. 119 G1063 gi99441 2.60E−07 [Volvox carteri] sulfated surface glycoprotein 185 - Volvox 119 G1063 gi1142621 5.00E−07 [Phaseolus vulgaris] phaseolin G-box binding protein PG2. 119 G1063 gi166428 8.10E−07 [Antirrhinum majus] DEL. 119 G1063 gi1247386 9.50E−07 [Nicotiana alata] PRP2. 119 G1063 gi82091 1.00E−06 [Lycopersicon esculentum] hydroxyproline-rich glycoprotein 119 G1063 gi1486263 1.40E−06 [Catharanthus roseus] extensin. 129 G2143 BH650724 3.00E−88 [Brassica oleracea] BOMIW43TR BO_2_3_KB Brassica oleracea gen 129 G2143 AW832545 1.50E−40 [Glycine max] sm12e10.y1 Gm-c1027 Glycine max cDNA clone GENO 129 G2143 BE451174 3.50E−40 [Lycopersicon esculentum] EST402062 tomato root, plants pre-a 129 G2143 AP004693 4.00E−38 [Oryza sativa] chromosome 8 clone P0461F06, ***SEQUENCING IN 129 G2143 AP004584 6.30E−33 [Oryza sativa ( ) chromosome 8 clo (japonica cultivar-group)] 129 G2143 AT002234 3.00E−31 [Brassica rapa subsp. pekinensis] AT002234 Flower bud cDNA Br 129 G2143 BF263465 2.90E−26 [Hordeum vulgare] HV_CEa0006N02f Hordeum vulgare seedling gre 129 G2143 BG557011 2.60E−22 [Sorghum bicolor] EM1_41_E02.g1_A002 Embryo 1 (EM1) Sorghum b 129 G2143 BG842856 3.50E−20 [Zea mays] MEST40-H05.T3 ISUM4-TN Zea mays cDNA clone MEST40- 129 G2143 BG559930 6.10E−18 [Sorghum propinquum] RHIZ2_75_D09.g1_A003 Rhizome2 (RHIZ2) So 129 G2143 gi15528743 5.50E−26 [Oryza sativa] contains EST C74560(E31855)˜unknown protein. 129 G2143 gi1086538 7.60E−09 [Oryza rufipogon] transcriptional activator Rb homolog. 129 G2143 gi6166283 1.10E−08 [Pinus taeda] helix-loop-helix protein 1A. 129 G2143 gi1142621 4.60E−07 [Phaseolus vulgaris] phaseolin G-box binding protein PG2. 129 G2143 gi3399777 5.20E−07 [Glycine max] symbiotic ammonium transporter; nodulin. 129 G2143 gi5923912 6.10E−07 [Tulipa gesneriana] bHLH transcription factor GBOF-1. 129 G2143 gi10998404 9.20E−07 [Petunia x hybrida] anthocyanin 1. 129 G2143 gi4321762 5.20E−06 [Zea mays] transcription factor MYC7E. 129 G2143 gi166428 6.00E−06 [Antirrhinum majus] DEL. 129 G2143 gi527665 7.40E−06 [Sorghum bicolor] myc-like regulatory R gene product. 133 G2557 BH511840 6.70E−62 [Brassica oleracea] BOGRJ19TR BOGR Brassica oleracea genomic 133 G2557 BE347811 3.70E−46 [Glycine max] sp05h10.y1 Gm-c1041 Glycine max cDNA clone GENO 133 G2557 AP003141 2.40E−33 [Oryza sativa] genomic DNA, chromosome 1, PAC clone: P0002B05, 133 G2557 BF263465 3.00E−31 [Hordeum vulgare] HV_CEa0006N02f Hordeum vulgare seedling gre 133 G2557 AT002234 6.60E−27 [Brassica rapa subsp. pekinensis] AT002234 Flower bud cDNA Br 133 G2557 BG557011 6.40E−26 [Sorghum bicolor] EM1_41_E02.g1_A002 Embryo 1 (EM1) Sorghum b 133 G2557 AP004462 7.90E−26 [Oryza sativa ( ) chromosome 8 clo (japonica cultivar-group)] 133 G2557 BE451174 3.90E−25 [Lycopersicon esculentum] EST402062 tomato root, plants pre-a 133 G2557 BG842856 5.60E−22 [Zea mays] MEST40-H05.T3 ISUM4-TN Zea mays cDNA clone MEST40- 133 G2557 BG559930 7.00E−14 [Sorghum propinquum] RHIZ2_75_D09.g1_A003 Rhizome2 (RHIZ2) So 133 G2557 gi15289790 2.40E−36 [Oryza sativa] contains EST C74560(E31855)˜unknown protein. 133 G2557 gi3399777 2.60E−06 [Glycine max] symbiotic ammonium transporter; nodulin. 133 G2557 gi4206118 1.10E−05 [Mesembryanthemum crystallinum] transporter homolog. 133 G2557 gi6166283 1.30E−05 [Pinus taeda] helix-loop-helix protein 1A. 133 G2557 gi527655 3.70E−05 [Pennisetum glaucum] myc-like regulatory R gene product. 133 G2557 gi5923912 3.70E−05 [Tulipa gesneriana] bHLH transcription factor GBOF-1. 133 G2557 gi527661 7.80E−05 [Phyllostachys acuta] myc-like regulatory R gene product. 133 G2557 gi527665 9.50E−05 [Sorghum bicolor] myc-like regulatory R gene product. 133 G2557 gi1086538 0.0001 [Oryza rufipogon] transcriptional activator Rb homolog. 133 G2557 gi5669656 0.00013 [Lycopersicon esculentum] ER33 protein. 697 G2430 BF632520 1.90E−14 [Medicago truncatula] NF039A08DT1F1054 Drought Medicago trunc 697 G2430 AW396912 1.20E−13 [Glycine max] sg64g09.y1 Gm-c1007 Glycine max cDNA clone GENO 697 G2430 D41804 4.50E−13 [Oryza sativa] RICS4626A Rice shoot Oryza sativa cDNA, mRNA s 697 G2430 BE214029 2.60E−10 [Hordeum vulgare] HV_CEb0001P06f Hordeum vulgare seedling gre 697 G2430 AW564570 2.70E−10 [Sorghum bicolor] LG1_296_E01.b1_A002 Light Grown 1 (LG1) Sor 697 G2430 BG129795 5.40E−10 [Lycopersicon esculentum] EST475441 tomato shoot/meristem Lyc 697 G2430 AB060130 5.40E−09 [Zea mays] ZmRR8 mRNA for response regulator 8, complete cds. 697 G2430 BF587105 2.50E−05 [Sorghum propinquum] FM1_32_C05.b1_A003 Floral-Induced Merist 697 G2430 AI163121 0.3 [Populus tremula x A033P70U Hybrid aspen Populus tremuloides] 697 G2430 BG595628 0.46 [Solanum tuberosum] EST494306 cSTS Solanum tuberosum cDNA clo 697 G2430 gi13661174 5.40E−18 [Zea mays] response regulator 8. 697 G2430 gi15289981 0.028 [Oryza sativa] hypothetical protein. 697 G2430 gi6942190 0.12 [Mesembryanthemum crystallinum] CDPK substrate protein 1; C 697 G2430 gi4519671 0.2 [Nicotiana tabacum] transfactor. 831 G1478 BF275913 1.50E−20 [Gossypium arboreum] GA_Eb0025C07f Gossypium arboreum 7-10 d 831 G1478 BG157399 6.50E−19 [Glycine max] sab36g12.y1 Gm-c1026 Glycine max cDNA clone GEN 831 G1478 C95300 2.20E−10 [Citrus unshiu] C95300 Citrus unshiu Miyagawa-wase maturation 831 G1478 AW034552 2.70E−10 [Lycopersicon esculentum] EST278168 tomato callus, TAMU Lycop 831 G1478 BI070429 3.40E−10 [Populus tremula x C037P68U Populus stra Populus tremuloides] 831 G1478 AF016011 5.10E−09 [Brassica napus] CONSTANS homolog (Bn9CON10) gene, complete c 831 G1478 BE598912 6.20E−09 [Sorghum bicolor] PI1_84_H11.b1_A002 Pathogen induced 1 (PI1) 831 G1478 BG605313 6.80E−09 [Triticum aestivum] WHE2331_C04_F07ZS Wheat pre-anthesis spik 831 G1478 BE558327 8.90E−09 [Hordeum vulgare] HV_CEb0017D19f Hordeum vulgare seedling gre 831 G1478 BG647091 1.20E−08 [Medicago truncatula] EST508710 HOGA Medicago truncatula cDNA 831 G1478 gi2895188 4.70E−11 [Brassica napus] CONSTANS homolog. 831 G1478 gi3618308 1.50E−09 [Oryza sativa] zinc finger protein. 831 G1478 gi11037308 4.70E−09 [Brassica nigra] constans-like protein. 831 G1478 gi3341723 1.30E−08 [Raphanus sativus] CONSTANS-like 1 protein. 831 G1478 gi4091806 1.50E−07 [Malus x domestica] CONSTANS-like protein 2. 831 G1478 gi10946337 3.10E−07 [Ipomoea nil] CONSTANS-like protein. 831 G1478 gi4557093 1.40E−05 [Pinus radiata] zinc finger protein. 831 G1478 gi619312 0.9 [Capparis masaikai] mabinlin III B-chain = sweet protein mabi 831 G1478 gi4732091 1 [Zea mays] bundle sheath defective protein 2. 831 G1478 gi4699629 1 [Nicotiana alata] Chain A, Putative Ancestral Protein Encod 579 G681 BG128147 6.80E−41 [Lycopersicon esculentum] EST473793 tomato shoot/meristem Lyc 579 G681 BF054497 1.50E−39 [Solanum tuberosum] EST439727 potato leaves and petioles Sola 579 G681 BE054276 8.40E−39 [Gossypium arboreum] GA_Ea0002O18f Gossypium arboreum 7-10 d 579 G681 BG269414 4.00E−38 [Mesembryanthemum crystallinum] L0-3478T3 Ice plant Lambda Un 579 G681 BF620286 7.40E−38 [Hordeum vulgare] HVSMEc0019F08f Hordeum vulgare seedling sho 579 G681 BE490032 1.00E−37 [Triticum aestivum] WHE0364_C04_E08ZS Wheat cold-stressed see 579 G681 BI542536 1.40E−36 [Zea mays] 949021A03.y1 949-Juvenile leaf and shoot cDNA fr 579 G681 BF425254 7.20E−36 [Glycine max] su42c10.y1 Gm-c1068 Glycine max cDNA clone GENO 579 G681 AW672062 3.20E−34 [Sorghum bicolor] LG1_354_G05.b1_A002 Light Grown 1 (LG1) Sor 579 G681 BG448527 1.00E−33 [Medicago truncatula] NF036F04RT1F1032 Developing root Medica 579 G681 gi13346188 9.10E−37 [Gossypium hirsutum] GHMYB25. 579 G681 gi20563 6.30E−36 [Petunia x hybrida] protein 1. 579 G681 gi485867 1.20E−34 [Antirrhinum majus] mixta. 579 G681 gi2605617 1.70E−32 [Oryza sativa] OSMYB1. 579 G681 gi1430846 2.00E−31 [Lycopersicon esculentum] myb-related transcription factor. 579 G681 gi6651292 2.20E−30 [Pimpinella brachycarpa] myb-related transcription factor. 579 G681 gi15042116 4.90E−30 [Zea mays subsp. parviglumis] CI protein. 579 G681 gi82730 6.10E−30 [Zea mays] transforming protein (myb) homolog (clone Zm38) 579 G681 gi5139806 8.30E−30 [Glycine max] GmMYB29A2. 579 G681 gi19055 1.10E−29 [Hordeum vulgare] MybHv5. 611 G878 AF096299 6.20E−90 [Nicotiana tabacum] DNA-binding protein 2 (WRKY2) mRNA, compl 611 G878 CUSSLDB 1.80E−83 [Cucumis sativus] SPF1-like DNA-binding protein mRNA, complet 611 G878 AF193802 3.50E−63 [Oryza sativa] zinc finger transcription factor WRKY1 mRNA, c 611 G878 AX192162 2.20E−62 [Glycine max] Sequence 9 from Patent WO0149840. 611 G878 IPBSPF1P 3.80E−58 [Ipomoea batatas] Sweet potato mRNA for SPF1 protein, complet 611 G878 AFABF1 2.00E−56 [Avena fatua] A.fatua mRNA for DNA-binding protein (clone ABF 611 G878 LES303343 7.20E−55 [Lycopersicon esculentum] mRNA for hypothetical protein (ORF 611 G878 AX192164 4.00E−54 [Triticum aestivum] Sequence 11 from Patent WO0149840. 611 G878 AF080595 2.10E−53 [Pimpinella brachycarpa] zinc finger protein (ZFP1) mRNA, com 611 G878 PCU48831 2.30E−53 [Petroselinum crispum] DNA-binding protein WRKY1 mRNA, comple 611 G878 gi4322940 3.30E−128 [Nicotiana tabacum] DNA-binding protein 2. 611 G878 gi927025 1.10E−109 [Cucumis sativus] SPF1-like DNA-binding protein. 611 G878 gi6689916 1.50E−74 [Oryza sativa] zinc finger transcription factor WRKY1. 611 G878 gi484261 1.10E−66 [Ipomoea batatas] SPF1 protein. 611 G878 gi1159877 2.30E−63 [Avena fatua] DNA-binding protein. 611 G878 gi13620227 4.60E−63 [Lycopersicon esculentum] hypothetical protein. 611 G878 gi5917653 1.70E−56 [Petroselinum crispum] zinc-finger type transcription facto 611 G878 gi4894965 5.00E−56 [Avena sativa] DNA-binding protein WRKY1. 611 G878 gi3420906 8.70E−56 [Pimpinella brachycarpa] zinc finger protein; WRKY1. 611 G878 gi13620168 4.20E−22 [Capsella rubella] hypothetical protein. 47 G374 AP004457 1.20E−73 [Oryza sativa ( ) chromosome 8 clo (japonica cultivar-group)] 47 G374 AP004693 1.90E−73 [Oryza sativa] chromosome 8 clone P0461F06, ***SEQUENCING IN 47 G374 BH552835 1.30E−62 [Brassica oleracea] BOHGT56TR BOHG Brassica oleracea genomic 47 G374 BG128229 6.50E−55 [Lycopersicon esculentum] EST473875 tomato shoot/meristem Lyc 47 G374 BG646959 3.20E−46 [Medicago truncatula] EST508578 HOGA Medicago truncatula cDNA 47 G374 BG890162 8.70E−41 [Solanum tuberosum] EST516013 cSTD Solanum tuberosum cDNA clo 47 G374 AW179366 6.00E−38 [Zea mays] 618046G06.y1 618 - Inbred Tassel cDNA Library Zea 47 G374 BF473206 1.50E−32 [Triticum aestivum] WHE0922_G12_M24ZS Wheat 5-15 DAP spike cD 47 G374 AW761011 2.90E−29 [Glycine max] sl61g11.y1 Gm-c1027 Glycine max cDNA clone GENO 47 G374 AJ436050 1.50E−27 [Hordeum vulgare] AJ436050 S00007 Hordeum vulgare cDNA clone 47 G374 gi422012 0.8 [Sorghum bicolor] lipid transfer protein - sorghum (fragmen 47 G374 gi1827893 1 [Zea mays] Maize Nonspecific Lipid Transfer Protein Complex 

1. A transgenic plant comprising a recombinant polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding a polypeptide comprising a sequence selected from those of SEQ ID NOs: 860, 802, 240, 274, 558, 24, 1120, 44, 460, 286, 120, 130, 134, 698, 832, 580, 612, and 48, or a complementary nucleotide sequence thereof; (b) a nucleotide sequence of SEQ ID NOs: 859, 801, 239, 273, 557, 23, 1119, 43, 459, 285, 119, 129, 133, 697, 831, 579, 611, 47, or a complementary nucleotide sequence thereof; and (c) a nucleotide sequence that hybridizes under stringent conditions to a nucleotide sequence of one or more polynucleotides of: (a) or (b).
 2. The transgenic plant of claim 1 wherein the transgenic plant possesses an altered trait as compared to another plant, or the transgenic plant exhibits an altered phenotype as compared to another plant, or the transgenic plant expresses an altered level of one or more genes associated with a plant trait as compared to another plant, wherein the other plant does not comprise the recombinant polynucleotide.
 3. The transgenic plant of claim 1 wherein the plant possesses an altered trait as compared to another plant wherein the trait is an alteration in one or more physical characteristics selected from the group consisting of: the number of trichomes, fruit and seed size and number, yield of stems, leaves, inflorescences, or roots, stability of seeds during storage, susceptibility of the seed to shattering, root hair length and quantity, internode distances, or the quality of seed coat.
 4. The transgenic plant of claim 1 wherein the plant possesses an altered trait as compared to another plant wherein the trait is an alteration in a plant growth characteristic selected from the group consisting of: growth rate, germination rate of seeds vigor of plants and seedlings, leaf and flower senescence, male sterility, apomixis, flowering time, flower abscission, rate of nitrogen uptake, osmotic sensitivity to soluble sugar concentrations, biomass or transpiration characteristics, apical dominance, branching patterns, number of organs, organ identity, and organ shape or size.
 5. The transgenic plant of claim 1 wherein the plant possesses an altered trait as compared to another plant wherein the trait is an alteration in one or more characteristics selected from the group consisting of protein or oil production, seed protein or oil production, insoluble sugar level, soluble sugar level, and starch composition.
 6. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 860. 7. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 802. 8. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 240. 9. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 274. 10. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 558. 11. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 24. 12. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 1120. 13. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 44. 14. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 460. 15. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 286. 16. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 120. 17. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 130. 18. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 134. 19. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 698. 20. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 832. 21. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 580. 22. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 612. 23. The transgenic plant of claim 1, wherein the recombinant polynuclzotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 48. 24. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 859. 25. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 801. 26. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 239. 27. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 273. 28. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 557. 29. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 23. 30. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 1119. 31. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 43. 32. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 459. 33. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 285. 34. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 119. 35. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 129. 36. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 133. 37. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 697. 38. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 831. 39. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 579. 40. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 611. 41. The transgenic plant of claim 1, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 47. 42. The transgenic plant of claim 1, further comprising a constitutive, inducible, or tissue-specific promoter operably linked to said nucleotide sequence.
 43. The transgenic plant of claim 1, wherein the plant is selected from the group consisting of: soybean, wheat, corn, potato, cotton, rice, oilseed rape, sunflower, alfalfa, sugarcane, turf, banana, blackberry, blueberry, strawberry, raspberry, cantaloupe, carrot, cauliflower, coffee, cucumber, eggplant, grapes, honeydew, lettuce, mango, melon, onion, papaya, peas, peppers, pineapple, pumpkin, spinach, squash, sweet corn, tobacco, tomato, watermelon, mint and other labiates, rosaceous fruits, and vegetable brassicas.
 44. The transgenic plant of claim 1 wherein the encoded polypeptide is expressed and regulates transcription of a gene.
 45. A method of using the transgenic plant of claim 1 to grow a progeny plant from a parent plant, the method comprising crossing the transgenic plant with another plant, selecting seed, and growing the progeny plant from the seed.
 46. An isolated or recombinant polynucleotide comprising a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding a polypeptide comprising a sequence selected from SEQ ID NOs: 240, 274, 558, 286, 698, and 832, or a complementary nucleotide sequence thereof; (b) a nucleotide sequence of SEQ ID NOs: 239, 273, 557, 285, 697, 831, or a complementary nucleotide sequence thereof, and (c) a nucleotide sequence that hybridizes under stringent conditions to a nucleotide sequence of one or more of: (a) or (b).
 47. The isolated or recombinant polynucleotide of claim 46, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 240. 48. The isolated or recombinant polynucleotide of claim 46, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 274. 49. The isolated or recombinant polynucleotide of claim 46, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 558. 50. The isolated or recombinant polynucleotide of claim 46, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 286. 51. The isolated or recombinant polynucleotide of claim 46, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 698. 52. The isolated or recombinant polynucleotide of claim 46, wherein the recombinant polynucleotide comprises a nucleotide sequence encoding a polypeptide of SEQ ID NO:
 832. 53. The isolated or recombinant polynucleotide of claim 46, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 239. 54. The isolated or recombinant polynucleotide of claim 46, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 273. 55. The isolated or recombinant polynucleotide of claim 46, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 557. 56. The isolated or recombinant polynucleotide of claim 46, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 285. 57. The isolated or recombinant polynucleotide of claim 46, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 697. 58. The isolated or recombinant polynucleotide of claim 46, wherein the recombinant polynucleotide comprises a nucleotide sequence of SEQ ID NO:
 831. 59. The isolated or recombinant polynucleotide of claim 46, further comprising a constitutive, inducible, or tissue-specific promoter operably linked to the nucleotide sequence.
 60. The isolated or recombinant polynucleotide of claim 46 wherein the encoded polypeptide is expressed and regulates transcription of a gene.
 61. A vector comprising the isolated or recombinant polynucleotide of claim
 46. 62. A host cell comprising the vector of claim
 61. 63. A method of using the isolated or recombinant polynucleotide of claim 46 for producing a plant having a modified trait, the method comprising selecting a polynucleotide that encodes a polypeptide, inserting the polynucleotide into an expression vector, introducing the vector into a plant or a cell of a plant to overexpress the polypeptide, thereby producing a modified plant, and selecting for a modified trait.
 64. The method of claim 63 wherein the plant possesses a modified trait as compared to another plant wherein the trait is an alteration in one or more physical characteristics selected from the group consisting of: the number of trichomes, fruit and seed size and number, yield of stems, leaves, inflorescences, or roots, stability of seeds during storage, susceptibility of the seed to shattering, root hair length and quantity, internode distances, or the quality of seed coat.
 65. The method of claim 63 wherein the plant possesses a modified as compared to another plant wherein the trait is an alteration in a plant growth characteristic selected from the group consisting of: growth rate, germination rate of seeds, vigor of plants and seedlings, leaf and flower senescence, male sterility, apomixis, flowering time, flower abscission, rate of nitrogen uptake, osmotic sensitivity to soluble sugar concentrations, biomass or transpiration characteristics, apical dominance, branching patterns, number of organs, organ identity, and orgar shape or size.
 66. The method of claim 63 wherein the plant possesses a modified trait as compared to another plant wherein the trait is an alteration in one or more characteristics selected from the group consisting of protein or oil production, seed protein or oil production, insoluble sugar level, soluble sugar level, and starch composition.
 67. A modified plant produced by the method of claim
 63. 68. A method of using the plant of claim 67 to grow a progeny plant from a parent plant, the method comprising crossing the transgenic plant with another plant, selecting seed, and growing the progeny plant from the seed.
 69. The plant produced by the method of claim
 68. 